From 2f38cb0197dbfaaad68c41c9487ce24532d0e428 Mon Sep 17 00:00:00 2001 From: Adam Taylor Date: Tue, 29 Oct 2024 10:01:25 +0000 Subject: [PATCH] Add slots and enums --- src/htan_linkml/schema/htan_linkml.yaml | 10131 +++++++++++++++++++++- 1 file changed, 10124 insertions(+), 7 deletions(-) diff --git a/src/htan_linkml/schema/htan_linkml.yaml b/src/htan_linkml/schema/htan_linkml.yaml index 4325776..5778bd2 100644 --- a/src/htan_linkml/schema/htan_linkml.yaml +++ b/src/htan_linkml/schema/htan_linkml.yaml @@ -307,11 +307,10128 @@ classes: - crdc_id -slots: - - - - - enums: - \ No newline at end of file + CTAquisitionProtocolElement_exposureModulationType_Code_enum: + permissible_values: + ANGULAR: {} + ECG-BASED: {} + LONGITUDINAL: {} + NONE: {} + ORGAN-BASED: {} + MRImageAcquisitionProtocolElement_acquisitionContrastCode_enum: + permissible_values: + DIFFUSION: {} + FLOW_ENCODED_Flow Encoded contrast: {} + FLUID_ATTENUATED_Fluid Attenuated T2 weighted contrast: {} + PERFUSION_Perfusion weighted contrast: {} + PROTON_DENSITY_Proton Density weighted contrast: {} + STIR_Short Tau Inversion Recovery: {} + T1_T1 weighted contrast: {} + T2_STAR_T2* weighted contrast: {} + T2_T2 weighted contrast: {} + TAGGING_Superposition of thin saturation bands onto image: {} + TOF_Time Of Flight weighted contrast: {} + MRImageAcquisitionProtocolElement_diffusionDirectionalityCode_enum: + permissible_values: + BMATRIX: {} + DIRECTIONAL: {} + ISOTROPIC: {} + NONE: {} + MRImageAcquisitionProtocolElement_echoPulseSequenceCategoryCode_enum: + permissible_values: + BOTH: {} + GRADIENT: {} + SPIN: {} + MRImageAcquisitionProtocolElement_resonantNucleusCode_enum: + permissible_values: + 129XE: {} + 13C: {} + 19F: {} + 1H: {} + 23NA: {} + 31P: {} + 3HE: {} + 7LI: {} + MRImageAcquisitionProtocolElement_spectrallySelectedSuppressionCode_enum: + permissible_values: + FAT: {} + FAT AND WATER: {} + NONE: {} + SILICON GEL: {} + WATER: {} + MRImageAcquisitionProtocolElement_steadyStatePulseSequenceCode_enum: + permissible_values: + FREE PRECESSION: {} + LONGITUDINAL: {} + NONE: {} + TIME REVERSED: {} + TRANSVERSE: {} + MRImageReconstructionProtocolElement_complexImageComponentCode_enum: + permissible_values: + IMAGINARY: {} + MAGNITUDE: {} + PHASE: {} + REAL: {} + adult_or_childhood_study_enum: + permissible_values: + Adult - legal age: {} + Pediatric: {} + data_access_level_enum: + permissible_values: + controlled: {} + mixed: {} + open: {} + de_identification_method_type_enum: + permissible_values: + Automatic: {} + Manual: {} + Not applicable: {} + Semiautomatic: {} + disease_type_enum: + permissible_values: + Acinar Cell Neoplasms: {} + Adenomas and Adenocarcinomas: {} + Adnexal and Skin Appendage Neoplasms: {} + Basal Cell Neoplasms: {} + Blood Vessel Tumors: {} + Complex Mixed and Stromal Neoplasms: {} + Cystic, Mucinous and Serous Neoplasms: {} + Ductal and Lobular Neoplasms: {} + Epithelial Neoplasms, NOS: {} + Fibroepithelial Neoplasms: {} + Fibromatous Neoplasms: {} + Germ Cell Neoplasms: {} + Giant Cell Tumors: {} + Gliomas: {} + Granular Cell Tumors and Alveolar Soft Part Sarcomas: {} + Immunoproliferative Diseases: {} + Leukemias: {} + Lipomatous Neoplasms: {} + Lymphatic Vessel Tumors: {} + Mast Cell Neoplasm: {} + Meningiomas: {} + Mesothelial Neoplasms: {} + Miscellaneous Bone Tumors: {} + Miscellaneous Tumors: {} + Mucoepidermoid Neoplasms: {} + Myelodysplastic Syndromes: {} + Myomatous Neoplasms: {} + Myxomatous Neoplasms: {} + Neoplasms, NOS: {} + Nerve Sheath Tumors: {} + Neuroepitheliomatous Neoplasms: {} + Nevi and Melanomas: {} + Not Applicable: {} + Not Otherwise Specified: {} + Not Reported: {} + Odontogenic Tumors: {} + Osseous and Chondromatous Neoplasms: {} + Paragangliomas and Glomus Tumors: {} + Plasma Cell Neoplasm: {} + Soft Tissue Tumors and Sarcomas, NOS: {} + Squamous Cell Neoplasms: {} + Synovial-like Neoplasms: {} + Thymic Epithelial Neoplasms: {} + Transitional Cell Papillomas and Carcinomas: {} + Trophoblastic neoplasms: {} + Unknown: {} + embedding_medium_enum: + permissible_values: + Agar embedding: {} + Carbowax: {} + Celloidin media: {} + Epoxy Resin (Araldite): {} + Gelatin: {} + Methacrylate: {} + None: {} + Other: {} + Paraffin wax: {} + Unknown: {} + ethnicity_enum: + permissible_values: + Hispanic or Latino: {} + Not Hispanic or Latino: {} + Not allowed to collect: {} + Not reported: {} + Unknown: {} + file_access_enum: + permissible_values: + Controlled: {} + Not specified in data: {} + Open: {} + file_mapping_level_enum: + permissible_values: + Participiant: {} + Sample: {} + Study: {} + file_type_enum: + permissible_values: + BAI: {} + BAM: {} + BED: {} + BW: {} + CNS: {} + CRAI: {} + CRAM: {} + CSV: {} + DICT: {} + FASTQ: {} + GVCF: {} + HTML: {} + IDAT: {} + JSON: {} + MAF: {} + NIFTI: {} + PDF: {} + PED: {} + PNG: {} + SEG: {} + SVG: {} + TAR: {} + TIFF: {} + TSV: {} + TXT: {} + VCF: {} + XLSX: {} + gender_enum: + permissible_values: + Female: {} + Intersex: {} + Male: {} + Not Reported: {} + Unknown: {} + Unspecified: {} + image_modality_enum: + permissible_values: + AR: {} + BDUS: {} + BI: {} + BMD: {} + CFM: {} + CR: {} + CT: {} + DG: {} + DMS: {} + DX: {} + ECG: {} + EEG: {} + EMG: {} + EOG: {} + EPS: {} + ES: {} + GM: {} + HD: {} + IO: {} + IVOCT: {} + IVUS: {} + KER: {} + LEN: {} + LS: {} + MG: {} + MR: {} + NM: {} + Not specified in data: {} + OAM: {} + OCT: {} + OP: {} + OPM: {} + OPT: {} + OPTBSV: {} + OPTENF: {} + OPV: {} + OSS: {} + PA: {} + POS: {} + PT: {} + PX: {} + RESP: {} + RF: {} + RG: {} + RTIMAGE: {} + SM: {} + SRF: {} + TG: {} + US: {} + VA: {} + XA: {} + XC: {} + incidence_type_enum: + permissible_values: + metastasis: {} + no_disease: {} + primary: {} + progression: {} + recurrence: {} + remission: {} + index_date_enum: + permissible_values: + date_of_birth: {} + date_of_collection: {} + date_of_diagnosis: {} + date_of_enrollment: {} + instrument_model_enum: + permissible_values: + 454 GS: {} + 454 GS 20: {} + 454 GS FLX: {} + 454 GS FLX Titanium: {} + 454 GS FLX+: {} + 454 GS Junior: {} + AB 310 Genetic Analyzer: {} + AB 3130 Genetic Analyzer: {} + AB 3130xL Genetic Analyzer: {} + AB 3500 Genetic Analyzer: {} + AB 3500xL Genetic Analyzer: {} + AB 3730 Genetic Analyzer: {} + AB 3730xL Genetic Analyzer: {} + AB 5500 Genetic Analyzer: {} + AB 5500x-Wl Genetic Analyzer: {} + AB 5500xl Genetic Analyzer: {} + AB SOLiD 2: {} + AB SOLiD 3: {} + AB SOLiD 3 Plus System: {} + AB SOLiD 4: {} + AB SOLiD 4hq System: {} + AB SOLiD PI System: {} + AB SOLiD System: {} + BGISEQ-500: {} + Complete Genomics: {} + DNBSEQ-G400: {} + DNBSEQ-G50: {} + DNBSEQ-T7: {} + GridION: {} + Helicos HeliScope: {} + Illumina Genome Analyzer: {} + Illumina Genome Analyzer II: {} + Illumina Genome Analyzer IIx: {} + Illumina HiScanSQ: {} + Illumina HiSeq 1000: {} + Illumina HiSeq 1500: {} + Illumina HiSeq 2000: {} + Illumina HiSeq 2500: {} + Illumina HiSeq 3000: {} + Illumina HiSeq 4000: {} + Illumina HiSeq X Five: {} + Illumina HiSeq X Ten: {} + Illumina MiSeq: {} + Illumina MiniSeq: {} + Illumina NextSeq: {} + Illumina NextSeq 2500: {} + Illumina NextSeq 500: {} + Illumina NextSeq 550: {} + Illumina NovaSeq: {} + Illumina NovaSeq 6000: {} + Illumina iSeq 100: {} + Ion Torrent PGM: {} + Ion Torrent Proton: {} + Ion Torrent S5: {} + Ion Torrent S5 XL: {} + MGISEQ-2000RS: {} + MinION: {} + Not Reported: {} + Other: {} + PacBio RS: {} + PacBio RS II: {} + PacBio Sequel: {} + PacBio Sequel II: {} + PromethION: {} + Ultima Genomics UG100: {} + Unknown: {} + last_known_disease_status_enum: + permissible_values: + Biochemical evidence of disease without structural correlate: {} + Distant met recurrence/progression: {} + Loco-regional recurrence/progression: {} + Metastasis: {} + No_disease: {} + Primary: {} + Progression: {} + Recurrence: {} + Remission: {} + Tumor free: {} + library_layout_enum: + permissible_values: + Paired-End: {} + Single-indexed: {} + library_selection_enum: + permissible_values: + 5-methylcytidine antibody: {} + Affinity Enrichment: {} + CAGE: {} + CF-H: {} + CF-M: {} + CF-S: {} + CF-T: {} + ChIP: {} + DNAse: {} + HMPR: {} + Hybrid Selection: {} + Inverse rRNA: {} + MBD2 protein methyl-CpG binding domain: {} + MDA: {} + MF: {} + MNase: {} + MSLL: {} + Not applicable: {} + Other: {} + PCR: {} + Padlock probes capture method: {} + Poly-A Enriched Genomic Library: {} + RACE: {} + RT-PCR: {} + Random: {} + Random PCR: {} + Reduced Representation: {} + Repeat fractionation: {} + Restriction Digest: {} + Size fractionation: {} + Unspecified: {} + cDNA: {} + cDNA oligo_dT: {} + cDNA random priming: {} + miRNA Size Fractionation: {} + rRNA Depletion: {} + library_source_enum: + permissible_values: + Bulk Whole Cell: {} + Genomic: {} + Genomic Single Cell: {} + Metagenomic: {} + Metatranscriptomic: {} + Other: {} + Single Cell: {} + Single Nucleus: {} + Synthetic: {} + Transcriptomic: {} + Transcriptomic Single Cell: {} + Viral RNA: {} + library_source_material_enum: + permissible_values: + Bulk Cells: {} + Bulk Nuclei: {} + Bulk Tissue: {} + Not Reported: {} + Single-cells: {} + Single-nuclei: {} + library_source_molecule_enum: + permissible_values: + Genomic: {} + Metagenomic: {} + Metatranscriptomic: {} + Not Reported: {} + Transcriptomic: {} + Viral RNA: {} + library_strategy_enum: + permissible_values: + AMPLICON: {} + ATAC-Seq: {} + Bisulfite-Seq: {} + CLONE: {} + CLONEEND: {} + CTS: {} + ChIA-PET: {} + ChIP-Seq: {} + DNA-Seq: {} + DNase-Hypersensitivity: {} + EST: {} + FAIRE-seq: {} + FINISHING: {} + FL-cDNA: {} + Hi-C: {} + MBD-Seq: {} + MNase-Seq: {} + MRE-Seq: {} + MeDIP-Seq: {} + Other: {} + POOLCLONE: {} + RAD-Seq: {} + RIP-Seq: {} + RNA-Seq: {} + SELEX: {} + Spatial-tx: {} + Synthetic-Long-Read: {} + Targeted-Capture: {} + Tethered Chromatin Conformation Capture: {} + Tn-Seq: {} + WCS: {} + WGA: {} + WGS: {} + WXS: {} + miRNA-Seq: {} + ncRNA-Seq: {} + scMultiome: {} + snATAC-Seq: {} + ssRNA-seq: {} + license_enum: + permissible_values: + CC BY 3.0 http://creativecommons.org/licenses/by/3.0/: {} + CC BY 4.0 https://creativecommons.org/licenses/by/4.0/: {} + CC BY-NC 3.0 https://creativecommons.org/licenses/by-nc/3.0/: {} + CC BY-NC 4.0 https://creativecommons.org/licenses/by-nc/4.0/: {} + Other: {} + morphology_enum: + permissible_values: + 8000/0: {} + 8000/1: {} + 8000/3: {} + 8000/6: {} + 8000/9: {} + 8001/0: {} + 8001/1: {} + 8001/3: {} + 8002/3: {} + 8003/3: {} + 8004/3: {} + 8005/0: {} + 8005/3: {} + 8010/0: {} + 8010/2: {} + 8010/3: {} + 8010/6: {} + 8010/9: {} + 8011/0: {} + 8011/3: {} + 8012/3: {} + 8013/3: {} + 8014/3: {} + 8015/3: {} + 8020/3: {} + 8020/6: {} + 8021/3: {} + 8022/3: {} + 8023/3: {} + 8030/3: {} + 8031/3: {} + 8032/3: {} + 8033/3: {} + 8034/3: {} + 8035/3: {} + 8040/0: {} + 8040/1: {} + 8040/3: {} + 8041/3: {} + 8041/34: {} + 8041/6: {} + 8042/3: {} + 8043/3: {} + 8044/3: {} + 8045/3: {} + 8046/3: {} + 8046/6: {} + 8050/0: {} + 8050/2: {} + 8050/3: {} + 8051/0: {} + 8051/3: {} + 8052/0: {} + 8052/2: {} + 8052/3: {} + 8053/0: {} + 8060/0: {} + 8070/2: {} + 8070/3: {} + 8070/33: {} + 8070/6: {} + 8071/2: {} + 8071/3: {} + 8072/3: {} + 8073/3: {} + 8074/3: {} + 8075/3: {} + 8076/2: {} + 8076/3: {} + 8077/0: {} + 8077/2: {} + 8078/3: {} + 8080/2: {} + 8081/2: {} + 8082/3: {} + 8083/3: {} + 8084/3: {} + 8085/3: {} + 8086/3: {} + 8090/1: {} + 8090/3: {} + 8091/3: {} + 8092/3: {} + 8093/3: {} + 8094/3: {} + 8095/3: {} + 8096/0: {} + 8097/3: {} + 8098/3: {} + 8100/0: {} + 8101/0: {} + 8102/0: {} + 8102/3: {} + 8103/0: {} + 8110/0: {} + 8110/3: {} + 8120/0: {} + 8120/1: {} + 8120/2: {} + 8120/3: {} + 8121/0: {} + 8121/1: {} + 8121/3: {} + 8122/3: {} + 8123/3: {} + 8124/3: {} + 8130/1: {} + 8130/2: {} + 8130/3: {} + 8131/3: {} + 8140/0: {} + 8140/1: {} + 8140/2: {} + 8140/3: {} + 8140/33: {} + 8140/6: {} + 8141/3: {} + 8142/3: {} + 8143/3: {} + 8144/3: {} + 8145/3: {} + 8146/0: {} + 8147/0: {} + 8147/3: {} + 8148/0: {} + 8148/2: {} + 8149/0: {} + 8150/0: {} + 8150/1: {} + 8150/3: {} + 8151/0: {} + 8151/3: {} + 8152/1: {} + 8152/3: {} + 8153/1: {} + 8153/3: {} + 8154/3: {} + 8155/1: {} + 8155/3: {} + 8156/1: {} + 8156/3: {} + 8158/1: {} + 8160/0: {} + 8160/3: {} + 8161/0: {} + 8161/3: {} + 8162/3: {} + 8163/0: {} + 8163/2: {} + 8163/3: {} + 8170/0: {} + 8170/3: {} + 8171/3: {} + 8172/3: {} + 8173/3: {} + 8174/3: {} + 8175/3: {} + 8180/3: {} + 8190/0: {} + 8190/3: {} + 8191/0: {} + 8200/0: {} + 8200/3: {} + 8201/2: {} + 8201/3: {} + 8202/0: {} + 8204/0: {} + 8210/0: {} + 8210/2: {} + 8210/3: {} + 8211/0: {} + 8211/3: {} + 8212/0: {} + 8213/0: {} + 8213/3: {} + 8214/3: {} + 8215/3: {} + 8220/0: {} + 8220/3: {} + 8221/0: {} + 8221/3: {} + 8230/2: {} + 8230/3: {} + 8231/3: {} + 8240/1: {} + 8240/3: {} + 8240/6: {} + 8241/3: {} + 8242/1: {} + 8242/3: {} + 8243/3: {} + 8244/3: {} + 8245/1: {} + 8245/3: {} + 8246/3: {} + 8246/6: {} + 8247/3: {} + 8248/1: {} + 8249/3: {} + 8249/6: {} + 8250/1: {} + 8250/2: {} + 8250/3: {} + 8251/0: {} + 8251/3: {} + 8252/3: {} + 8253/3: {} + 8254/3: {} + 8255/3: {} + 8256/3: {} + 8257/3: {} + 8260/0: {} + 8260/3: {} + 8261/0: {} + 8261/2: {} + 8261/3: {} + 8262/3: {} + 8263/0: {} + 8263/2: {} + 8263/3: {} + 8264/0: {} + 8265/3: {} + 8270/0: {} + 8270/3: {} + 8271/0: {} + 8272/0: {} + 8272/3: {} + 8280/0: {} + 8280/3: {} + 8281/0: {} + 8281/3: {} + 8290/0: {} + 8290/3: {} + 8300/0: {} + 8300/3: {} + 8310/0: {} + 8310/3: {} + 8310/6: {} + 8311/1: {} + 8311/3: {} + 8311/6: {} + 8312/3: {} + 8313/0: {} + 8313/1: {} + 8313/3: {} + 8314/3: {} + 8315/3: {} + 8316/3: {} + 8317/3: {} + 8318/3: {} + 8319/3: {} + 8320/3: {} + 8321/0: {} + 8322/0: {} + 8322/3: {} + 8323/0: {} + 8323/3: {} + 8324/0: {} + 8325/0: {} + 8330/0: {} + 8330/1: {} + 8330/3: {} + 8331/3: {} + 8332/3: {} + 8333/0: {} + 8333/3: {} + 8334/0: {} + 8335/3: {} + 8336/0: {} + 8337/3: {} + 8339/3: {} + 8340/3: {} + 8341/3: {} + 8342/3: {} + 8343/2: {} + 8343/3: {} + 8344/3: {} + 8345/3: {} + 8346/3: {} + 8347/3: {} + 8350/3: {} + 8360/1: {} + 8361/0: {} + 8370/0: {} + 8370/1: {} + 8370/3: {} + 8371/0: {} + 8372/0: {} + 8373/0: {} + 8374/0: {} + 8375/0: {} + 8380/0: {} + 8380/1: {} + 8380/2: {} + 8380/3: {} + 8380/6: {} + 8381/0: {} + 8381/1: {} + 8381/3: {} + 8382/3: {} + 8383/3: {} + 8384/3: {} + 8390/0: {} + 8390/3: {} + 8391/0: {} + 8392/0: {} + 8400/0: {} + 8400/1: {} + 8400/3: {} + 8401/0: {} + 8401/3: {} + 8402/0: {} + 8402/3: {} + 8403/0: {} + 8403/3: {} + 8404/0: {} + 8405/0: {} + 8406/0: {} + 8407/0: {} + 8407/3: {} + 8408/0: {} + 8408/1: {} + 8408/3: {} + 8409/0: {} + 8409/3: {} + 8410/0: {} + 8410/3: {} + 8413/3: {} + 8420/0: {} + 8420/3: {} + 8430/1: {} + 8430/3: {} + 8440/0: {} + 8440/3: {} + 8441/0: {} + 8441/2: {} + 8441/3: {} + 8441/6: {} + 8442/1: {} + 8443/0: {} + 8444/1: {} + 8450/0: {} + 8450/3: {} + 8451/1: {} + 8452/1: {} + 8452/3: {} + 8453/0: {} + 8453/2: {} + 8453/3: {} + 8454/0: {} + 8460/0: {} + 8460/2: {} + 8460/3: {} + 8461/0: {} + 8461/3: {} + 8461/6: {} + 8462/1: {} + 8463/1: {} + 8470/0: {} + 8470/2: {} + 8470/3: {} + 8471/0: {} + 8471/1: {} + 8471/3: {} + 8472/1: {} + 8473/1: {} + 8474/1: {} + 8474/3: {} + 8480/0: {} + 8480/1: {} + 8480/3: {} + 8480/6: {} + 8481/3: {} + 8482/3: {} + 8482/6: {} + 8490/3: {} + 8490/6: {} + 8500/2: {} + 8500/3: {} + 8500/6: {} + 8501/2: {} + 8501/3: {} + 8502/3: {} + 8503/0: {} + 8503/2: {} + 8503/3: {} + 8504/0: {} + 8504/2: {} + 8504/3: {} + 8505/0: {} + 8506/0: {} + 8507/2: {} + 8507/3: {} + 8508/3: {} + 8509/2: {} + 8509/3: {} + 8510/3: {} + 8512/3: {} + 8513/3: {} + 8514/3: {} + 8519/2: {} + 8520/2: {} + 8520/3: {} + 8521/1: {} + 8521/3: {} + 8522/1: {} + 8522/2: {} + 8522/3: {} + 8522/6: {} + 8523/3: {} + 8524/3: {} + 8525/3: {} + 8530/3: {} + 8540/3: {} + 8541/3: {} + 8542/3: {} + 8543/3: {} + 8550/0: {} + 8550/1: {} + 8550/3: {} + 8551/3: {} + 8552/3: {} + 8560/0: {} + 8560/3: {} + 8561/0: {} + 8562/3: {} + 8570/3: {} + 8571/3: {} + 8572/3: {} + 8573/3: {} + 8574/3: {} + 8575/3: {} + 8576/3: {} + 8580/0: {} + 8580/1: {} + 8580/3: {} + 8581/1: {} + 8581/3: {} + 8582/1: {} + 8582/3: {} + 8583/1: {} + 8583/3: {} + 8584/1: {} + 8584/3: {} + 8585/1: {} + 8585/3: {} + 8586/3: {} + 8587/0: {} + 8588/3: {} + 8589/3: {} + 8590/1: {} + 8591/1: {} + 8592/1: {} + 8593/1: {} + 8594/1: {} + 8600/0: {} + 8600/3: {} + 8601/0: {} + 8602/0: {} + 8610/0: {} + 8620/1: {} + 8620/3: {} + 8621/1: {} + 8622/1: {} + 8623/1: {} + 8630/0: {} + 8630/1: {} + 8630/3: {} + 8631/0: {} + 8631/1: {} + 8631/3: {} + 8632/1: {} + 8633/1: {} + 8634/1: {} + 8634/3: {} + 8640/1: {} + 8640/3: {} + 8641/0: {} + 8642/1: {} + 8650/0: {} + 8650/1: {} + 8650/3: {} + 8660/0: {} + 8670/0: {} + 8670/3: {} + 8671/0: {} + 8680/0: {} + 8680/1: {} + 8680/3: {} + 8681/1: {} + 8682/1: {} + 8683/0: {} + 8690/1: {} + 8691/1: {} + 8692/1: {} + 8693/1: {} + 8693/3: {} + 8700/0: {} + 8700/3: {} + 8710/3: {} + 8711/0: {} + 8711/3: {} + 8712/0: {} + 8713/0: {} + 8714/3: {} + 8720/0: {} + 8720/2: {} + 8720/3: {} + 8720/6: {} + 8721/3: {} + 8722/0: {} + 8722/3: {} + 8723/0: {} + 8723/3: {} + 8725/0: {} + 8726/0: {} + 8727/0: {} + 8728/0: {} + 8728/1: {} + 8728/3: {} + 8730/0: {} + 8730/3: {} + 8740/0: {} + 8740/3: {} + 8741/2: {} + 8741/3: {} + 8742/2: {} + 8742/3: {} + 8743/3: {} + 8744/3: {} + 8745/3: {} + 8746/3: {} + 8750/0: {} + 8760/0: {} + 8761/0: {} + 8761/1: {} + 8761/3: {} + 8762/1: {} + 8770/0: {} + 8770/3: {} + 8771/0: {} + 8771/3: {} + 8772/0: {} + 8772/3: {} + 8773/3: {} + 8774/3: {} + 8780/0: {} + 8780/3: {} + 8790/0: {} + 8800/0: {} + 8800/3: {} + 8800/6: {} + 8800/9: {} + 8801/3: {} + 8801/6: {} + 8802/3: {} + 8803/3: {} + 8804/3: {} + 8804/6: {} + 8805/3: {} + 8806/3: {} + 8806/6: {} + 8810/0: {} + 8810/1: {} + 8810/3: {} + 8811/0: {} + 8811/1: {} + 8811/3: {} + 8812/0: {} + 8812/3: {} + 8813/0: {} + 8813/3: {} + 8814/3: {} + 8815/0: {} + 8815/1: {} + 8815/3: {} + 8820/0: {} + 8821/1: {} + 8822/1: {} + 8823/0: {} + 8824/0: {} + 8824/1: {} + 8825/0: {} + 8825/1: {} + 8825/3: {} + 8826/0: {} + 8827/1: {} + 8830/0: {} + 8830/1: {} + 8830/3: {} + 8831/0: {} + 8832/0: {} + 8832/3: {} + 8833/3: {} + 8834/1: {} + 8835/1: {} + 8836/1: {} + 8840/0: {} + 8840/3: {} + 8841/1: {} + 8842/0: {} + 8842/3: {} + 8850/0: {} + 8850/1: {} + 8850/3: {} + 8851/0: {} + 8851/3: {} + 8852/0: {} + 8852/3: {} + 8853/3: {} + 8854/0: {} + 8854/3: {} + 8855/3: {} + 8856/0: {} + 8857/0: {} + 8857/3: {} + 8858/3: {} + 8860/0: {} + 8861/0: {} + 8862/0: {} + 8870/0: {} + 8880/0: {} + 8881/0: {} + 8890/0: {} + 8890/1: {} + 8890/3: {} + 8891/0: {} + 8891/3: {} + 8892/0: {} + 8893/0: {} + 8894/0: {} + 8894/3: {} + 8895/0: {} + 8895/3: {} + 8896/3: {} + 8897/1: {} + 8898/1: {} + 8900/0: {} + 8900/3: {} + 8901/3: {} + 8902/3: {} + 8903/0: {} + 8904/0: {} + 8905/0: {} + 8910/3: {} + 8912/3: {} + 8920/3: {} + 8920/6: {} + 8921/3: {} + 8930/0: {} + 8930/3: {} + 8931/3: {} + 8932/0: {} + 8933/3: {} + 8934/3: {} + 8935/0: {} + 8935/1: {} + 8935/3: {} + 8936/0: {} + 8936/1: {} + 8936/3: {} + 8940/0: {} + 8940/3: {} + 8941/3: {} + 8950/3: {} + 8950/6: {} + 8951/3: {} + 8959/0: {} + 8959/1: {} + 8959/3: {} + 8960/1: {} + 8960/3: {} + 8963/3: {} + 8964/3: {} + 8965/0: {} + 8966/0: {} + 8967/0: {} + 8970/3: {} + 8971/3: {} + 8972/3: {} + 8973/3: {} + 8974/1: {} + 8975/1: {} + 8980/3: {} + 8981/3: {} + 8982/0: {} + 8982/3: {} + 8983/0: {} + 8983/3: {} + 8990/0: {} + 8990/1: {} + 8990/3: {} + 8991/3: {} + 9000/0: {} + 9000/1: {} + 9000/3: {} + 9010/0: {} + 9011/0: {} + 9012/0: {} + 9013/0: {} + 9014/0: {} + 9014/1: {} + 9014/3: {} + 9015/0: {} + 9015/1: {} + 9015/3: {} + 9016/0: {} + 9020/0: {} + 9020/1: {} + 9020/3: {} + 9030/0: {} + 9040/0: {} + 9040/3: {} + 9041/3: {} + 9042/3: {} + 9043/3: {} + 9044/3: {} + 9045/3: {} + 9050/0: {} + 9050/3: {} + 9051/0: {} + 9051/3: {} + 9052/0: {} + 9052/3: {} + 9053/3: {} + 9054/0: {} + 9055/0: {} + 9055/1: {} + 9060/3: {} + 9061/3: {} + 9062/3: {} + 9063/3: {} + 9064/2: {} + 9064/3: {} + 9065/3: {} + 9070/3: {} + 9071/3: {} + 9072/3: {} + 9073/1: {} + 9080/0: {} + 9080/1: {} + 9080/3: {} + 9081/3: {} + 9082/3: {} + 9083/3: {} + 9084/0: {} + 9084/3: {} + 9085/3: {} + 9086/3: {} + 9090/0: {} + 9090/3: {} + 9091/1: {} + 9100/0: {} + 9100/1: {} + 9100/3: {} + 9101/3: {} + 9102/3: {} + 9103/0: {} + 9104/1: {} + 9105/3: {} + 9110/0: {} + 9110/1: {} + 9110/3: {} + 9120/0: {} + 9120/3: {} + 9121/0: {} + 9122/0: {} + 9123/0: {} + 9124/3: {} + 9125/0: {} + 9130/0: {} + 9130/1: {} + 9130/3: {} + 9131/0: {} + 9132/0: {} + 9133/1: {} + 9133/3: {} + 9135/1: {} + 9136/1: {} + 9137/3: {} + 9140/3: {} + 9141/0: {} + 9142/0: {} + 9150/0: {} + 9150/1: {} + 9150/3: {} + 9160/0: {} + 9161/0: {} + 9161/1: {} + 9170/0: {} + 9170/3: {} + 9171/0: {} + 9172/0: {} + 9173/0: {} + 9174/0: {} + 9174/1: {} + 9175/0: {} + 9180/0: {} + 9180/3: {} + 9180/6: {} + 9181/3: {} + 9182/3: {} + 9183/3: {} + 9184/3: {} + 9185/3: {} + 9186/3: {} + 9187/3: {} + 9191/0: {} + 9192/3: {} + 9193/3: {} + 9194/3: {} + 9195/3: {} + 9200/0: {} + 9200/1: {} + 9210/0: {} + 9210/1: {} + 9220/0: {} + 9220/1: {} + 9220/3: {} + 9221/0: {} + 9221/3: {} + 9230/0: {} + 9230/3: {} + 9231/3: {} + 9240/3: {} + 9241/0: {} + 9242/3: {} + 9243/3: {} + 9250/1: {} + 9250/3: {} + 9251/1: {} + 9251/3: {} + 9252/0: {} + 9252/3: {} + 9260/3: {} + 9261/3: {} + 9262/0: {} + 9270/0: {} + 9270/1: {} + 9270/3: {} + 9271/0: {} + 9272/0: {} + 9273/0: {} + 9274/0: {} + 9275/0: {} + 9280/0: {} + 9281/0: {} + 9282/0: {} + 9290/0: {} + 9290/3: {} + 9300/0: {} + 9301/0: {} + 9302/0: {} + 9302/3: {} + 9310/0: {} + 9310/3: {} + 9311/0: {} + 9312/0: {} + 9320/0: {} + 9321/0: {} + 9322/0: {} + 9330/0: {} + 9330/3: {} + 9340/0: {} + 9341/1: {} + 9341/3: {} + 9342/3: {} + 9350/1: {} + 9351/1: {} + 9352/1: {} + 9360/1: {} + 9361/1: {} + 9362/3: {} + 9363/0: {} + 9364/3: {} + 9365/3: {} + 9370/3: {} + 9371/3: {} + 9372/3: {} + 9373/0: {} + 9380/3: {} + 9381/3: {} + 9382/3: {} + 9383/1: {} + 9384/1: {} + 9385/3: {} + 9390/0: {} + 9390/1: {} + 9390/3: {} + 9391/3: {} + 9392/3: {} + 9393/3: {} + 9394/1: {} + 9395/3: {} + 9396/3: {} + 9400/3: {} + 9401/3: {} + 9410/3: {} + 9411/3: {} + 9412/1: {} + 9413/0: {} + 9420/3: {} + 9421/1: {} + 9423/3: {} + 9424/3: {} + 9425/3: {} + 9430/3: {} + 9431/1: {} + 9432/1: {} + 9440/3: {} + 9440/6: {} + 9441/3: {} + 9442/1: {} + 9442/3: {} + 9444/1: {} + 9445/3: {} + 9450/3: {} + 9451/3: {} + 9460/3: {} + 9470/3: {} + 9471/3: {} + 9472/3: {} + 9473/3: {} + 9474/3: {} + 9475/3: {} + 9476/3: {} + 9477/3: {} + 9478/3: {} + 9480/3: {} + 9490/0: {} + 9490/3: {} + 9491/0: {} + 9492/0: {} + 9493/0: {} + 9500/3: {} + 9501/0: {} + 9501/3: {} + 9502/0: {} + 9502/3: {} + 9503/3: {} + 9504/3: {} + 9505/1: {} + 9505/3: {} + 9506/1: {} + 9507/0: {} + 9508/3: {} + 9509/1: {} + 9510/0: {} + 9510/3: {} + 9511/3: {} + 9512/3: {} + 9513/3: {} + 9514/1: {} + 9520/3: {} + 9521/3: {} + 9522/3: {} + 9523/3: {} + 9530/0: {} + 9530/1: {} + 9530/3: {} + 9531/0: {} + 9532/0: {} + 9533/0: {} + 9534/0: {} + 9535/0: {} + 9537/0: {} + 9538/1: {} + 9538/3: {} + 9539/1: {} + 9539/3: {} + 9540/0: {} + 9540/1: {} + 9540/3: {} + 9541/0: {} + 9542/3: {} + 9550/0: {} + 9560/0: {} + 9560/1: {} + 9560/3: {} + 9561/3: {} + 9562/0: {} + 9570/0: {} + 9571/0: {} + 9571/3: {} + 9580/0: {} + 9580/3: {} + 9581/3: {} + 9582/0: {} + 9590/3: {} + 9591/3: {} + 9596/3: {} + 9597/3: {} + 9650/3: {} + 9651/3: {} + 9652/3: {} + 9653/3: {} + 9654/3: {} + 9655/3: {} + 9659/3: {} + 9661/3: {} + 9662/3: {} + 9663/3: {} + 9664/3: {} + 9665/3: {} + 9667/3: {} + 9670/3: {} + 9671/3: {} + 9673/3: {} + 9675/3: {} + 9678/3: {} + 9679/3: {} + 9680/3: {} + 9684/3: {} + 9687/3: {} + 9688/3: {} + 9689/3: {} + 9690/3: {} + 9691/3: {} + 9695/3: {} + 9698/3: {} + 9699/3: {} + 9700/3: {} + 9701/3: {} + 9702/3: {} + 9705/3: {} + 9708/3: {} + 9709/3: {} + 9712/3: {} + 9714/3: {} + 9716/3: {} + 9717/3: {} + 9718/3: {} + 9719/3: {} + 9724/3: {} + 9725/3: {} + 9726/3: {} + 9727/3: {} + 9728/3: {} + 9729/3: {} + 9731/3: {} + 9732/3: {} + 9733/3: {} + 9734/3: {} + 9735/3: {} + 9737/3: {} + 9738/3: {} + 9740/1: {} + 9740/3: {} + 9741/1: {} + 9741/3: {} + 9742/3: {} + 9750/3: {} + 9751/1: {} + 9751/3: {} + 9752/1: {} + 9753/1: {} + 9754/3: {} + 9755/3: {} + 9756/3: {} + 9757/3: {} + 9758/3: {} + 9759/3: {} + 9760/3: {} + 9761/3: {} + 9762/3: {} + 9764/3: {} + 9765/1: {} + 9766/1: {} + 9767/1: {} + 9768/1: {} + 9769/1: {} + 9800/3: {} + 9801/3: {} + 9805/3: {} + 9806/3: {} + 9807/3: {} + 9808/3: {} + 9809/3: {} + 9811/3: {} + 9812/3: {} + 9813/3: {} + 9814/3: {} + 9815/3: {} + 9816/3: {} + 9817/3: {} + 9818/3: {} + 9820/3: {} + 9823/3: {} + 9826/3: {} + 9827/3: {} + 9831/3: {} + 9832/3: {} + 9833/3: {} + 9834/3: {} + 9835/3: {} + 9836/3: {} + 9837/3: {} + 9840/3: {} + 9860/3: {} + 9861/3: {} + 9863/3: {} + 9865/3: {} + 9866/3: {} + 9867/3: {} + 9869/3: {} + 9870/3: {} + 9871/3: {} + 9872/3: {} + 9873/3: {} + 9874/3: {} + 9875/3: {} + 9876/3: {} + 9891/3: {} + 9895/3: {} + 9896/3: {} + 9897/3: {} + 9898/1: {} + 9898/3: {} + 9910/3: {} + 9911/3: {} + 9920/3: {} + 9930/3: {} + 9931/3: {} + 9940/3: {} + 9945/3: {} + 9946/3: {} + 9948/3: {} + 9950/3: {} + 9960/3: {} + 9961/3: {} + 9962/3: {} + 9963/3: {} + 9964/3: {} + 9965/3: {} + 9966/3: {} + 9967/3: {} + 9970/1: {} + 9971/1: {} + 9971/3: {} + 9975/3: {} + 9980/3: {} + 9982/3: {} + 9983/3: {} + 9984/3: {} + 9985/3: {} + 9986/3: {} + 9987/3: {} + 9989/3: {} + 9991/3: {} + 9992/3: {} + Not Reported: {} + Unknown: {} + performed_imaging_study_bodyPositionCode_enum: + permissible_values: + Standing: {} + Supine: {} + Trendelenburg: {} + performed_imaging_study_cardiacSynchronizationTechniqueCode_enum: + permissible_values: + NONE: {} + PACED: {} + PROSPECTIVE: {} + REALTIME: {} + RETROSPECTIVE: {} + performed_imaging_study_lossyImageCompressionIndicator_enum: + permissible_values: + '0': {} + '1': {} + performed_imaging_study_respiratoryMotionTechniqueCode_enum: + permissible_values: + BREATH-HOLD: {} + CORRECTION: {} + GATING: {} + NONE: {} + REALTIME: {} + RETROSPECTIVE: {} + TRACKING: {} + platform_enum: + permissible_values: + ABI Solid: {} + BGISEQ: {} + Capillary: {} + Complete Genomics: {} + Helicos: {} + Illumina: {} + Ion Torrent: {} + LS 454: {} + Oxford Nanopore: {} + PacBio SMRT: {} + Ultima: {} + primary_diagnosis_enum: + permissible_values: + Abdominal Fibromatosis: {} + Acinar Cell Carcinoma: {} + Acral Lentiginous Melanoma, Malignant: {} + Acute Erythroid Leukemia: {} + Acute Leukemia, NOS: {} + Acute Lymphoblastic Leukemia: {} + Acute Megakaryoblastic Leukemia: {} + Acute Monoblastic And Monocytic Leukemia: {} + Acute Monoblastic Leukemia: {} + Acute Monocytic Leukemia: {} + Acute Myeloid Leukemia (Megakaryoblastic) With T(1;22)(P13;Q13); RBM15-MKL1: {} + Acute Myeloid Leukemia With Abnormal Marrow Eosinophils: {} + Acute Myeloid Leukemia With Mutated CEBPA: {} + Acute Myeloid Leukemia With Mutated NPM1: {} + Acute Myeloid Leukemia With Myelodysplasia-Related Changes: {} + Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Juvenile Myelomonocytic Leukemia, NOS: {} + Acute Myeloid Leukemia With T(9;11)(P22;Q23); MLLT3-MLL: {} + Acute Myeloid Leukemia Without Maturation: {} + Acute Myeloid Leukemia, Inv(16)(P13;Q22): {} + Acute Myeloid Leukemia, Minimal Differentiation: {} + Acute Myeloid Leukemia, NOS: {} + Acute Myeloid Leukemia, NOS, Juvenile Myelomonocytic Leukemia, NOS: {} + Acute Myeloid Leukemia, NOS, Myeloproliferative Neoplasm, Unclassifiable: {} + Acute Myeloid Leukemia, T(16;16)(P 13;Q 11): {} + Acute Myeloid Leukemia, T(8;21)(Q22;Q22): {} + Acute Myelomonocytic Leukemia: {} + Acute Myelomonocytic Leukemia, NOS: {} + Acute Promyelocytic Leukaemia, T(15;17)(Q22;Q11-12): {} + Acute Promyelocytic Leukemia, T(15;17)(Q22;Q11-12): {} + Adamantinomatous Craniopharyngioma: {} + Adamantinomatous Craniopharyngioma (CNS WHO Grade 1): {} + Adamantinomatous Craniopharyngioma, CNS WHO Grade 1: {} + Adamantinomatous Craniopharyngioma, WHO Grade 1: {} + Adenocarcinoma: {} + Adenocarcinoma Combined With Other Types Of Carcinoma: {} + Adenocarcinoma In Adenomatous Polyposis Coli: {} + Adenocarcinoma In Situ In Adenomatous Polyp: {} + Adenocarcinoma In Situ, NOS: {} + Adenocarcinoma In Situ, Non-Mucinous: {} + Adenocarcinoma In Villous Adenoma: {} + Adenocarcinoma With Mixed Subtypes: {} + Adenocarcinoma With Neuroendocrine Differentiation: {} + Adenocarcinoma, Endocervical Type: {} + Adenocarcinoma, Intestinal Type: {} + Adenocarcinoma, Metastatic NOS: {} + Adenocarcinoma, NOS: {} + Adenocarcinoma, Pancreatobiliary Type: {} + Adenocarcinoma, Pancreatobiliary Type, Pancreatobiliary-Type Carcinoma: {} + Adenocarcinoma,NOS, Glioblastoma, NOS: {} + Adenoid Cystic Carcinoma: {} + Adenoma: {} + Adenoma, NOS: {} + Adenosarcoma: {} + Adenosquamous Carcinoma: {} + Adrenal Cortical Adenoma, NOS: {} + Adrenal Cortical Carcinoma: {} + Adrenal Cortical Tumor, NOS: {} + Adult Granulosa Cell Tumor Of Testis: {} + Aggressive Fibromatosis: {} + Alveolar Rhabdomyosarcoma: {} + Alveolar Soft Part Sarcoma: {} + Amelanotic Melanoma: {} + Ameloblastic Carcinosarcoma: {} + Anaplastic Astrocytoma, IDH-Wildtype, Glioblastoma, IDH Wildtype: {} + Anaplastic Ependymoma: {} + Anaplastic Ganglioglioma: {} + Anaplastic Large Cell Lymphoma, ALK Positive: {} + Anaplastic Large Cell Lymphoma, T-Cell And Null-Cell Type: {} + Angiocentric Glioma: {} + Angiomatoid Fibrous Histiocytoma: {} + Angiomyofibroblastoma: {} + Angiomyosarcoma: {} + Appearances Consistent With Alveolar Soft Part Sarcoma: {} + Arteriovenous Malformation: {} + Astroblastoma: {} + Astroblastoma, Astroblastoma, MN1-Altered, High-Grade Glioma: {} + Astroblastoma, MN1-Altered. Histologically High-Grade: {} + Astroblastoma, Other, Other CNS Tumor, NOS Or NEC: {} + Astrocytic Glioma, Histologically Low-Grade, Most Compatible With Pilocytic Astrocytoma: {} + Astrocytoma: {} + Astrocytoma, Anaplastic: {} + Astrocytoma, Anaplastic, NOS: {} + Astrocytoma, Benign: {} + Astrocytoma, IDH-Mutant, CNS WHO Grade 3: {} + Astrocytoma, IDH-Mutant, CNS WHO Grade 4: {} + Astrocytoma, IDH-Mutant, WHO Grade 2: {} + Astrocytoma, NOS: {} + Astrocytoma, NOS, Angiocentric Glioma, Low-Grade Glioma: {} + Astrocytoma, NOS, Astrocytoma, IDH-Mutant, Low-Grade Glioma: {} + Astrocytoma, NOS, Diffuse Pediatric-Type High-Grade Glioma, H3-Wildtype And IDH-Wildtype, High-Grade Glioma: {} + Astrocytoma, NOS, High-Grade Glioma, High-Grade Glioma, NOS Or NEC: {} + Astrocytoma, NOS, High-Grade Glioma, Infant-Type Hemispheric Glioma: {} + Astrocytoma, NOS, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Astrocytoma, NOS, Low-Grade Glioma, Pilocytic Astrocytoma: {} + Astrocytoma, NOS, Low-Grade Glioma, Pleomorphic Xanthoastrocytoma: {} + Astrocytoma, NOS, Low-Grade Glioma, Subependymal Giant Cell Astrocytoma: {} + Astrocytoma, NOS, Other, Other CNS Tumor, NOS Or NEC: {} + Atypical Choroid Plexus Papilloma: {} + Atypical Choroid Plexus Papilloma, Choroid Plexus Tumors: {} + Atypical Lymphoid Infiltrate: {} + Atypical Meningioma: {} + Atypical Smooth Muscle Neoplasm: {} + Atypical Teratoid Rhabdoid Tumor, CNS WHO Grade 4: {} + Atypical Teratoid-Rhabdoid Tumor, CNS WHO Grade 4: {} + Atypical Teratoid-Rhabdoid Tumor, WHO Grade 4: {} + Atypical Teratoid/Rhabdoid Tumor: {} + Atypical Teratoid/Rhabdoid Tumor, ATRT, NOS Or NEC: {} + Atypical Teratoid/Rhabdoid Tumor, ATRT-MYC: {} + Atypical Teratoid/Rhabdoid Tumor, ATRT-TYR: {} + Atypical Teratoid/Rhabdoid Tumor, INI1/SMARCB1-Altered, WHO Grade 4: {} + B Lymphoblastic Leukemia/Lymphoma With Hyperdiploidy: {} + B Lymphoblastic Leukemia/Lymphoma With Hypodiploidy: {} + B Lymphoblastic Leukemia/Lymphoma With T(12;21)(P13;Q22); TEL-AML1 (ETV6-RUNX1): {} + B Lymphoblastic Leukemia/Lymphoma With T(1;19)(Q23;P13.3); E2A-PBX1 (TCF3-PBX1): {} + B Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34;Q11.2); BCR-ABL1: {} + B Lymphoblastic Leukemia/Lymphoma With T(V;11q23); MLL Rearranged: {} + B Lymphoblastic Leukemia/Lymphoma, NOS: {} + B-Lymphoblastic Leukemia/Lymphoma, NOS: {} + Basal Cell Adenocarcinoma: {} + Basaloid Squamous Cell Carcinoma: {} + Benign Cystic Nephroma: {} + Bland Myofibroblastic Proliferation With Associated Florid Lymphoplasmacytic Inflammation: {} + Blue Nevus, Malignant: {} + Brain Tumor: {} + Brain Tumor, Low Grade Glioma: {} + Bronchio-Alveolar Carcinoma, Mucinous: {} + Bronchiolo-Alveolar Carcinoma, Non-Mucinous: {} + Burkitt Lymphoma, NOS: {} + CNS Embryonal Tumor With Rhabdoid Features: {} + CNS Embryonal Tumor, NOS: {} + CNS Embryonal Tumor, NOS, CNS Embryonal Tumor, NOS Or NEC, Other CNS Embryonal Tumors: {} + CNS Primative Neuroectodermal Tumor (PNET): {} + CPNET: {} + Carcinoid Tumor: {} + Carcinoid Tumor Of Uncertain Malignant Potential: {} + Carcinoma In Situ, NOS: {} + Carcinoma NOS: {} + Carcinoma, Diffuse Type: {} + Carcinoma, Metastatic, NOS: {} + Carcinoma, NOS, Medulloblastoma, Medulloblastoma, NOS Or NEC: {} + Carcinoma, Undifferentiated, NOS: {} + Carcinosarcoma NOS: {} + Cavernoma: {} + Central Neuroblastoma: {} + Central Neurocytoma: {} + Central Neurocytoma, Glioneuronal And Neuronal Tumors: {} + Central Neurocytoma, Low-Grade Glioma, Subependymal Giant Cell Astrocytoma: {} + Central Osteosarcoma, NOS: {} + Central Primitive Neuroectodermal Tumor: {} + Cholangiocarcinoma: {} + Chondroblastic Osteosarcoma: {} + Chondroid Chordoma: {} + Chondrosarcoma, NOS: {} + Chordoma: {} + Chordoma, NOS: {} + Chordoma, NOS, Chordoma (Including Poorly Differentiated Chordoma), Other: {} + Chordoma, NOS, Ganglioneuroblastoma: {} + Choriocarcinoma Combined With Other Germ Cell Elements: {} + Choriocarcinoma, NOS: {} + Choroid Plexus Carcinoma: {} + Choroid Plexus Carcinoma WHO Grade 3: {} + Choroid Plexus Carcinoma, Choroid Plexus Tumors: {} + Choroid Plexus Carcinoma, WHO Grade 3: {} + Choroid Plexus Neoplasm: {} + Choroid Plexus Papillary Tumor: {} + Choroid Plexus Papilloma, NOS: {} + Choroid Plexus Papilloma, NOS, Choroid Plexus Tumors: {} + Choroid Plexus Papilloma, NOS, Other CNS Embryonal Tumors, Pineoblastoma: {} + Chronic Eosinophilic Leukemia: {} + Chronic Myelogenous Leukemia: {} + Chronic Myelogenous Leukemia, BCR-ABL Positive: {} + Chronic Myelogenous Leukemia, BCR/ABL Positive: {} + Chronic Myeloid Leukemia, BCR-ABL1-Positive: {} + Chronic Myeloid Leukemia, NOS: {} + Classic Medulloblastoma, CNS WHO Grade 4: {} + Clear Cell Adenocarcinoma, NOS: {} + Clear Cell Meningioma: {} + Clear Cell Meningioma, Meningioma, Other: {} + Clear Cell Sarcoma Of Kidney: {} + Clear Cell Sarcoma, NOS: {} + Colon Adenocarcinoma: {} + Colorectal Carcinoma: {} + Combined Small Cell-Adenocarcinoma: {} + Combined Small Cell-Large Carcinoma: {} + Combined Small Cell-Squamous Cell Carcinoma: {} + Composite Hodgkin And Non-Hodgkin Lymphoma: {} + Control: {} + Craniopharyngioma: {} + Craniopharyngioma, Adamantinomatous: {} + Craniopharyngioma, Adamantinomatous, Adamantinomatous Craniopharyngioma: {} + Craniopharyngioma, NOS: {} + Craniopharyngioma, NOS, Adamantinomatous Craniopharyngioma: {} + Cribriform Carcinoma, NOS: {} + Cutaneous T-Cell Lymphoma, NOS: {} + Cystosarcoma Phyllodes, NOS: {} + Dedifferentiated Liposarcoma: {} + Dermatofibrosarcoma Protuberans, Fibrosarcomatous: {} + Dermatofibrosarcoma Protuberans, NOS: {} + Dermoid Cyst: {} + Desmoplastic Fibroma: {} + Desmoplastic Infantile Astrocytoma: {} + Desmoplastic Melanoma, NOS: {} + Desmoplastic Nodular Medulloblastoma: {} + Desmoplastic Nodular Medulloblastoma, Medulloblastoma, Medulloblastoma, Group 4: {} + Desmoplastic Nodular Medulloblastoma, Medulloblastoma, Medulloblastoma, SHH-Activated And TP53-Wildtype: {} + Desmoplastic Small Round Cell Tumor: {} + Desmoplastic/Nodular Medulloblastoma: {} + Desmoplastic/Nodular Medulloblastoma (Histologically Defined), CNS WHO Grade 4: {} + Differentiating Neuroblastoma: {} + Diffuse Glioma: {} + Diffuse Glioma, Favor High Grade: {} + Diffuse Large B-Cell Lymphoma, NOS: {} + Diffuse Midline Glioma, H3 K27 Altered, WHO Grade 4: {} + Diffuse Midline Glioma, H3 K27-Altered: {} + Diffuse Midline Glioma, H3 K27M-Mutant: {} + Diffuse Midline Glioma, H3K27M-Mutant, CNS WHO Grade 4: {} + Ductal Carcinoma In Situ, NOS: {} + Ductal Carcinoma NOS: {} + Dysembryoplastic Neuroepithelial Tumor: {} + Dysembryoplastic Neuroepithelial Tumor With Adjacent Cortical Dysplasia, WHO Grade 1: {} + Dysembryoplastic Neuroepithelial Tumor, Angiocentric Glioma, Low-Grade Glioma: {} + Dysembryoplastic Neuroepithelial Tumor, Glioneuronal And Neuronal Tumors: {} + Dysembryoplastic Neuroepithelial Tumor, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Dysembryoplastic Neuroepithelial Tumor, Low-Grade Glioma, Polymorphous Low-Grade Neuroepithelial Tumor Of The Young: {} + Dysplasia: {} + Embryonal Carcinoma, NOS: {} + Embryonal Carcinoma, NOS, Embryonal Tumor With Multilayered Rosettes, C19MC Altered, Other CNS Embryonal Tumors: {} + Embryonal Carcinoma, NOS, Ependymoma, Supratentorial Ependymoma, NOS Or NEC: {} + Embryonal Neoplasm With INI-1 Loss By Immunohistochemistry: {} + Embryonal Rhabdomyosarcoma: {} + Embryonal Rhabdomyosarcoma With Anaplastic Features: {} + Embryonal Rhabdomyosarcoma, High-Grade: {} + Embryonal Rhabdomyosarcoma, NOS: {} + Embryonal Rhabdomyosarcoma, NOS, CNS Embryonal Tumor, NOS: {} + Embryonal Sarcoma: {} + Embryonal Tumor: {} + Embryonal Tumor With Multi-Layered Rosettes: {} + Embryonal Tumor With Multilayered Rosettes C19MC-Altered: {} + Embryonal Tumor With Multilayered Rosettes With C19MC Alteration: {} + Endometrioid Adenocarcinoma, NOS: {} + Endometrioid Carcinoma, NOS: {} + Ependymoma (CNS WHO Grade 3): {} + Ependymoma (WHO Grade 2): {} + Ependymoma NOS: {} + Ependymoma WHO Grade 2: {} + Ependymoma WHO Grade 3: {} + Ependymoma, Anaplastic: {} + Ependymoma, Anaplastic, Supratentorial Ependymoma, NOS Or NEC: {} + Ependymoma, NOS: {} + Ependymoma, NOS, Atypical Meningioma: {} + Ependymoma, NOS, Choroid Plexus Tumors, Choroid Plexus Papilloma: {} + Ependymoma, NOS, Medulloblastoma, Medulloblastoma, NOS Or NEC: {} + Ependymoma, NOS, Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH: {} + Ependymoma, NOS, Posterior Fossa Ependymoma, Group PFA: {} + Ependymoma, NOS, Posterior Fossa Ependymoma, Group PFB: {} + Ependymoma, NOS, Posterior Fossa Ependymoma, NOS Or NEC: {} + Ependymoma, NOS, Supratentorial Ependymoma, NOS Or NEC: {} + Ependymoma, NOS, Supratentorial Ependymoma, ZFTA Fusion-Positive: {} + Epithelial Tumor, Benign: {} + Epithelial-Myoepithelial Carcinoma: {} + Epithelioid Cell Melanoma: {} + Epithelioid Hemangioendothelioma, NOS: {} + Epithelioid Mesothelioma, Malignant: {} + Epithelioid Sarcoma, NOS: {} + Ewing Sarcoma: {} + Extra Adrenal Paraganglioma: {} + Familial Adenomatous Polyposis: {} + Favor Anaplastic Ependymoma: {} + Favor Ganglioglioma: {} + Favor Pilocytic Astrocytoma With Increased Proliferation Indices: {} + Favor Pilocytic Astrocytoma, CNS WHO Grade 1: {} + Favor Posterior Fossa Ependymoma, WHO GRADE 3: {} + Favor Teratoma: {} + Fibrillary Astrocytoma: {} + Fibroma: {} + Fibrosarcoma, NOS: {} + Follicular Adenocarcinoma, NOS: {} + Follicular Adenocarcinoma, Well Differentiated, Neuroblastoma, NOS: {} + Follicular Carcinoma, Minimally Invasive: {} + Gangliocytoma, NOS: {} + Ganglioglioma: {} + Ganglioglioma, Anaplastic: {} + Ganglioglioma, NOS: {} + Ganglioglioma, NOS, Diffuse Astrocytoma, MYB- Or MYBL1-Altered, Low-Grade Glioma: {} + Ganglioglioma, NOS, Ependymoma, Supratentorial Ependymoma, NOS Or NEC: {} + Ganglioglioma, NOS, Glioneuronal And Neuronal Tumors: {} + Ganglioglioma, NOS, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Ganglioglioma, NOS, Malignant Peripheral Nerve Sheath Tumor, NOS: {} + Ganglioglioma, NOS, Other, Other CNS Tumor, NOS Or NEC: {} + Ganglioneuroblastoma: {} + Ganglioneuroblastoma, Nodular Type: {} + Ganglioneuroma: {} + Ganglioneuroma, High-Grade Glioma, High-Grade Glioma, NOS Or NEC: {} + Ganglioneuroma, Maturing Type, Favorable Histology: {} + Ganglioneuroma, Other, Schwannoma: {} + Gastrointestinal Stromal Tumor: {} + Gastrointestinal Stromal Tumor, Benign: {} + Gastrointestinal Stromal Tumor, NOS: {} + Genital Rhabdomyoma: {} + Germ Cell Tumor, Nonseminomatous: {} + Germ Cell Tumor, Nonseminomatous, CNS Germ Cell Tumors, CNS Non-Germinomatous Germ Cell Tumor: {} + Germinoma: {} + Germinoma, CNS Germ Cell Tumors, CNS Germinoma: {} + Germinoma, CNS Germ Cell Tumors, CNS Non-Germinomatous Germ Cell Tumor: {} + Giant Cell Glioblastoma: {} + Giant Cell Glioblastoma, Glioblastoma, IDH-Wildtype, High-Grade Glioma: {} + Giant Cell Tumor Of Bone, Malignant: {} + Giant Cell Tumor Of Bone, NOS: {} + Giant Cell Tumor Of Soft Parts, NOS: {} + Glial Neoplasm: {} + Glial Neoplasm Showing High-Grade Features: {} + Glial Neoplasm, Astrocytoma: {} + Glial Neoplasm, Favor Pilocytic Astrocytoma: {} + Glial Tumor: {} + Glioblastoma: {} + Glioblastoma Multiforme: {} + Glioblastoma, IDH Wildtype: {} + Glioblastoma, NOS: {} + Glioblastoma, NOS, High-Grade Glioma, High-Grade Glioma, NOS Or NEC: {} + Glioblastoma, NOS, Medulloblastoma, NOS: {} + Glioma: {} + Glioma, Histologically Low Grade: {} + Glioma, Malignant: {} + Glioma, Malignant, Angiocentric Glioma, Low-Grade Glioma: {} + Glioma, Malignant, Astrocytoma, IDH-Mutant, High-Grade Glioma: {} + Glioma, Malignant, Astrocytoma, IDH-Mutant, Low-Grade Glioma: {} + Glioma, Malignant, Diffuse Hemispheric Glioma, H3 G34-Mutant, High-Grade Glioma: {} + Glioma, Malignant, Diffuse Midline Glioma, H3 K27-Altered, High-Grade Glioma: {} + Glioma, Malignant, Diffuse Pediatric-Type High-Grade Glioma, H3-Wildtype And IDH-Wildtype, High-Grade Glioma: {} + Glioma, Malignant, Dysembryoplastic Neuroepithelial Tumor, Glioneuronal And Neuronal Tumors: {} + Glioma, Malignant, Embryonal Tumor With Multilayered Rosettes, C19MC Altered, Other CNS Embryonal Tumors: {} + Glioma, Malignant, Ganglioglioma, Glioneuronal And Neuronal Tumors: {} + Glioma, Malignant, Glioneuronal And Neuronal Tumors, Glioneuronal And Neuronal Tumors, NOS Or NEC: {} + Glioma, Malignant, High-Grade Glioma, High-Grade Glioma, NOS Or NEC: {} + Glioma, Malignant, High-Grade Glioma, Infant-Type Hemispheric Glioma: {} + Glioma, Malignant, High-Grade Glioma, Pleomorphic Xanthoastrocytoma: {} + Glioma, Malignant, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Glioma, Malignant, Low-Grade Glioma, Pilocytic Astrocytoma: {} + Glioma, Malignant, Low-Grade Glioma, Polymorphous Low-Grade Neuroepithelial Tumor Of The Young: {} + Glioma, Malignant, Malignant Peripheral Nerve Sheath Tumor, NOS: {} + Glioma, Malignant, Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH: {} + Glioma, Malignant, Other, Other CNS Tumor, NOS Or NEC: {} + Glioma, Malignant, Other, Other Low-Grade B-Cell Lymphomas Of The CNS: {} + Gliomatosis Cerebri: {} + Glioneuronal Tumor With Focal Increased Atypia: {} + Gliosarcoma: {} + Glomus Tumor, Malignant: {} + Granulosa Cell Tumor, Juvenile: {} + Granulosa Cell Tumor, Malignant: {} + HHV8 Positive Diffuse Large B-Cell Lymphoma: {} + Hamartoma: {} + Head & Neck Squamous Cell Carcinoma: {} + Hemangioblastoma: {} + Hemangioblastoma, CNS WHO Grade 1: {} + Hemangioblastoma, Other: {} + Hemangioendothelioma, Malignant: {} + Hemangioendothelioma, NOS: {} + Hemangioma, NOS: {} + Hemangiosarcoma: {} + Hepatoblastoma: {} + Hepatoblastoma, NOS: {} + Hepatocellular Carcinoma, Fibrolamellar: {} + Hepatocellular Carcinoma, NOS: {} + Hepatocellular Carcinoma, NOS, Nephroblastoma, NOS: {} + Hepatosplenic T-Cell Lymphoma, Precursor Cell Lymphoblastic Leukemia, NOS: {} + High Grade Carcinosarcoma: {} + High Grade Follicular Derived Thyroid Carcinoma: {} + High Grade Glioma With Necrosis, WHO Grade 4: {} + High Grade Malignant Epithelioid Neoplasm: {} + ? High Grade Malignant Peripheral Nerve Sheath Tumor With Heterologous Rhabdomyoblastic + Differentiation (Malignant Triton Tumor) + : {} + High Grade Neuroepithelial Tumor: {} + High Grade Spindle Cell Sarcoma: {} + High-Grade Neuroepithelial Tumor: {} + High-Grade Serous Carcinoma: {} + Histologically Low-Grade Glioma: {} + Hodgkin Lymphoma, NOS: {} + Hodgkin Lymphoma, Nodular Sclerosis, NOS: {} + Hypercellular Lesion With Atypia: {} + Hypercellular Neuroepithelial Tumor With Some Features Of Glioma, Possibly High Grade: {} + Hypocellular Low Grade Lesion: {} + Infantile Fibrosarcoma: {} + Infiltrating Duct And Lobular Carcinoma: {} + Infiltrating Duct And Mucinous Carcinoma: {} + Infiltrating Duct Carcinoma NOS: {} + Infiltrating Duct Mixed With Other Types Of Carcinoma: {} + Infiltrating Ductal Carcinoma: {} + Infiltrating Lobular Carcinoma, NOS: {} + Inflammatory Carcinoma: {} + Inflammatory Myofibroblastic Tumor With An Associated Odontogenic Keratocyst: {} + Intraductal Carcinoma NOS: {} + Intraductal Papillary Carcinoma: {} + Intraductal Papillary Mucinous Neoplasm With An Associated Invasive Carcinoma: {} + Invasive Carcinoma: {} + Invasive Ductal Carcinoma: {} + Invasive Lobular Carcinoma: {} + Invasive Mammary Carcinoma: {} + Juvenile Granulosa Cell Tumor: {} + Juvenile Myelomonocytic Leukemia: {} + Juvenile Myelomonocytic Leukemia, NOS: {} + Kidney Clear Cell Renal Carcinoma: {} + Lactotroph Adenoma: {} + Langerhans Cell Histiocytosis: {} + Langerhans Cell Histiocytosis, Disseminated: {} + Langerhans Cell Histiocytosis, NOS: {} + Large Cell Medulloblastoma: {} + Large Cell Medulloblastoma, Embryonal Tumor With Multilayered Rosettes, NOS, Other CNS Embryonal Tumors: {} + Large Cell Medulloblastoma, Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH: {} + Leiomyoma, NOS: {} + Leiomyosarcoma, NOS: {} + Lentiginous Melanocytic Nevus: {} + Leukemia, NOS: {} + Leydig Cell Tumor, Benign: {} + Leydig Cell Tumor, NOS: {} + Lipoblastomatosis: {} + Liposarcoma, NOS: {} + Lobular Adenocarcinoma: {} + Lobular And Ductal Carcinoma: {} + Lobular Carcinoma, NOS: {} + Low Cumulative Sun Damage Melanoma: {} + Low Grade Fibromyxoid Sarcoma: {} + Low Grade Glial Neoplasm: {} + Low Grade Glial/ Glioneuronal Tumor: {} + Low Grade Glioma: {} + Low Grade Glioneuronal Tumor: {} + Low Grade Neoplasm. Features Suggestive Of Pilocytic Astrocytoma.: {} + Low-Grade Glioneuronal, Neuronal Tumor: {} + Lung Adenocarcinoma, NOS: {} + Lung Squamous Cell Carcinoma, NOS: {} + Lymphangioma, NOS: {} + Lymphoepithelial Carcinoma: {} + Lymphoid Leukemia, NOS: {} + Lymphoma, NOS: {} + Lymphoproliferative Disorder, NOS: {} + Malignant Epithelioid And Myxoid Neoplasm: {} + Malignant Glioma: {} + Malignant Histiocytosis: {} + Malignant Lymphoma, NOS: {} + Malignant Lymphoma, Non-Hodgkin, NOS: {} + Malignant Melanocytic Neoplasm: {} + Malignant Melanoma, NOS: {} + Malignant Melanoma, NOS, Meningeal Melanocytic Neoplasms (Includes Melanoma), Other: {} + Malignant Neoplasm Of Prostate: {} + Malignant Neoplasm With Rhabdomyoblastic Differentiation, High Grade: {} + Malignant Peripheral Nerve Sheath Tumor: {} + Malignant Peripheral Nerve Sheath Tumor (Mpnst): {} + Malignant Peripheral Nerve Sheath Tumor With Rhabdomyoblastic Differentiation: {} + Malignant Peripheral Nerve Sheath Tumor, NOS: {} + Malignant Peripheral Nerve Sheath Tumor, NOS, CNS Sarcoma, CNS Sarcoma, NOS Or NEC: {} + Malignant Rhabdoid Tumor: {} + Malignant Sarcoma With DICER1 Mutation, Favor Primary Intracranial Sarcoma, DICER1 Mutant: {} + Malignant Tumor: {} + Malignant Tumor, Small Cell Type: {} + Malignant Tumor, Spindle Cell Type: {} + Malignant Tumor, Spindle Cell Type, CNS Sarcoma, CNS Sarcoma, NOS Or NEC: {} + Marginal Zone B-Cell Lymphoma, NOS: {} + Mast Cell Leukaemia: {} + Medullary Carcinoma: {} + Medullary Carcinoma, NOS: {} + Medulloblastoma: {} + Medulloblastoma By Morphology, NON-WNT By Immunohistochemistry: {} + Medulloblastoma WHO Grade 4: {} + Medulloblastoma, Classic (Biphasic) Histologic Type, Non-SHH/Non-WNT Molecular Group, CNS WHO Grade 4: {} + Medulloblastoma, Classic Histologic Type (CNS WHO Grade 4): {} + Medulloblastoma, Classic Histologic Type, CNS WHO Grade 4: {} + Medulloblastoma, Classic Histology: {} + Medulloblastoma, Classic Morphology, CNS WHO Grade 4, NON-WNT/NON-SHH, Group 4 Subtype By Methylation: {} + Medulloblastoma, Classic Variant, WHO Grade 4: {} + Medulloblastoma, Group 3 Subtype (WHO Grade 4): {} + Medulloblastoma, NOS: {} + Medulloblastoma, NOS, Diffuse Hemispheric Glioma, H3 G34-Mutant, High-Grade Glioma: {} + Medulloblastoma, NOS, Medulloblastoma, Group 3: {} + Medulloblastoma, NOS, Medulloblastoma, Group 4: {} + Medulloblastoma, NOS, Medulloblastoma, NOS Or NEC: {} + Medulloblastoma, NOS, Medulloblastoma, Non-WNT/Non-SHH: {} + Medulloblastoma, NOS, Medulloblastoma, SHH-Activated And TP53-Mutant: {} + Medulloblastoma, NOS, Medulloblastoma, SHH-Activated And TP53-Wildtype: {} + Medulloblastoma, NOS, Medulloblastoma, WNT-Activated: {} + Medulloblastoma, Nodular/Desmoplastic With Anaplastic/Large Cell Features, Non-WNT/Non-SHH; WHO Grade 4: {} + Medulloblastoma, SHH-Activated And TP53-Mutant: {} + Medulloblastoma, SHH-Activated And TP53-Wildtype: {} + Medulloblastoma, WHO Grade 4: {} + Medulloblastoma; Hypercellular Lesion With Marked Atypia: {} + Medulloepithelioma, NOS: {} + Melanoma In Situ: {} + Melanoma, NOS: {} + Melanotic Neuroectodermal Tumor: {} + Melanotic Schwannoma, Other: {} + Meningeal Melanocytoma: {} + Meningeal Melanomatosis: {} + Meningioangiomatosis: {} + Meningioma: {} + Meningioma, Atypical, CNS WHO Grade 2: {} + Meningioma, Malignant: {} + Meningioma, NOS: {} + Meningioma, NOS, Embryonal Tumor With Multilayered Rosettes, NOS, Other CNS Embryonal Tumors: {} + Meningioma, NOS, Other: {} + Meningiomatosis, NOS: {} + Meningothelial Meningioma: {} + Meningothelial Meningioma, Grade 1: {} + Meningothelial Meningioma, Meningioma, Other: {} + Merkel Cell Carcinoma: {} + Merkel Cell Tumor: {} + Mesenchymal Chondrosarcoma: {} + Mesenchymal Chondrosarcoma, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Mesenchymal Lesion: {} + Mesoblastic Nephroma: {} + Mesothelioma, Biphasic, Malignant, B Lymphoblastic Leukemia/Lymphoma, NOS: {} + Metaplastic Carcinoma, NOS: {} + Metastatic Neuroblastoma: {} + Metastatic Secondary Tumors: {} + Metastatic Signet Ring Cell Carcinoma: {} + Micropapillary Carcinoma, NOS: {} + Mitotically Active Glial/ Glioneuronal Neoplasm: {} + Mixed Adenocarcinoma And Squamous Cell Carcinoma, Pancreatobiliary-Type Carcinoma: {} + Mixed Epithelioid And Spindle Cell Melanoma: {} + Mixed Germ Cell Tumor: {} + Mixed Germ Cell Tumor, Acute Megakaryoblastic Leukemia: {} + Mixed Germ Cell Tumor, CNS Germ Cell Tumors, CNS Germinoma: {} + Mixed Germ Cell Tumor, CNS Germ Cell Tumors, CNS Non-Germinomatous Germ Cell Tumor: {} + Mixed Germ Cell Tumor, Myelodysplastic Syndrome With Excess Blasts: {} + Mixed Glioma: {} + Mixed Phenotype Acute Leukemia With T(V;11q23); MLL Rearranged: {} + Mixed Phenotype Acute Leukemia, B/Myeloid, NOS: {} + Mixed Phenotype Acute Leukemia, T/Myeloid, NOS: {} + Mixed Type Rhabdomyosarcoma: {} + Mixed-Phenotype Acute Leukemia, B/Myeloid, Not Otherwise Specified: {} + Mixed-Phenotype Acute Leukemia, T/Myeloid, Not Otherwise Specified: {} + Morphologically Consistent With Pilocytic Astrocytoma, WHO Grade 1: {} + Mucinous Adenocarcinoma: {} + Mucinous Adenocarcinoma, Endocervical Type: {} + Mucinous Carcinoma: {} + Mucoepidermoid Carcinoma: {} + Mucous Adenocarcinoma: {} + Multiple Myeloma: {} + Mycosis Fungoides, Langerhans Cell Histiocytosis, NOS: {} + Myelodysplastic Syndrome With Multilineage Dysplasia: {} + Myelodysplastic Syndrome With Single Lineage Dysplasia: {} + Myelodysplastic Syndrome, NOS: {} + Myeloid Leukemia Associated With Down Syndrome: {} + Myeloid Leukemia With Myelodysplasia-Related Changes: {} + Myeloid Leukemia, NOS: {} + Myeloid Sarcoma: {} + Myoepithelial Carcinoma: {} + Myofibroblastic Tumor: {} + Myofibroblastic Tumor, NOS: {} + Myofibroma: {} + Myofibromatosis: {} + Myxofibrosarcoma: {} + Myxoid Liposarcoma: {} + Myxoid Spindle Cell Tumor: {} + Myxopapillary Ependymoma: {} + Myxopapillary Ependymoma (CNS WHO Grade II): {} + Myxopapillary Ependymoma, Anaplastic: {} + Myxopapillary Ependymoma, Ependymoma: {} + Nasopharyngeal Carcinoma: {} + Neoplasm: {} + Neoplasm, Benign: {} + Neoplasm, Malignant: {} + Neoplasm, Malignant, ATRT, NOS Or NEC, Atypical Teratoid/Rhabdoid Tumor: {} + Neoplasm, Malignant, ATRT-SHH, Atypical Teratoid/Rhabdoid Tumor: {} + Neoplasm, Malignant, Astrocytoma, IDH-Mutant, Low-Grade Glioma: {} + Neoplasm, Malignant, CNS Embryonal Tumor, NOS Or NEC, Other CNS Embryonal Tumors: {} + Neoplasm, Malignant, CNS Germ Cell Tumors, CNS Non-Germinomatous Germ Cell Tumor: {} + Neoplasm, Malignant, CNS Neuroblastoma, FOXR2-Activated, Other CNS Embryonal Tumors: {} + Neoplasm, Malignant, Diffuse Midline Glioma, H3 K27-Altered, High-Grade Glioma: {} + Neoplasm, Malignant, Diffuse Pediatric-Type High-Grade Glioma, H3-Wildtype And IDH-Wildtype, High-Grade Glioma: {} + Neoplasm, Malignant, Glioneuronal And Neuronal Tumors, Glioneuronal And Neuronal Tumors, NOS Or NEC: {} + Neoplasm, Malignant, High-Grade Glioma, High-Grade Glioma, NOS Or NEC: {} + Neoplasm, Malignant, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Neoplasm, Malignant, Low-Grade Glioma, Pilocytic Astrocytoma: {} + Neoplasm, Malignant, Medulloblastoma, Medulloblastoma, NOS Or NEC: {} + Neoplasm, Malignant, Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH: {} + Neoplasm, Malignant, Medulloblastoma, Medulloblastoma, WNT-Activated: {} + Neoplasm, Malignant, Uncertain Whether Primary Or Metastatic: {} + Neoplasm, Metastatic: {} + Neoplasm, NOS: {} + Neoplasm, Uncertain Whether Benign Or Malignant: {} + Neoplasm, Uncertain Whether Benign Or Malignant, ATRT, NOS Or NEC, Atypical Teratoid/Rhabdoid Tumor: {} + Neoplasm, Uncertain Whether Benign Or Malignant, ATRT-SHH, Atypical Teratoid/Rhabdoid Tumor: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Adamantinomatous Craniopharyngioma, Craniopharyngioma: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Astrocytoma, IDH-Mutant, Low-Grade Glioma: {} + Neoplasm, Uncertain Whether Benign Or Malignant, CNS Germ Cell Tumors, CNS Germinoma: {} + Neoplasm, Uncertain Whether Benign Or Malignant, CNS Sarcoma, Ewing Sarcoma: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Choroid Plexus Tumors, Choroid Plexus Papilloma: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Diffuse Midline Glioma, H3 K27-Altered, High-Grade Glioma: {} + ? Neoplasm, Uncertain Whether Benign Or Malignant, Diffuse Pediatric-Type High-Grade + Glioma, H3-Wildtype And IDH-Wildtype, High-Grade Glioma + : {} + Neoplasm, Uncertain Whether Benign Or Malignant, Dysembryoplastic Neuroepithelial Tumor, Glioneuronal And Neuronal Tumors: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Ependymoma, Posterior Fossa Ependymoma, Group PFA: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Ependymoma, Supratentorial Ependymoma, NOS Or NEC: {} + Neoplasm, Uncertain Whether Benign Or Malignant, High-Grade Glioma, High-Grade Glioma, NOS Or NEC: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Low-Grade Glioma, Oligodendroglioma, IDH-Mutant, And 1p/19q-Codeleted: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Low-Grade Glioma, Pilocytic Astrocytoma: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Low-Grade Glioma, Subependymal Giant Cell Astrocytoma: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Medulloblastoma, Medulloblastoma, Group 4: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Medulloblastoma, Medulloblastoma, NOS Or NEC: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Medulloblastoma, Medulloblastoma, SHH-Activated And TP53-Wildtype: {} + Neoplasm, Uncertain Whether Benign Or Malignant, Meningioma, Other: {} + Nephroblastoma (Wilms Tumor): {} + Nephroblastoma, NOS: {} + Neuroblastoma: {} + Neuroblastoma, NOS: {} + Neuroblastoma, Schwannian Stroma Poor, Poorly Differentiated, Low MKI, Favorable Histology: {} + Neuroblastoma, Undifferentiated Type: {} + Neurocytoma: {} + Neuroendocrine Carcinoma, NOS: {} + Neuroendocrine Tumor, NOS: {} + Neuroepithelial Tumor: {} + Neuroepithelial Tumor With Glioneuronal-Like Features: {} + Neuroepithelioma, NOS: {} + Neurofibroma: {} + Neurofibroma, NOS: {} + Neurofibroma, NOS, Other, Solitary Fibrous Tumor: {} + Neurofibromatosis, NOS: {} + Neuroma, NOS: {} + Nodular Melanoma: {} + Non-Germinomatous Germ Cell Tumor: {} + Not Applicable: {} + Not Reported: {} + Not Specified In Data: {} + Nuclear Protein In Testis (NUT)-Associated Carcinoma: {} + Olfactory Neuroblastoma: {} + Olfactory Neurocytoma: {} + Oligoastrocytoma, NOS: {} + Oligoastrocytoma, NOS, Glioneuronal And Neuronal Tumors, Glioneuronal And Neuronal Tumors, NOS Or NEC: {} + Oligoastrocytoma, NOS, Glioneuronal And Neuronal Tumors, Papillary Glioneuronal Tumor: {} + Oligoastrocytoma, NOS, Other, Other CNS Tumor, NOS Or NEC: {} + Oligodendroglioma: {} + Oligodendroglioma, Anaplastic: {} + Oligodendroglioma, Anaplastic, NOS: {} + Oligodendroglioma, NOS: {} + Oligodendroglioma, NOS, High-Grade Glioma, Oligodendroglioma, IDH-Mutant, And 1p/19q-Codeleted: {} + Oligodendroglioma, NOS, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Oligodendroglioma, NOS, Low-Grade Glioma, Oligodendroglioma, IDH-Mutant, And 1p/19q-Codeleted: {} + Oligodendroglioma, NOS, Other, Other CNS Tumor, NOS Or NEC: {} + Ossifying Fibroma: {} + Ossifying Fibromyxoid Tumor, NOS: {} + Osteoblastoma: {} + Osteoblastoma, NOS: {} + Osteosarcoma, NOS: {} + Oxyphilic Adenocarcinoma: {} + Pancreas-Adenocarcinoma Ductal Type: {} + Pancreas-Adenosquamous Carcinoma: {} + Pancreas-Undifferentiated Carcinoma: {} + Pancreatic Neuroendocrine Tumor, Nonfunctioning: {} + Pancreatobiliary-Type Carcinoma: {} + Pancreatoblastoma: {} + Papillary Adenocarcinoma, NOS: {} + Papillary Carcinoma: {} + Papillary Carcinoma, Columnar Cell: {} + Papillary Carcinoma, Follicular Variant: {} + Papillary Carcinoma, NOS: {} + Papillary Glioneuronal Tumor: {} + Papillary Glioneuronal Tumor, WHO Grade 1: {} + Papillary Intralymphatic Angioendothelioma: {} + Papillary Lesion With Atypical/High Grade Features: {} + Papillary Microcarcinoma: {} + Papillary Serous Adenocarcinoma: {} + Papillary Thyroid Carcinoma: {} + Papillary Thyroid Carcinoma, Classic Type: {} + Papillary Transitional Cell Carcinoma: {} + Papillary Tumor Of Pineal Region: {} + Papillary Urothelial Carcinoma, Non-Invasive: {} + Paraganglioma, Malignant: {} + Paraganglioma, NOS: {} + Paratesticular Rhabdomyosarcoma With Diffuse Anaplasia: {} + Parosteal Osteosarcoma: {} + Perineuroma: {} + Periosteal Osteosarcoma: {} + Pheochromocytoma: {} + Pheochromocytoma, NOS: {} + Pigmented Dermatofibrosarcoma Protuberans: {} + Pilocytic Astrocytoma: {} + Pilocytic Astrocytoma WHO Grade 1: {} + Pilocytic Astrocytoma, CNS WHO Grade 1: {} + Pilocytic Astrocytoma, Diffuse Leptomeningeal Glioneuronal Tumor, Glioneuronal And Neuronal Tumors: {} + Pilocytic Astrocytoma, Glioneuronal And Neuronal Tumors, Glioneuronal And Neuronal Tumors, NOS Or NEC: {} + Pilocytic Astrocytoma, Low-Grade Glioma: {} + Pilocytic Astrocytoma, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Pilocytic Astrocytoma, Low-Grade Glioma, Pleomorphic Xanthoastrocytoma: {} + Pilocytic Astrocytoma, WHO Grade 1: {} + Pilocytic Astrocytoma, WHO Grade 1, KIAA1549-BRAF Fusion: {} + Pilomyxoid Astrocytoma: {} + Pinealoblastoma: {} + Pinealoma: {} + Pineoblastoma: {} + Pineoblastoma, CNS Germ Cell Tumors, CNS Germinoma: {} + Pineoblastoma, Other CNS Embryonal Tumors: {} + Pineoblastoma, Other, Other CNS Tumor, NOS Or NEC: {} + Pituitary Adenoma, NOS: {} + Plasmacytoma, Extramedullary: {} + Pleomorphic Liposarcoma: {} + Pleomorphic Rhabdomyosarcoma, Adult Type: {} + Pleomorphic Sarcoma: {} + Pleomorphic Xanthoastrocytoma, NOS: {} + Pleomorphic Xanthoastrocytoma, NOS, High-Grade Glioma: {} + Pleomorphic Xanthoastrocytoma, NOS, Low-Grade Glioma: {} + Pleuropulmonary Blastoma: {} + Plexiform Fibrohistiocytic Tumor: {} + Poorly Differentiated Chordoma: {} + Poorly Differentiated Neuroblastoma: {} + Poorly Differentiated Sertoli-Leydig Cell Tumor With Heterologous Rhabdomyosarcomatous Differentiation: {} + Poorly Differentiated, Intermediate Mitotic-Karyorrhectic Index: {} + Poorly-Differentiated Neuroblastoma: {} + Posterior Fossa Ependymoma, CNS WHO Grade 2: {} + Precursor B-Cell Acute Lymphoblastic Leukemia With Hyperdiploidy: {} + Precursor B-Cell Lymphoblastic Leukemia: {} + Precursor Cell Lymphoblastic Leukemia, NOS: {} + Precursor Cell Lymphoblastic Lymphoma, NOS: {} + Precursor T-Cell Lymphoblastic Leukemia: {} + Precursor T-Cell Lymphoblastic Leukemia, Acute Myeloid Leukemia, NOS: {} + Primary Cutaneous CD30 Positive T-Cell Lymphoproliferative Disorder: {} + Primary Cutaneous Follicle Center Lymphoma: {} + Primary Mediastinal (Thymic) Large B-Cell Lymphoma: {} + Proliferative Dermal Lesion In Congenital Nevus: {} + Prostate Cancer: {} + Rasmussen Encephalitis: {} + Reactive Connective Tissue: {} + Renal Cell Adenocarcinoma: {} + Renal Cell Carcinoma: {} + Renal Cell Carcinoma, NOS: {} + Residual Astrocytoma: {} + Residual Low Grade Neuroendocrine Tumor (Typical Carcinoid): {} + Retinoblastoma: {} + Retinoblastoma, Grade 3: {} + Retinoblastoma, NOS: {} + Rhabdoid Tumor, Malignant: {} + Rhabdoid Tumor, NOS: {} + Rhabdomyoma, NOS: {} + Rhabdomyosarcoma: {} + Rhabdomyosarcoma, Embryonal Subtype: {} + Rhabdomyosarcoma, Embryonal Subtype Is Favored: {} + Rhabdomyosarcoma, Favor Alveolar Type: {} + Rhabdomyosarcoma, Most Likely An Embryonal Carcinoma: {} + Rhabdomyosarcoma, NOS: {} + Sarcoma: {} + Sarcoma, NOS: {} + Schawannoma: {} + Schwannian Stroma Poor Peripheral Neuroblastic Tumor, Consistent With Neuroblastoma: {} + Schwannoma: {} + Schwannoma, NOS: {} + Schwannoma, NOS, Low-Grade Glioma, Low-Grade Glioma, NOS Or NEC: {} + Schwannoma, NOS, Other: {} + Sclerosing Stromal Tumor: {} + Secretory Carcinoma: {} + Seminoma, NOS: {} + Serous Adenocarcinoma, NOS: {} + Serous Carcinoma, NOS: {} + Serous Cystadenocarcinoma NOS: {} + Serous Cystadenocarcinoma, NOS: {} + Serous Surface Papillary Carcinoma: {} + Sertoli Cell Tumor, NOS: {} + Sertoli Leydig Cell Tumor: {} + Sertoli-Leydig Cell Tumor Of Intermediate Differentiation, NOS: {} + Sertoli-Leydig Cell Tumor, Intermediate Differentiation, With Heterologous Elements: {} + Sertoli-Leydig Cell Tumor, Poorly Differentiated: {} + Sertoli-Leydig Cell Tumor, Poorly Differentiated, With Heterologous Elements: {} + Sex Cord Stromal Tumor NOS: {} + Sex Cord-Gonadal Stromal Tumor, Incompletely Differentiated: {} + Sex Cord-Gonadal Stromal Tumor, Mixed Forms: {} + Sex Cord-Gonadal Stromal Tumor, NOS: {} + Signet Ring Cell Carcinoma: {} + Small Blue Cell Tumor. Favor Medulloblastoma: {} + Small Cell Carcinoma, NOS: {} + Small Cell Neuroendocrine Carcinoma: {} + Small Cell Sarcoma: {} + Small Round Blue Cell Tumor: {} + Smooth Muscle Tumor Of Uncertain Malignant Potential: {} + Soft Tissue Sarcoma: {} + Soft Tissue Tumor, Benign: {} + Solid Pseudopapillary Neoplasm Of Pancreas: {} + Solid Pseudopapillary Tumor Of Ovary: {} + Solitary Fibrous Tumor, NOS: {} + Solitary Fibrous Tumor, NOS, Other: {} + Spinal Ependymoma, Histologically Low Grade (CNS WHO Grade 2): {} + Spinal Ependymoma, WHO Grade 2: {} + Spindle Cell Carcinoma, NOS: {} + Spindle Cell Melanoma, NOS: {} + Spindle Cell Melanoma, Type B: {} + Spindle Cell Rhabdomyosarcoma: {} + Spindle Cell Rhabdomyosaroma: {} + Spindle Cell Sarcoma: {} + Spindled And Epithelioid Tumor With Features Of Intracranial Mesenchymal Tumor: {} + Squamous Cell Carcinoma In Situ, NOS: {} + Squamous Cell Carcinoma NOS: {} + Squamous Cell Carcinoma, Keratinizing, NOS: {} + Squamous Cell Carcinoma, Large Cell, Nonkeratinizing, NOS: {} + Squamous Cell Carcinoma, Metastatic, NOS: {} + Squamous Cell Carcinoma, NOS: {} + Squamous Cell Carcinoma, Small Cell, Nonkeratinizing: {} + Stroma Poor, Poorly Differentiated Neuroblastoma With Low MKI, Favorable Histology: {} + Subcutaneous Panniculitis-Like T-Cell Lymphoma: {} + Subependymal Giant Cell Astrocytoma: {} + Subependymal Giant Cell Astrocytoma, Glioneuronal And Neuronal Tumors, Glioneuronal And Neuronal Tumors, NOS Or NEC: {} + Subependymoma: {} + Subependymoma, Ependymoma, Supratentorial Ependymoma, NOS Or NEC: {} + Supratentorial Ependymoma: {} + Supratentorial Ependymoma CNS WHO Grade 3: {} + Supratentorial Ependymoma, NOS: {} + Synovial Sarcoma: {} + Synovial Sarcoma, Biphasic: {} + Synovial Sarcoma, NOS: {} + Synovial Sarcoma, Spindle Cell: {} + T Lymphoblastic Leukemia/Lymphoma: {} + T-Cell/Histiocyte Rich Large B-Cell Lymphoma: {} + T-Lymphoblastic Leukemia: {} + T-Lymphoblastic Lymphoma: {} + Telangiectatic Osteosarcoma: {} + Tenosynovial Giant Cell Tumor, NOS: {} + Teratocarcinoma: {} + Teratoma: {} + Teratoma, Malignant, NOS: {} + Teratoma, NOS: {} + Therapy Related Myeloid Neoplasm: {} + Therapy-Related Myeloid Neoplasms: {} + Thymic Carcinoma, NOS: {} + Thymoma, NOS: {} + Transient Abnormal Myelopoiesis: {} + Transitional Cell Carcinoma: {} + Transitional Cell Carcinoma, NOS: {} + Tubular Adenocarcinoma: {} + Tumor Cells, Benign: {} + Tumor Cells, Malignant: {} + Tumor Cells, Malignant, Diffuse Leptomeningeal Glioneuronal Tumor, Glioneuronal And Neuronal Tumors: {} + Tumor Cells, Malignant, Medulloblastoma, Medulloblastoma, NOS Or NEC: {} + Tumor Cells, Malignant, Other, Pineal Parenchymal Tumor Of Intermediate Differentiation: {} + Tumor Cells, Uncertain Whether Benign Or Malignant: {} + Tumor Cells, Uncertain Whether Benign Or Malignant, Other CNS Embryonal Tumors, Pineoblastoma: {} + Unclassified Sarcoma With Round Cell Morphology: {} + Undiagnosed Spindle Cell Tumor: {} + Undifferentiated Leukaemia: {} + Undifferentiated Nasopharyngeal Carcinoma: {} + Undifferentiated Sarcoma: {} + Undifferentiated Small Round Cell Sarcoma: {} + Unknown: {} + Unknown, To Be Completed Later, Diffuse Midline Glioma, H3 K27-Altered, High-Grade Glioma: {} + Unknown, To Be Completed Later, Glioneuronal And Neuronal Tumors, Papillary Glioneuronal Tumor: {} + Unknown, To Be Completed Later, Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH: {} + Vascular Lesion, Consistent With Hemangioma: {} + Well Differentiated Neuroendocrince Tumor, Grade 1: {} + Xanthogranuloma: {} + Yolk Sac Tumor: {} + Yolk Sac Tumor, NOS: {} + Yolk Sac Tumor, NOS, CNS Germ Cell Tumors, CNS Non-Germinomatous Germ Cell Tumor: {} + primary_site_enum: + permissible_values: + Abdomen: {} + Abdominal Wall: {} + Acetabulum: {} + Adjacent Organ: {} + Adrenal Gland: {} + Anal/Perianal: {} + Ankle Joint: {} + Anterior Skull Base: {} + Anus: {} + Appendix: {} + Ascitic Fluid: {} + Axilla: {} + Axillary Nodes: {} + Bladder: {} + Bladder/Prostate: {} + Bone: {} + Bone Face: {} + Bone Marrow: {} + Bone or Bone Marrow: {} + Brain: {} + Brain/Leptomeninges: {} + Breast: {} + Bronchus: {} + Buttock: {} + Calcaneum: {} + Carpal Bone: {} + Cauda Equina Spinal Cord: {} + Celiac Nodes: {} + Central Nervous System: {} + Cerebellum: {} + Cerebrospinal Fluid: {} + Cervical Nodes: {} + Cervical Spine: {} + Cervical Vertebra: {} + Cervix: {} + Cheek: {} + Chest: {} + Chest Wall: {} + Choroid: {} + Clavicle: {} + Coccyx: {} + Colon: {} + Craniospinal: {} + Cutaneous: {} + Deep Facial Areas: {} + Deep Gray (e.g. Basal ganglia or Thalamus): {} + Dermis: {} + Distant Lymph Nodes: {} + Dorsal Spine: {} + Duodenum: {} + Ear - Lateral Skull Base and Nasopharynx: {} + Elbow Joint: {} + Epididymis: {} + Epitrochlear: {} + Epitrochlear or Brachial Nodes: {} + Esophagus: {} + Ethmoid Bone: {} + Eyelid: {} + Face: {} + Fallopian Tube: {} + Female Reproductive System Part: {} + Femur: {} + Fibula: {} + Fibula Head: {} + Finger: {} + Foot: {} + Foot Bone: {} + Foot Joint: {} + Foot Phalanges: {} + Forearm: {} + Fourth Ventricle: {} + Frontal Bone: {} + Frontal Cortex: {} + Frontal Lobe: {} + Gallbladder: {} + Gastrointestinal Tract: {} + Hand: {} + Hand Bone: {} + Hand Joint: {} + Hand Phalanges: {} + Head: {} + Head and Neck: {} + Heart: {} + Hip: {} + Hip/Inguinal Region: {} + Humerus: {} + Hypodermis: {} + Hypopharynx: {} + Iliac Crest: {} + Ilium: {} + Inferior Limb: {} + Infraclavicular Nodes: {} + Inguinal: {} + Inguinal or Femoral Nodes: {} + Intra-abdominal: {} + Intraperitoneal: {} + Intraspinal: {} + Intrathoracic: {} + Ischium: {} + Kidney: {} + Knee Joint: {} + Lacrimal Bone: {} + Large Vessels: {} + Larynx: {} + Larynx - Trachea: {} + Lateral Ventricle: {} + Leg: {} + Leptomeningeal: {} + Liver: {} + Liver/Biliary Tract: {} + Lower Arm: {} + Lower Extremity: {} + Lower Leg: {} + Lumbar Spinal Cord: {} + Lumbar Spine: {} + Lumbar Vertebra: {} + Lung: {} + Lymph Node: {} + Lymphatic Basin: {} + Mandible: {} + Maxilla: {} + Mediastinum: {} + Medulla: {} + Meninges: {} + Mesenteric Nodes: {} + Metacarpals: {} + Metatarsals: {} + Midbrain: {} + Middle Ear: {} + Nasal Bone: {} + Nasal Cavity: {} + Nasal Cavity and Paranasal Sinuses: {} + Nasal Septum: {} + Nasopharynx: {} + Neck: {} + Not Reported: {} + Occipital Bone: {} + Occipital Cortex: {} + Occipital Lobe: {} + Oculus Dexter (Right Eye): {} + Oculus Sinister (Left Eye): {} + Oculus Uterque (Both Eyes): {} + Omentum: {} + Optic Chiasm: {} + Optic Nerve: {} + Oral Cavity: {} + Orbit: {} + Oropharynx: {} + Other: {} + Ovary: {} + Pancreas: {} + Para-Aortic Lymph Nodes: {} + Paranasal Sinus: {} + Parapharyngeal Area: {} + Paraspinal: {} + Paratesticular: {} + Parathyroid: {} + Parietal Bone: {} + Parietal Cortex: {} + Parietal Lobe: {} + Parotid: {} + Patella: {} + Pectoral Nodes: {} + Pelvis: {} + Pelvis/Sacrum: {} + Penis: {} + Perineum: {} + Peritoneum: {} + Pineal: {} + Pleura: {} + Pleura Thymus: {} + Pleural Effusion: {} + Pons Varolii: {} + Popliteal Nodes: {} + Pre-auricular Nodes: {} + Prostate: {} + Radius Bone: {} + Rectum: {} + Regional Lymph Nodes: {} + Retroperitoneum: {} + Rib: {} + Sacrococcygeal: {} + Sacrum: {} + Salivary Gland: {} + Scalp: {} + Scapula: {} + Scapula/Clavicle: {} + Schlemm's Canal: {} + Shoulder: {} + Shoulder Girdle: {} + Shoulder Joint: {} + Skin: {} + Skull: {} + Skull and Face Bone: {} + Small Intestine: {} + Soft Tissue: {} + Soft Tissue, NOS: {} + Sphenoid Bone: {} + Spinal Cord: {} + Spine: {} + Spleen: {} + Splenic Hilar Nodes: {} + Sternum: {} + Sternum/Chest Wall: {} + Stomach: {} + Superior Limb and Shoulder: {} + Superior Maxilla: {} + Supraclavicular Nodes: {} + Suprasellar Pituitary: {} + Talus: {} + Tarsal Bone: {} + Temporal Bone: {} + Temporal Cortex: {} + Temporal Lobe: {} + Testis: {} + Thalamus: {} + Thigh: {} + Third Ventricle: {} + Thoracic Spinal Cord: {} + Thoracic Vertebra: {} + Thorax: {} + Thymus: {} + Thyroid: {} + Thyroid and Parathyroid: {} + Tibia: {} + Toe: {} + Tonsil: {} + Trabecular Meshwork: {} + Trachea: {} + Trunk: {} + Trunk - Paraspinal: {} + Ulna: {} + Unknown: {} + Upper Airway: {} + Upper Arm: {} + Upper Extremity: {} + Ureter: {} + Urogenital: {} + Uterus: {} + Vagina: {} + Vasculo-Nervous: {} + Viscera: {} + Vulva: {} + Waldeyer's Ring: {} + Wrist Joint: {} + Zygomatic Bone: {} + progression_or_recurrence_enum: + permissible_values: + 'No': {} + Not Allowed To Collect: {} + Not Reported: {} + Unknown: {} + 'Yes': {} + race_enum: + permissible_values: + American Indian or Alaska Native: {} + Asian: {} + Black or African American: {} + Native Hawaiian or other Pacific Islander: {} + Not Reported: {} + Not allowed to collect: {} + Unknown: {} + White: {} + reference_genome_assembly_enum: + permissible_values: + GRCh37: {} + GRCh37-lite: {} + GRCh38: {} + Not specified in data: {} + sample_anatomic_site_enum: + permissible_values: + 4th ventricle: {} + Abdomen: {} + Abdominal Wall: {} + Abdominal mass: {} + Acetabulum: {} + Adenoid: {} + Adipose: {} + Adrenal: {} + Adrenal mass: {} + Alveolar Ridge: {} + Amniotic Fluid: {} + Ampulla Of Vater: {} + Anal Sphincter: {} + Ankle: {} + Anorectum: {} + Antecubital Fossa: {} + Antrum: {} + Anus: {} + Aorta: {} + Aortic Body: {} + Appendix: {} + Aqueous Fluid: {} + Arm: {} + Artery: {} + Ascending Colon: {} + Ascending Colon Hepatic Flexure: {} + Auditory Canal: {} + Autonomic Nervous System: {} + Axilla: {} + Back: {} + Bilateral: {} + Bile Duct: {} + Bladder: {} + Blood: {} + Blood Vessel: {} + Bone: {} + Bone Marrow: {} + Bone Marrow metastasis: {} + Bone marrow: {} + Bowel: {} + Brain: {} + Brain Stem: {} + Brain stem: {} + Breast: {} + Broad Ligament: {} + Bronchiole: {} + Bronchus: {} + Brow: {} + Buccal Cavity: {} + Buccal Mucosa: {} + Buttock: {} + Calf: {} + Capillary: {} + Cardia: {} + Carina: {} + Carotid Artery: {} + Carotid Body: {} + Cartilage: {} + Cecum: {} + Cell-Line: {} + Central Nervous System: {} + Cerebellum: {} + Cerebral Cortex: {} + Cerebrospinal Fluid: {} + Cerebrum: {} + Cervical Spine: {} + Cervical node: {} + Cervix: {} + Chest: {} + Chest Wall: {} + Chin: {} + Clavicle: {} + Clitoris: {} + Colon: {} + Colon - Mucosa Only: {} + Common Duct: {} + Conjunctiva: {} + Connective Tissue: {} + Dermal: {} + Descending Colon: {} + Diaphragm: {} + Distal femur: {} + Duodenum: {} + Ear: {} + Ear Canal: {} + Ear, Pinna (External): {} + Effusion: {} + Elbow: {} + Endocrine Gland: {} + Epididymis: {} + Epidural Space: {} + Esophageal; Distal: {} + Esophageal; Mid: {} + Esophageal; Proximal: {} + Esophagogastric Junction: {} + Esophagus: {} + Esophagus - Mucosa Only: {} + Eye: {} + Fallopian Tube: {} + Femoral Artery: {} + Femoral Vein: {} + Femur: {} + Fibroblasts: {} + Fibula: {} + Finger: {} + Floor Of Mouth: {} + Fluid: {} + Foot: {} + Forearm: {} + Forehead: {} + Foreskin: {} + Frontal Cortex: {} + Frontal Lobe: {} + Fundus Of Stomach: {} + Gallbladder: {} + Ganglia: {} + Gastroesophageal Junction: {} + Gastrointestinal Tract: {} + Glottis: {} + Groin: {} + Gum: {} + Hand: {} + Hard Palate: {} + Head & Neck: {} + Head - Face Or Neck, Nos: {} + Heart: {} + Hepatic: {} + Hepatic Duct: {} + Hepatic Flexure: {} + Hepatic Vein: {} + Hip: {} + Hippocampus: {} + Humerus: {} + Hypopharynx: {} + Ileum: {} + Ilium: {} + Index Finger: {} + Ischium: {} + Islet Cells: {} + Jaw: {} + Jejunum: {} + Joint: {} + Kidney: {} + Knee: {} + L. Distal Femur: {} + L. Femur: {} + L. Kidney: {} + L. Occipital mass: {} + L. Proximal Tibia: {} + Lacrimal Gland: {} + Large Bowel: {} + Laryngopharynx: {} + Larynx: {} + Left Bone marrow: {} + Left thigh: {} + Leg: {} + Leptomeninges: {} + Ligament: {} + Lip: {} + Liver: {} + Liver metastasis: {} + Lumbar Spine: {} + Lung: {} + Lung mass: {} + Lung met: {} + Lung metastasis: {} + Lung/pleura: {} + Lymph Node: {} + Lymph Node met: {} + Lymph Node(s) Axilla: {} + Lymph Node(s) Cervical: {} + Lymph Node(s) Distant: {} + Lymph Node(s) Epitrochlear: {} + Lymph Node(s) Femoral: {} + Lymph Node(s) Hilar: {} + Lymph Node(s) Iliac-Common: {} + Lymph Node(s) Iliac-External: {} + Lymph Node(s) Inguinal: {} + Lymph Node(s) Internal Mammary: {} + Lymph Node(s) Mammary: {} + Lymph Node(s) Mesenteric: {} + Lymph Node(s) Occipital: {} + Lymph Node(s) Paraaortic: {} + Lymph Node(s) Parotid: {} + Lymph Node(s) Pelvic: {} + Lymph Node(s) Popliteal: {} + Lymph Node(s) Regional: {} + Lymph Node(s) Retroperitoneal: {} + Lymph Node(s) Scalene: {} + Lymph Node(s) Splenic: {} + Lymph Node(s) Subclavicular: {} + Lymph Node(s) Submandibular: {} + Lymph Node(s) Supraclavicular: {} + Lymph Nodes(s) Mediastinal: {} + Mandible: {} + Maxilla: {} + Mediastinal Soft Tissue: {} + Mediastinum: {} + Mesentery: {} + Mesothelium: {} + Middle Finger: {} + Mitochondria: {} + Muscle: {} + Nails: {} + Nasal Cavity: {} + Nasal Soft Tissue: {} + Nasopharynx: {} + Neck: {} + Nerve: {} + Nerve(s) Cranial: {} + Not Allowed To Collect: {} + Not Reported: {} + Not specified in data: {} + Occipital Cortex: {} + Ocular Orbits: {} + Omentum: {} + Oral Cavity: {} + Oral Cavity - Mucosa Only: {} + Orbit: {} + Oropharynx: {} + Os frontalis: {} + Other: {} + Ovary: {} + Palate: {} + Pancreas: {} + Paracaval Lymph Node metastasis: {} + Paranasal Sinuses: {} + Paraspinal Ganglion: {} + Paraspinal mass: {} + Paratesticular: {} + Parathyroid: {} + Parotid Gland: {} + Patella: {} + Pelvis: {} + Penis: {} + Pericardium: {} + Perineum: {} + Periorbital Soft Tissue: {} + Peripheral blood: {} + Peritoneal Cavity: {} + Peritoneum: {} + Pharynx: {} + Pineal: {} + Pineal Gland: {} + Pituitary Gland: {} + Placenta: {} + Pleura: {} + Pleural effusion met: {} + Popliteal Fossa: {} + Posterior mediastil mass (mediastinum): {} + Prostate: {} + Pylorus: {} + R. Breast metastasis: {} + R. Buttock: {} + R. Distal Femur: {} + R. Humerus: {} + R. Kidney: {} + R. Neck mass: {} + R. Parietal Lobe: {} + R. Proximal Ulna: {} + R. Sylvian Fissure: {} + R. femur/rib/verebra: {} + Rectosigmoid Junction: {} + Rectum: {} + Retina: {} + Retro-Orbital Region: {} + Retroperitoneal mass: {} + Retroperitoneum: {} + Rib: {} + Right Bone marrow: {} + Ring Finger: {} + Round Ligament: {} + Sacrum: {} + Salivary Gland: {} + Scalp: {} + Scapula: {} + Sciatic Nerve: {} + Scrotum: {} + Seminal Vesicle: {} + Shoulder: {} + Sigmoid Colon: {} + Sinus: {} + Sinus(es), Maxillary: {} + Skeletal Muscle: {} + Skin: {} + Skull: {} + Small Bowel: {} + Small Bowel - Mucosa Only: {} + Small Finger: {} + Soft Tissue: {} + Spinal Column: {} + Spinal Cord: {} + Spleen: {} + Splenic Flexure: {} + Sternum: {} + Stomach: {} + Stomach - Mucosa Only: {} + Subcutaneous Tissue: {} + Subglottis: {} + Sublingual Gland: {} + Submandibular Gland: {} + Supraglottis: {} + Synovium: {} + Temporal Cortex: {} + Tendon: {} + Testis: {} + Thigh: {} + Thoracic Spine: {} + Thorax: {} + Throat: {} + Thumb: {} + Thymus: {} + Thyroid: {} + Tibia: {} + Tongue: {} + Tonsil: {} + Tonsil (Pharyngeal): {} + Trachea / Major Bronchi: {} + Transverse Colon: {} + Trunk: {} + Umbilical Cord: {} + Unknowm: {} + Unknown: {} + Ureter: {} + Urethra: {} + Urinary Tract: {} + Uterus: {} + Uvula: {} + Vagina: {} + Vas Deferens: {} + Vein: {} + Venous: {} + Ventricular mass: {} + Vertebra: {} + Vulva: {} + White Blood Cells: {} + Wrist: {} + not reported: {} + post mortem blood: {} + post mortem liver: {} + post mortem liver tumor: {} + tumor: {} + sample_tumor_status_enum: + permissible_values: + Normal: {} + Not Reported: {} + Peritumoral: {} + Tumor: {} + Unknown: {} + sample_type_enum: + permissible_values: + Analyte: {} + Ascites: {} + Blood: {} + Bone Marrow: {} + Cells: {} + Fluids: {} + Mouth Rinse: {} + Sputum: {} + Stool: {} + Tissue: {} + Urine: {} + sex_enum: + permissible_values: + Decline to answer: {} + Don't know: {} + Female: {} + Intersex: {} + Male: {} + None of these describe me: {} + Prefer not to answer: {} + Unknown: {} + site_of_resection_or_biopsy_enum: + permissible_values: + Abdominal Aorta: {} + Abdominal Esophagus: {} + Abdominal Muscle: {} + Abdominal Skin: {} + Abdominal Wall: {} + Abducens Nerve: {} + Accessory Nerve: {} + Acetabulum: {} + Acromioclavicular Joint: {} + Adipose Tissue: {} + Adrenal Cortex: {} + Adrenal Gland: {} + Adrenal Medulla: {} + Ampulla of Vater: {} + Anal Canal: {} + Anal Transitional Zone: {} + Ankle Joint: {} + Ankle Skin: {} + Antecubital Region: {} + Anterior Cranial Fossa: {} + Anterior Mediastinum: {} + Anterior Surface of the Epiglottis: {} + Anterior Wall of the Bladder: {} + Anterior Wall of the Nasopharynx: {} + Antrum Pylori: {} + Anus: {} + Aorta: {} + Aortocaval Lymph Node: {} + Apex of the Tongue: {} + Aponeurosis: {} + Appendage of the Uterus: {} + Appendix: {} + Areola: {} + Arm Skin: {} + Artery: {} + Articular Cartilage: {} + Aryepiglottic Fold: {} + Arytenoid Cartilage: {} + Ascending Colon: {} + Autonomic Nervous System: {} + Axilla: {} + Axillary Artery: {} + Axillary Lymph Node: {} + Axillary Tail of the Breast: {} + Back: {} + Bartholin Gland: {} + Basal Ganglia: {} + Base of the Tongue: {} + Biceps: {} + Biceps Femoris: {} + Bile Canaliculus: {} + Bile Duct: {} + Biliary Tract: {} + Bladder: {} + Bladder Neck: {} + Bladder Trigone: {} + Blood: {} + Blood Vessel: {} + Body of Stomach: {} + Body of the Pancreas: {} + Body of the Penis: {} + Bone: {} + Bone Marrow: {} + Bone of the Extremity: {} + Brachial Lymph Node: {} + Brachial Plexus: {} + Brachialis: {} + Brain: {} + Brain Dura Mater: {} + Brain Stem: {} + Brain Ventricle: {} + Branchial Cleft Remnant: {} + Breast: {} + Broad Ligament: {} + Bronchial Lymph Node: {} + Bronchiole: {} + Bronchus: {} + Buccal Mucosa: {} + Buttock: {} + C1 Vertebra: {} + C2 Vertebra: {} + Calcaneum: {} + Calf: {} + Cardiac Atrium: {} + Cardiac Ventricle: {} + Carina: {} + Carotid Artery: {} + Carotid Body: {} + Carpal Bone: {} + Carpal Region: {} + Cartilage: {} + Cauda Equina: {} + Cecum: {} + Celiac Artery: {} + Celiac Lymph Node: {} + Central Nervous System: {} + Central Portion of the Breast: {} + Cerebellopontine Angle: {} + Cerebellum: {} + Cerebral Cortex: {} + Cerebral Hemisphere: {} + Cerebral Meninges: {} + Cerebral Peduncle: {} + Cerebral White Matter: {} + Ceruminous Gland: {} + Cervical Esophagus: {} + Cervical Gland: {} + Cervical Lymph Node: {} + Cervix Uteri: {} + Cheek: {} + Chest: {} + Chest Wall: {} + Choroid: {} + Choroid Plexus: {} + Choroid Plexus of the Fourth Ventricle: {} + Choroid Plexus of the Lateral Ventricle: {} + Choroid Plexus of the Third Ventricle: {} + Ciliary Body: {} + Clitoris: {} + Coccyx: {} + Cochlear Nerve: {} + Colon: {} + Commissure of the Lip: {} + Common Bile Duct: {} + Concha: {} + Conjunctiva: {} + Connective Tissue: {} + Conus Medullaris: {} + Coracobrachialis: {} + Cornea: {} + Corneoscleral Limbus: {} + Corpus Callosum: {} + Corpus Striatum: {} + Corpus Uteri: {} + Costal Cartilage: {} + Costovertebral Joint: {} + Cowper Gland: {} + Cranial Nerve: {} + Craniopharyngeal Duct: {} + Cricoid Cartilage: {} + Cul-de-sac: {} + Cuneiform Cartilage: {} + Cystic Duct: {} + Descending Colon: {} + Diaphragm: {} + Diaphragmatic Lymph Node: {} + Dome of the Bladder: {} + Duct of Gartner: {} + Ductus Santorini: {} + Duodenum: {} + Dura Mater: {} + Ear: {} + Ear Skin: {} + Ectocervix: {} + Elbow Joint: {} + Elbow Skin: {} + Endocardium: {} + Endocervix: {} + Endocrine Gland: {} + Endometrial Stroma: {} + Endometrium: {} + Ependyma: {} + Epicardium: {} + Epididymis: {} + Epidural Spinal Canal Space: {} + Epiglottis: {} + Epitrochlear Lymph Node: {} + Esophagus: {} + Ethmoid Bone: {} + Ethmoid Sinus: {} + Eustachian Tube: {} + External Acoustic Meatus: {} + External Ear: {} + External Lip: {} + External Lower Lip: {} + External Nose: {} + External Upper Lip: {} + Extrahepatic Bile Duct: {} + Eye: {} + Eyebrow: {} + Eyelid: {} + Facial Bone: {} + Facial Nerve: {} + Fallopian Tube: {} + False Vocal Cord: {} + Falx Cerebelli: {} + Falx Cerebri: {} + Fascia: {} + Female Genitalia: {} + Femoral Artery: {} + Femoral Lymph Node: {} + Femoral Nerve: {} + Femur: {} + Fibrous Tissue: {} + Fibula: {} + Finger: {} + Fingernail: {} + Flank: {} + Floor of Mouth: {} + Foot: {} + Foot Bone: {} + Foot Phalanx: {} + Foot Skin: {} + Forearm: {} + Forehead: {} + Fourth Ventricle: {} + Frontal Bone: {} + Frontal Lobe: {} + Frontal Pole: {} + Frontal Sinus: {} + Fundus Uteri: {} + Fundus of the Stomach: {} + Gallbladder: {} + Gastric Cardia: {} + Gastric Lymph Node: {} + Gastrocnemius Muscle: {} + Gastroesophageal Junction: {} + Gastrointestinal Tract: {} + Gingiva: {} + Gland of Littre: {} + Glans Penis: {} + Globus Pallidus: {} + Glossopharyngeal Nerve: {} + Glottis: {} + Gluteus Maximus: {} + Greater Curvature of the Stomach: {} + Hand: {} + Hand Digit 1: {} + Hand Phalanx: {} + Hand Skin: {} + Hard Palate: {} + Head Skin: {} + Head and Neck Lymph Node: {} + Head of the Pancreas: {} + Heart: {} + Helix: {} + Hematopoietic System: {} + Hepatic: {} + Hepatic Duct: {} + Hepatic Flexure: {} + Hepatic Lymph Node: {} + Hip: {} + Hip Joint: {} + Hippocampus: {} + Humerus: {} + Hymen: {} + Hyoid Bone: {} + Hypoglossal Nerve: {} + Hypopharynx: {} + Hypothalamus: {} + Ileocecal Valve: {} + Ileum: {} + Iliac Artery: {} + Iliac Lymph Node: {} + Iliac Vein: {} + Iliopsoas Muscle: {} + Ilium: {} + Inferior Vena Cava: {} + Infraclavicular Lymph Node: {} + Infraclavicular Region: {} + Infratentorial Brain: {} + Inguinal Lymph Node: {} + Inguinal Region: {} + Inner Canthus: {} + Inner Ear: {} + Intercostal Lymph Node: {} + Intercostal Muscle: {} + Intercostal Nerve: {} + Internal Capsule: {} + Internal Iliac Lymph Node: {} + Internal Mammary Artery: {} + Internal Mammary Lymph Node: {} + Internal Nare: {} + Intervertebral Disc: {} + Intestine: {} + Intra-Abdominal Lymph Node: {} + Intrahepatic Bile Duct: {} + Intraocular Route of Administration: {} + Intrathoracic Lymph Node: {} + Iris: {} + Ischiorectal Fossa: {} + Ischium: {} + Islet of Langerhans: {} + Isthmus Uteri: {} + Jaw Bone: {} + Jaw Joint: {} + Jejunum: {} + Joint: {} + Kidney: {} + Knee Joint: {} + Knee Skin: {} + Labium: {} + Labium Majus: {} + Labium Minus: {} + Lacrimal Gland: {} + Lacrimal Sac: {} + Large Intestine: {} + Laryngeal Cartilage: {} + Larynx: {} + Lateral Ventricle: {} + Lateral Wall of the Bladder: {} + Lateral Wall of the Nasopharynx: {} + Lateral Wall of the Oropharynx: {} + Lateral Wall of the Pharynx: {} + Leg Skin: {} + Lens: {} + Lesser Curvature of the Stomach: {} + Ligament: {} + Lingual Tonsil: {} + Lingula of the Lung: {} + Lip: {} + Liver: {} + Lobule of the Auricle: {} + Lower Extremity: {} + Lower Gingiva: {} + Lower Lobe of the Lung: {} + Lower Third of the Esophagus: {} + Lower-Inner Quadrant of the Breast: {} + Lower-Outer Quadrant of the Breast: {} + Lumbar Nerve: {} + Lumbosacral Plexus: {} + Lung: {} + Lymph Node: {} + Lymph Node of Inguinal Region or Leg: {} + Lymphatic: {} + Main Bronchus: {} + Male Genitalia: {} + Male Prepuce: {} + Mammary Gland: {} + Mandible: {} + Masseter Muscle: {} + Maxilla: {} + Maxillary Sinus: {} + Meckel Diverticulum: {} + Median Nerve: {} + Mediastinal Lymph Node: {} + Mediastinum: {} + Medulla Oblongata: {} + Meibomian Gland: {} + Meninges: {} + Meniscus Lateralis: {} + Meniscus Medialis: {} + Mentum: {} + Mesencephalon: {} + Mesenteric Artery: {} + Mesenteric Lymph Node: {} + Mesentery: {} + Mesonephric Duct: {} + Mesonephros: {} + Mesovarium: {} + Metacarpal Bone: {} + Metatarsal Bone: {} + Middle Cranial Fossa: {} + Middle Ear: {} + Middle Lobe of the Right Lung: {} + Middle Third of the Esophagus: {} + Minor Salivary Gland: {} + Mons Pubis: {} + Mucosa of the Lip: {} + Mucosa of the Lower Lip: {} + Mucosa of the Upper Lip: {} + Muscle: {} + Musculus Latissimus Dorsi: {} + Myocardium: {} + Myometrium: {} + Nasal Bone: {} + Nasal Cartilage: {} + Nasal Cavity: {} + Nasal Septum: {} + Nasal Turbinate: {} + Nasolacrimal Duct: {} + Nasopharynx: {} + Neck Skin: {} + Nerve: {} + Nervous System: {} + Nipple: {} + Nose: {} + Nostril: {} + Obturator Lymph Node: {} + Obturator Nerve: {} + Occipital Bone: {} + Occipital Lobe: {} + Occipital Lymph Node: {} + Oculomotor Muscle: {} + Oculomotor Nerve: {} + Olfactory Nerve: {} + Omentum: {} + Optic Chiasm: {} + Optic Nerve: {} + Optic Tract: {} + Oral Cavity: {} + Orbit: {} + Oropharynx: {} + Other Specified Parts of Pancreas: {} + Outer Canthus: {} + Ovary: {} + Palate: {} + Palatine Tonsil: {} + Palmar Fascia: {} + Pancreas: {} + Pancreatic Duct: {} + Pancreatic Lymph Node: {} + Paraaortic Lymph Node: {} + Paraganglion: {} + Parametrium: {} + Paranasal Sinus: {} + Parasympathetic Nervous System: {} + Parathyroid Gland: {} + Paratracheal Lymph Node: {} + Parietal Bone: {} + Parietal Lobe: {} + Parietal Pleura: {} + Parotid Duct: {} + Parotid Gland: {} + Parotid Gland Lymph Node: {} + Patella: {} + Pectoral Lymph Node: {} + Pectoralis Major: {} + Pelvic Lymph Node: {} + Pelvis: {} + Penis: {} + Pericardium: {} + Perineum: {} + Peripheral Nerve: {} + Peritoneal Cavity: {} + Peritoneum: {} + Pharyngeal Tonsil: {} + Pharynx: {} + Pia Mater: {} + Pineal Gland: {} + Pituitary Gland: {} + Placenta: {} + Plantar Fascia: {} + Plantar Region: {} + Pleura: {} + Pons Varolii: {} + Popliteal Lymph Node: {} + Portal Lymph Node: {} + Postcricoid Region: {} + Posterior Cranial Fossa: {} + Posterior Mediastinum: {} + Posterior Wall of the Bladder: {} + Posterior Wall of the Hypopharynx: {} + Posterior Wall of the Nasopharynx: {} + Posterior Wall of the Oropharynx: {} + Posterior Wall of the Pharynx: {} + Preauricular Lymph Node: {} + Prostate Gland: {} + Prostatic Utricle: {} + Psoas Muscle: {} + Pubic Bone: {} + Pubic Symphysis: {} + Pulmonary: {} + Pulmonary Hilar Lymph Node: {} + Putamen: {} + Pylorus: {} + Pyriform Sinus: {} + Quadriceps Muscle of the Thigh: {} + Radial Artery: {} + Radial Nerve: {} + Radius Bone: {} + Rathke Pouch: {} + Rectosigmoid Colon: {} + Rectosigmoid Region: {} + Rectum: {} + Rectus Abdominis: {} + Renal: {} + Renal Artery: {} + Renal Calyx: {} + Renal Pelvis: {} + Reticuloendothelial System: {} + Retina: {} + Retromolar Trigone: {} + Retroperitoneal Lymph Node: {} + Retroperitoneum: {} + Retropharyngeal Lymph Node: {} + Round Ligament of the Uterus: {} + Sacral Bone: {} + Sacral Lymph Node: {} + Sacral Nerve: {} + Sacral Plexus: {} + Salivary Gland: {} + Scalene Lymph Node: {} + Scalp: {} + Scapula: {} + Sciatic Nerve: {} + Sclera: {} + Scrotum: {} + Sella Turcica: {} + Seminal Vesicle: {} + Shoulder: {} + Shoulder Girdle: {} + Shoulder Joint: {} + Sigmoid Colon: {} + Skeletal Muscle Tissue: {} + Skin: {} + Skin Of The Axilla: {} + Skin of the Face: {} + Skin of the Lip: {} + Skin of the Lower Limb and Hip: {} + Skin of the Scalp and Neck: {} + Skin of the Trunk: {} + Skin of the Upper Limb and Shoulder: {} + Skull: {} + Skullcap: {} + Small Intestine: {} + Spermatic Cord: {} + Sphenoid Bone: {} + Sphenoid Sinus: {} + Sphincter of Oddi: {} + Spinal Cord: {} + Spinal Cord Dura Mater: {} + Spinal Meninges: {} + Spinal Nerve: {} + Spleen: {} + Splenic Flexure: {} + Splenic Hilar Lymph Node: {} + Sternocleidomastoid Muscle: {} + Sternocostal Joint: {} + Stomach: {} + Subclavian Artery: {} + Subcutis: {} + Subglottis: {} + Sublingual Lymph Node: {} + Sublingual Salivary Gland: {} + Submandibular Duct: {} + Submandibular Gland: {} + Submandibular Lymph Node: {} + Superior Vena Cava: {} + Superior Wall of the Nasopharynx: {} + Supraclavicular: {} + Supraclavicular Lymph Node: {} + Supraglottis: {} + Suprasellar Region: {} + Supratentorial Brain: {} + Sympathetic Nervous System: {} + Synovial Bursa: {} + Synovial Fluid: {} + Tail of the Pancreas: {} + Tarsal Bone: {} + Temporal Bone: {} + Temporal Lobe: {} + Tendon: {} + Tendon Sheath: {} + Tentorium Cerebelli: {} + Testis: {} + Thalamus: {} + Thigh: {} + Third Ventricle: {} + Thoracic Duct: {} + Thoracic Esophagus: {} + Thoracic Lymph Node: {} + Thorax: {} + Thymus Gland: {} + Thyroglossal Duct: {} + Thyroid Cartilage: {} + Thyroid Gland: {} + Tibia: {} + Toe: {} + Toenail: {} + Tongue: {} + Tonsillar Fossa: {} + Tonsillar Pillar: {} + Tooth Socket: {} + Trachea: {} + Tracheobronchial Lymph Node: {} + Tragus: {} + Transverse Colon: {} + Trapezius Muscle: {} + Triceps Brachii: {} + Trigeminal Nerve: {} + Trochlear Nerve: {} + True Vocal Cord: {} + Trunk: {} + Tunica Vaginalis: {} + Ulna: {} + Ulnar Artery: {} + Ulnar Nerve: {} + Umbilicus: {} + Uncus: {} + Undescended Testes: {} + Upper Extremity: {} + Upper Gingiva: {} + Upper Lobe of the Lung: {} + Upper Third of the Esophagus: {} + Upper-Inner Quadrant of the Breast: {} + Upper-Outer Quadrant of the Breast: {} + Urachus: {} + Ureter: {} + Ureteric Orifice: {} + Ureteropelvic Junction: {} + Urethra: {} + Uterine Gland: {} + Uterine Ligament: {} + Uterus: {} + Uvea: {} + Uvula: {} + Vagina: {} + Vaginal Fornix: {} + Vagus Nerve: {} + Vallecula: {} + Vas Deferens: {} + Vein: {} + Vena Cava: {} + Vermis: {} + Vertebra: {} + Vertebral Column: {} + Visceral Pleura: {} + Vocal Cord: {} + Vulva: {} + Waldeyer's Tonsillar Ring: {} + Wall of the Pharynx: {} + Wrist Joint: {} + Wrist Skin: {} + staining_method_enum: + permissible_values: + CODEX: {} + GeoMX-DSP: {} + H&E: {} + IHC: {} + IMC: {} + MIBI: {} + MxIF: {} + SABER: {} + mIHC: {} + t-CyCIF: {} + study_access_enum: + permissible_values: + Controlled: {} + Open: {} + study_data_types_enum: + permissible_values: + Genomic: {} + Imaging: {} + Proteomic: {} + therapeutic_agents_enum: + permissible_values: + 10-Deacetyltaxol: {} + 11C Topotecan: {} + 11D10 AluGel Anti-Idiotype Monoclonal Antibody: {} + 12-Allyldeoxoartemisinin: {} + 13-Deoxydoxorubicin: {} + 14C BMS-275183: {} + 17beta-Hydroxysteroid Dehydrogenase Type 5 Inhibitor ASP9521: {} + 2'-F-ara-deoxyuridine: {} + 2,6-Diaminopurine: {} + 2,6-Dimethoxyquinone: {} + 2-Deoxy-D-glucose: {} + 2-Ethylhydrazide: {} + 2-Fluoroadenine: {} + 2-Fluorofucose-containing SGN-2FF: {} + 2-Hydroxyestradiol: {} + 2-Hydroxyestrone: {} + 2-Hydroxyflutamide Depot: {} + 2-Hydroxyoleic Acid: {} + 2-Methoxyestradiol: {} + 2-Methoxyestradiol Nanocrystal Colloidal Dispersion: {} + 2-Methoxyestrone: {} + 2-O, 3-O Desulfated Heparin: {} + 3'-C-ethynylcytidine: {} + 3'-dA Phosphoramidate NUC-7738: {} + 4'-Iodo-4'-Deoxydoxorubicin: {} + 4-Nitroestrone 3-Methyl Ether: {} + 4-Thio-2-deoxycytidine: {} + 5-Aza-4'-thio-2'-deoxycytidine: {} + 5-Fluoro-2-Deoxycytidine: {} + 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatases Isoform 3 Inhibitor ACT-PFK-158: {} + 7-Cyanoquinocarcinol: {} + 7-Ethyl-10-Hydroxycamptothecin: {} + 7-Hydroxystaurosporine: {} + 8-Azaguanine: {} + 9-Ethyl 6-Mercaptopurine: {} + 9H-Purine-6Thio-98D: {} + A2A Receptor Antagonist EOS100850: {} + ADH-1: {} + AE37 Peptide/GM-CSF Vaccine: {} + AEE788: {} + AKR1C3-activated Prodrug OBI-3424: {} + AKT 1/2 Inhibitor BAY1125976: {} + AKT Inhibitor ARQ 092: {} + ALK Inhibitor: {} + ALK Inhibitor ASP3026: {} + ALK Inhibitor PLB 1003: {} + ALK Inhibitor RO5424802: {} + ALK Inhibitor TAE684: {} + ALK Inhibitor WX-0593: {} + ALK-2 Inhibitor TP-0184: {} + ALK-FAK Inhibitor CEP-37440: {} + ALK/FAK/Pyk2 Inhibitor CT-707: {} + ALK/ROS1/Met Inhibitor TQ-B3101: {} + ALK/TRK Inhibitor TSR-011: {} + ALK/c-Met Inhibitor TQ-B3139: {} + APC8015F: {} + APE1/Ref-1 Redox Inhibitor APX3330: {} + AR Antagonist BMS-641988: {} + ARC Fusion Protein SL-279252: {} + ASP4132: {} + ATM Inhibitor M 3541: {} + ATM Kinase Inhibitor AZD0156: {} + ATM Kinase Inhibitor AZD1390: {} + ATR Inhibitor RP-3500: {} + ATR Kinase Inhibitor BAY1895344: {} + ATR Kinase Inhibitor M1774: {} + ATR Kinase Inhibitor M6620: {} + ATR Kinase Inhibitor VX-803: {} + AXL Inhibitor DS-1205c: {} + AXL Inhibitor SLC-391: {} + AXL Receptor Tyrosine Kinase/cMET Inhibitor BPI-9016M: {} + AXL/ FLT3/VEGFR2 Inhibitor KC1036: {} + Abagovomab: {} + Abarelix: {} + Abemaciclib: {} + Abemaciclib Mesylate: {} + Abexinostat: {} + Abexinostat Tosylate: {} + Abiraterone: {} + Abiraterone Acetate: {} + Abituzumab: {} + Acai Berry Juice: {} + Acalabrutinib: {} + Acalisib: {} + Aceglatone: {} + Acetylcysteine: {} + Acitretin: {} + Acivicin: {} + Aclacinomycin B: {} + Aclarubicin: {} + Acodazole: {} + Acodazole Hydrochloride: {} + Acolbifene Hydrochloride: {} + Acridine: {} + Acridine Carboxamide: {} + Acronine: {} + Actinium Ac 225 Lintuzumab: {} + Actinium Ac 225-FPI-1434: {} + Actinium Ac-225 Anti-PSMA Monoclonal Antibody J591: {} + Actinomycin C2: {} + Actinomycin C3: {} + Actinomycin F1: {} + Activin Type 2B Receptor Fc Fusion Protein STM 434: {} + Acyclic Nucleoside Phosphonate Prodrug ABI-1968: {} + Ad-RTS-hIL-12: {} + Adagloxad Simolenin: {} + Adavosertib: {} + Adecatumumab: {} + Adenosine A2A Receptor Antagonist AZD4635: {} + Adenosine A2A Receptor Antagonist CS3005: {} + Adenosine A2A Receptor Antagonist NIR178: {} + Adenosine A2A Receptor Antagonist/Phosphodiesterase 10A PBF-999: {} + Adenosine A2A/A2B Receptor Antagonist AB928: {} + Adenosine A2B Receptor Antagonist PBF-1129: {} + Adenovector-transduced AP1903-inducible MyD88/CD40-expressing Autologous PSMA-specific Prostate Cancer Vaccine BPX-201: {} + Adenoviral Brachyury Vaccine ETBX-051: {} + Adenoviral Cancer Vaccine PF-06936308: {} + Adenoviral MUC1 Vaccine ETBX-061: {} + Adenoviral PSA Vaccine ETBX-071: {} + Adenoviral Transduced hIL-12-expressing Autologous Dendritic Cells INXN-3001 Plus Activator Ligand INXN-1001: {} + Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP: {} + Adenoviral Tumor-specific Neoantigen Priming Vaccine GRT-C901: {} + Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE: {} + Adenovirus Serotype 26-expressing HPV16 Vaccine JNJ-63682918: {} + Adenovirus Serotype 26-expressing HPV18 Vaccine JNJ-63682931: {} + Adenovirus-expressing TLR5/TLR5 Agonist Nanoformulation M-VM3: {} + Adenovirus-mediated Human Interleukin-12 INXN-2001 Plus Activator Ligand INXN-1001: {} + Aderbasib: {} + Aerosol Gemcitabine: {} + Aerosolized Aldesleukin: {} + Aerosolized Liposomal Rubitecan: {} + Afatinib: {} + Afatinib Dimaleate: {} + Afimoxifene: {} + Afuresertib: {} + Agatolimod Sodium: {} + Agerafenib: {} + Aglatimagene Besadenovec: {} + Agonistic Anti-CD40 Monoclonal Antibody ADC-1013: {} + Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949: {} + Agonistic Anti-OX40 Monoclonal Antibody MEDI6469: {} + Akt Inhibitor LY2780301: {} + Akt Inhibitor MK2206: {} + Akt Inhibitor SR13668: {} + Akt/ERK Inhibitor ONC201: {} + Alacizumab Pegol: {} + Alanosine: {} + Albumin-binding Cisplatin Prodrug BTP-114: {} + Aldesleukin: {} + Aldoxorubicin: {} + Alectinib: {} + Alefacept: {} + Alemtuzumab: {} + Alestramustine: {} + Alflutinib Mesylate: {} + Algenpantucel-L: {} + Alisertib: {} + Alitretinoin: {} + Alkotinib: {} + Allodepleted T Cell Immunotherapeutic ATIR101: {} + Allogeneic Anti-BCMA CAR-transduced T-cells ALLO-715: {} + Allogeneic Anti-BCMA-CAR T-cells PBCAR269A: {} + Allogeneic Anti-BCMA/CS1 Bispecific CAR-T Cells: {} + Allogeneic Anti-CD19 CAR T-cells ALLO-501A: {} + Allogeneic Anti-CD19 Universal CAR-T Cells CTA101: {} + Allogeneic Anti-CD19-CAR T-cells PBCAR0191: {} + Allogeneic Anti-CD20 CAR T-cells LUCAR-20S: {} + Allogeneic Anti-CD20-CAR T-cells PBCAR20A: {} + Allogeneic CD22-specific Universal CAR-expressing T-lymphocytes UCART22: {} + Allogeneic CD3- CD19- CD57+ NKG2C+ NK Cells FATE-NK100: {} + Allogeneic CD56-positive CD3-negative Natural Killer Cells CYNK-001: {} + Allogeneic CD8+ Leukemia-associated Antigens Specific T Cells NEXI-001: {} + Allogeneic CRISPR-Cas9 Engineered Anti-BCMA T Cells CTX120: {} + Allogeneic CRISPR-Cas9 Engineered Anti-CD70 CAR-T Cells CTX130: {} + Allogeneic CS1-specific Universal CAR-expressing T-lymphocytes UCARTCS1A: {} + Allogeneic Cellular Vaccine 1650-G: {} + Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM: {} + Allogeneic GM-CSF-secreting Lethally Irradiated Prostate Cancer Vaccine: {} + Allogeneic GM-CSF-secreting Lethally Irradiated Whole Melanoma Cell Vaccine: {} + Allogeneic GM-CSF-secreting Tumor Vaccine PANC 10.05 pcDNA-1/GM-Neo: {} + Allogeneic GM-CSF-secreting Tumor Vaccine PANC 6.03 pcDNA-1/GM-Neo: {} + Allogeneic IL13-Zetakine/HyTK-Expressing-Glucocorticoid Resistant Cytotoxic T Lymphocytes GRm13Z40-2: {} + Allogeneic Irradiated Melanoma Cell Vaccine CSF470: {} + Allogeneic Large Multivalent Immunogen Melanoma Vaccine LP2307: {} + Allogeneic Melanoma Vaccine AGI-101H: {} + Allogeneic Natural Killer Cell Line MG4101: {} + Allogeneic Natural Killer Cell Line NK-92: {} + Allogeneic Plasmacytoid Dendritic Cells Expressing Lung Tumor Antigens PDC*lung01: {} + Allogeneic Renal Cell Carcinoma Vaccine MGN1601: {} + Allogeneic Third-party Suicide Gene-transduced Anti-HLA-DPB1*0401 CD4+ T-cells CTL 19: {} + Allosteric ErbB Inhibitor BDTX-189: {} + Allovectin-7: {} + Almurtide: {} + Alobresib: {} + Alofanib: {} + Alpelisib: {} + Alpha Galactosylceramide: {} + Alpha V Beta 1 Inhibitor ATN-161: {} + Alpha V Beta 8 Antagonist PF-06940434: {} + Alpha-Gal AGI-134: {} + Alpha-Thioguanine Deoxyriboside: {} + Alpha-lactalbumin-derived Synthetic Peptide-lipid Complex Alpha1H: {} + Alpha-tocopheryloxyacetic Acid: {} + Alsevalimab: {} + Altiratinib: {} + Altretamine: {} + Alvespimycin: {} + Alvespimycin Hydrochloride: {} + Alvocidib: {} + Alvocidib Hydrochloride: {} + Alvocidib Prodrug TP-1287: {} + Amatuximab: {} + Ambamustine: {} + Ambazone: {} + Amblyomin-X: {} + Amcasertib: {} + Ametantrone: {} + Amifostine: {} + Amino Acid Injection: {} + Aminocamptothecin: {} + Aminocamptothecin Colloidal Dispersion: {} + Aminoflavone Prodrug AFP464: {} + Aminopterin: {} + Aminopterin Sodium: {} + Amivantamab: {} + Amolimogene Bepiplasmid: {} + Amonafide L-Malate: {} + Amrubicin: {} + Amrubicin Hydrochloride: {} + Amsacrine: {} + Amsacrine Lactate: {} + Amsilarotene: {} + Amustaline: {} + Amustaline Dihydrochloride: {} + Amuvatinib: {} + Amuvatinib Hydrochloride: {} + Anakinra: {} + Anastrozole: {} + Anaxirone: {} + Ancitabine: {} + Ancitabine Hydrochloride: {} + Andecaliximab: {} + Androgen Antagonist APC-100: {} + Androgen Receptor Antagonist BAY 1161116: {} + Androgen Receptor Antagonist SHR3680: {} + Androgen Receptor Antagonist TAS3681: {} + Androgen Receptor Antagonist TRC253: {} + Androgen Receptor Antisense Oligonucleotide AZD5312: {} + Androgen Receptor Antisense Oligonucleotide EZN-4176: {} + Androgen Receptor Degrader ARV-110: {} + Androgen Receptor Degrader CC-94676: {} + Androgen Receptor Downregulator AZD3514: {} + Androgen Receptor Inhibitor EPI-7386: {} + Androgen Receptor Ligand-binding Domain-encoding Plasmid DNA Vaccine MVI-118: {} + Androgen Receptor/Glucocorticoid Receptor Antagonist CB-03-10: {} + Andrographolide: {} + Androstane Steroid HE3235: {} + Anetumab Ravtansine: {} + Ang2/VEGF-Binding Peptides-Antibody Fusion Protein CVX-241: {} + Angiogenesis Inhibitor GT-111: {} + Angiogenesis Inhibitor JI-101: {} + Angiogenesis/Heparanase Inhibitor PG545: {} + Angiopoietin-2-specific Fusion Protein PF-04856884: {} + Anhydrous Enol-oxaloacetate: {} + Anhydrovinblastine: {} + Aniline Mustard: {} + Anlotinib Hydrochloride: {} + Annamycin: {} + Annamycin Liposomal: {} + Annonaceous Acetogenins: {} + Ansamitomicin P-3: {} + Anthramycin: {} + Anthrapyrazole: {} + Anti c-KIT Antibody-drug Conjugate LOP628: {} + Anti-5T4 Antibody-Drug Conjugate PF-06263507: {} + Anti-5T4 Antibody-drug Conjugate ASN004: {} + Anti-5T4 Antibody-drug Conjugate SYD1875: {} + Anti-A33 Monoclonal Antibody KRN330: {} + Anti-A5B1 Integrin Monoclonal Antibody PF-04605412: {} + Anti-ACTR/4-1BB/CD3zeta-Viral Vector-transduced Autologous T-Lymphocytes ACTR087: {} + Anti-AG7 Antibody Drug Conjugate AbGn-107: {} + Anti-AGS-16 Monoclonal Antibody AGS-16M18: {} + Anti-AGS-5 Antibody-Drug Conjugate ASG-5ME: {} + Anti-AGS-8 Monoclonal Antibody AGS-8M4: {} + Anti-ANG2 Monoclonal Antibody MEDI-3617: {} + Anti-APRIL Monoclonal Antibody BION-1301: {} + Anti-AXL Fusion Protein AVB-S6-500: {} + Anti-AXL/PBD Antibody-drug Conjugate ADCT-601: {} + Anti-B7-H3 Antibody DS-5573a: {} + Anti-B7-H3/DXd Antibody-drug Conjugate DS-7300a: {} + Anti-B7-H4 Monoclonal Antibody FPA150: {} + Anti-B7H3 Antibody-drug Conjugate MGC018: {} + Anti-BCMA Antibody SEA-BCMA: {} + Anti-BCMA Antibody-drug Conjugate AMG 224: {} + Anti-BCMA Antibody-drug Conjugate CC-99712: {} + Anti-BCMA Antibody-drug Conjugate GSK2857916: {} + Anti-BCMA SparX Protein Plus BCMA-directed Anti-TAAG ARC T-cells CART-ddBCMA: {} + Anti-BCMA/Anti-CD3 Bispecific Antibody REGN5459: {} + Anti-BCMA/CD3 BiTE Antibody AMG 420: {} + Anti-BCMA/CD3 BiTE Antibody AMG 701: {} + Anti-BCMA/CD3 BiTE Antibody REGN5458: {} + Anti-BCMA/PBD ADC MEDI2228: {} + Anti-BTLA Monoclonal Antibody TAB004: {} + Anti-BTN3A Agonistic Monoclonal Antibody ICT01: {} + Anti-C-met Monoclonal Antibody SAIT301: {} + Anti-C4.4a Antibody-Drug Conjugate BAY1129980: {} + Anti-C5aR Monoclonal Antibody IPH5401: {} + Anti-CA19-9 Monoclonal Antibody 5B1: {} + Anti-CA6-DM4 Immunoconjugate SAR566658: {} + Anti-CCR7 Antibody-drug Conjugate JBH492: {} + Anti-CD117 Monoclonal Antibody JSP191: {} + Anti-CD122 Humanized Monoclonal Antibody Mik-Beta-1: {} + Anti-CD123 ADC IMGN632: {} + Anti-CD123 Monoclonal Antibody CSL360: {} + Anti-CD123 Monoclonal Antibody KHK2823: {} + Anti-CD123 x Anti-CD3 Bispecific Antibody XmAb1404: {} + Anti-CD123-Pyrrolobenzodiazepine Dimer Antibody Drug Conjugate SGN-CD123A: {} + Anti-CD123/CD3 BiTE Antibody SAR440234: {} + Anti-CD123/CD3 Bispecific Antibody APVO436: {} + Anti-CD123/CD3 Bispecific Antibody JNJ-63709178: {} + Anti-CD137 Agonistic Monoclonal Antibody ADG106: {} + Anti-CD137 Agonistic Monoclonal Antibody AGEN2373: {} + Anti-CD137 Agonistic Monoclonal Antibody ATOR-1017: {} + Anti-CD137 Agonistic Monoclonal Antibody CTX-471: {} + Anti-CD137 Agonistic Monoclonal Antibody LVGN6051: {} + Anti-CD157 Monoclonal Antibody MEN1112: {} + Anti-CD166 Probody-drug Conjugate CX-2009: {} + Anti-CD19 Antibody-T-cell Receptor-expressing T-cells ET019003: {} + Anti-CD19 Antibody-drug Conjugate SGN-CD19B: {} + Anti-CD19 Monoclonal Antibody DI-B4: {} + Anti-CD19 Monoclonal Antibody MDX-1342: {} + Anti-CD19 Monoclonal Antibody MEDI-551: {} + Anti-CD19 Monoclonal Antibody XmAb5574: {} + Anti-CD19 iCAR NK Cells: {} + Anti-CD19-DM4 Immunoconjugate SAR3419: {} + Anti-CD19/Anti-CD22 Bispecific Immunotoxin DT2219ARL: {} + Anti-CD19/CD22 CAR NK Cells: {} + Anti-CD19/CD3 BiTE Antibody AMG 562: {} + Anti-CD19/CD3 Tetravalent Antibody AFM11: {} + Anti-CD20 Monoclonal Antibody B001: {} + Anti-CD20 Monoclonal Antibody BAT4306F: {} + Anti-CD20 Monoclonal Antibody MIL62: {} + Anti-CD20 Monoclonal Antibody PRO131921: {} + Anti-CD20 Monoclonal Antibody SCT400: {} + Anti-CD20 Monoclonal Antibody TL011: {} + Anti-CD20 Monoclonal Antibody-Interferon-alpha Fusion Protein IGN002: {} + Anti-CD20-engineered Toxin Body MT-3724: {} + Anti-CD20/Anti-CD3 Bispecific IgM Antibody IGM2323: {} + Anti-CD20/CD3 Monoclonal Antibody REGN1979: {} + Anti-CD20/CD3 Monoclonal Antibody XmAb13676: {} + Anti-CD205 Antibody-drug Conjugate OBT076: {} + Anti-CD22 ADC TRPH-222: {} + Anti-CD22 Monoclonal Antibody-MMAE Conjugate DCDT2980S: {} + Anti-CD228/MMAE Antibody-drug Conjugate SGN-CD228A: {} + Anti-CD25 Monoclonal Antibody RO7296682: {} + Anti-CD25-PBD Antibody-drug Conjugate ADCT-301: {} + Anti-CD26 Monoclonal Antibody YS110: {} + Anti-CD27 Agonistic Monoclonal Antibody MK-5890: {} + Anti-CD27L Antibody-Drug Conjugate AMG 172: {} + Anti-CD3 Immunotoxin A-dmDT390-bisFv(UCHT1): {} + Anti-CD3/Anti-5T4 Bispecific Antibody GEN1044: {} + Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody JNJ-64007957: {} + Anti-CD3/Anti-BCMA Bispecific Monoclonal Antibody PF-06863135: {} + Anti-CD3/Anti-CD20 Trifunctional Bispecific Monoclonal Antibody FBTA05: {} + Anti-CD3/Anti-GPRC5D Bispecific Monoclonal Antibody JNJ-64407564: {} + Anti-CD3/Anti-GUCY2C Bispecific Antibody PF-07062119: {} + Anti-CD3/CD20 Bispecific Antibody GEN3013: {} + Anti-CD3/CD38 Bispecific Monoclonal Antibody AMG 424: {} + Anti-CD3/CD7-Ricin Toxin A Immunotoxin: {} + Anti-CD30 Monoclonal Antibody MDX-1401: {} + Anti-CD30 Monoclonal Antibody XmAb2513: {} + Anti-CD30/CD16A Monoclonal Antibody AFM13: {} + Anti-CD30/DM1 Antibody-drug Conjugate F0002: {} + Anti-CD32B Monoclonal Antibody BI-1206: {} + Anti-CD33 Antibody-drug Conjugate IMGN779: {} + Anti-CD33 Antigen/CD3 Receptor Bispecific Monoclonal Antibody AMV564: {} + Anti-CD33 Monoclonal Antibody BI 836858: {} + Anti-CD33 Monoclonal Antibody-DM4 Conjugate AVE9633: {} + Anti-CD33/CD3 BiTE Antibody AMG 330: {} + Anti-CD33/CD3 BiTE Antibody AMG 673: {} + Anti-CD33/CD3 Bispecific Antibody GEM 333: {} + Anti-CD33/CD3 Bispecific Antibody JNJ-67571244: {} + Anti-CD352 Antibody-drug Conjugate SGN-CD352A: {} + Anti-CD37 Antibody-Drug Conjugate IMGN529: {} + Anti-CD37 Bispecific Monoclonal Antibody GEN3009: {} + Anti-CD37 MMAE Antibody-drug Conjugate AGS67E: {} + Anti-CD37 Monoclonal Antibody BI 836826: {} + Anti-CD38 Antibody-drug Conjugate STI-6129: {} + Anti-CD38 Monoclonal Antibody MOR03087: {} + Anti-CD38 Monoclonal Antibody SAR442085: {} + Anti-CD38 Monoclonal Antibody TAK-079: {} + Anti-CD38-targeted IgG4-attenuated IFNa TAK-573: {} + Anti-CD38/CD28xCD3 Tri-specific Monoclonal Antibody SAR442257: {} + Anti-CD38/CD3 Bispecific Monoclonal Antibody GBR 1342: {} + Anti-CD39 Monoclonal Antibody SRF617: {} + Anti-CD39 Monoclonal Antibody TTX-030: {} + Anti-CD40 Agonist Monoclonal Antibody ABBV-927: {} + Anti-CD40 Agonist Monoclonal Antibody CDX-1140: {} + Anti-CD40 Monoclonal Antibody Chi Lob 7/4: {} + Anti-CD40 Monoclonal Antibody SEA-CD40: {} + Anti-CD40/Anti-4-1BB Bispecific Agonist Monoclonal Antibody GEN1042: {} + Anti-CD40/Anti-TAA Bispecific Monoclonal Antibody ABBV-428: {} + Anti-CD40L Fc-Fusion Protein BMS-986004: {} + Anti-CD44 Monoclonal Antibody RO5429083: {} + Anti-CD45 Monoclonal Antibody AHN-12: {} + Anti-CD46 Antibody-drug Conjugate FOR46: {} + Anti-CD47 ADC SGN-CD47M: {} + Anti-CD47 Monoclonal Antibody AO-176: {} + Anti-CD47 Monoclonal Antibody CC-90002: {} + Anti-CD47 Monoclonal Antibody Hu5F9-G4: {} + Anti-CD47 Monoclonal Antibody IBI188: {} + Anti-CD47 Monoclonal Antibody IMC-002: {} + Anti-CD47 Monoclonal Antibody SHR-1603: {} + Anti-CD47 Monoclonal Antibody SRF231: {} + Anti-CD47 Monoclonal Antibody TJC4: {} + Anti-CD47/CD19 Bispecific Monoclonal Antibody TG-1801: {} + Anti-CD48/MMAE Antibody-drug Conjugate SGN-CD48A: {} + Anti-CD52 Monoclonal Antibody ALLO-647: {} + Anti-CD70 Antibody-Drug Conjugate MDX-1203: {} + Anti-CD70 Antibody-drug Conjugate SGN-CD70A: {} + Anti-CD70 CAR-expressing T Lymphocytes: {} + Anti-CD70 Monoclonal Antibody MDX-1411: {} + Anti-CD71/vcMMAE Probody-drug Conjugate CX-2029: {} + Anti-CD73 Monoclonal Antibody BMS-986179: {} + Anti-CD73 Monoclonal Antibody CPI-006: {} + Anti-CD73 Monoclonal Antibody NZV930: {} + Anti-CD73 Monoclonal Antibody TJ4309: {} + Anti-CD74 Antibody-drug Conjugate STRO-001: {} + Anti-CD98 Monoclonal Antibody IGN523: {} + Anti-CDH6 Antibody-drug Conjugate HKT288: {} + Anti-CEA BiTE Monoclonal Antibody AMG211: {} + Anti-CEA/Anti-DTPA-In (F6-734) Bispecific Antibody: {} + Anti-CEA/Anti-HSG Bispecific Monoclonal Antibody TF2: {} + Anti-CEACAM1 Monoclonal Antibody CM-24: {} + Anti-CEACAM5 Antibody-Drug Conjugate SAR408701: {} + Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47: {} + Anti-CEACAM6 Antibody BAY1834942: {} + Anti-CLDN6 Monoclonal Antibody ASP1650: {} + Anti-CLEC12A/CD3 Bispecific Antibody MCLA117: {} + Anti-CLEVER-1 Monoclonal Antibody FP-1305: {} + Anti-CSF1 Monoclonal Antibody PD-0360324: {} + Anti-CSF1R Monoclonal Antibody IMC-CS4: {} + Anti-CSF1R Monoclonal Antibody SNDX-6352: {} + Anti-CTGF Monoclonal Antibody FG-3019: {} + Anti-CTLA-4 Monoclonal Antibody ADG116: {} + Anti-CTLA-4 Monoclonal Antibody ADU-1604: {} + Anti-CTLA-4 Monoclonal Antibody AGEN1181: {} + Anti-CTLA-4 Monoclonal Antibody BCD-145: {} + Anti-CTLA-4 Monoclonal Antibody HBM4003: {} + Anti-CTLA-4 Monoclonal Antibody MK-1308: {} + Anti-CTLA-4 Monoclonal Antibody ONC-392: {} + Anti-CTLA-4 Monoclonal Antibody REGN4659: {} + Anti-CTLA-4 Probody BMS-986288: {} + Anti-CTLA-4/Anti-PD-1 Monoclonal Antibody Combination BCD-217: {} + Anti-CTLA-4/LAG-3 Bispecific Antibody XmAb22841: {} + Anti-CTLA-4/OX40 Bispecific Antibody ATOR-1015: {} + Anti-CTLA4 Antibody Fc Fusion Protein KN044: {} + Anti-CTLA4 Monoclonal Antibody BMS-986218: {} + Anti-CXCR4 Monoclonal Antibody PF-06747143: {} + Anti-Claudin18.2 Monoclonal Antibody TST001: {} + Anti-DKK-1 Monoclonal Antibody LY2812176: {} + Anti-DKK1 Monoclonal Antibody BHQ880: {} + Anti-DLL3/CD3 BiTE Antibody AMG 757: {} + Anti-DLL4 Monoclonal Antibody MEDI0639: {} + Anti-DLL4/VEGF Bispecific Monoclonal Antibody OMP-305B83: {} + Anti-DR5 Agonist Monoclonal Antibody TRA-8: {} + Anti-DR5 Agonistic Antibody DS-8273a: {} + Anti-DR5 Agonistic Monoclonal Antibody INBRX-109: {} + Anti-Denatured Collagen Monoclonal Antibody TRC093: {} + Anti-EGFR Monoclonal Antibody CPGJ 602: {} + Anti-EGFR Monoclonal Antibody EMD 55900: {} + Anti-EGFR Monoclonal Antibody GC1118: {} + Anti-EGFR Monoclonal Antibody GT-MAB 5.2-GEX: {} + Anti-EGFR Monoclonal Antibody HLX-07: {} + Anti-EGFR Monoclonal Antibody Mixture MM-151: {} + Anti-EGFR Monoclonal Antibody RO5083945: {} + Anti-EGFR Monoclonal Antibody SCT200: {} + Anti-EGFR Monoclonal Antibody SYN004: {} + Anti-EGFR TAP Antibody-drug Conjugate IMGN289: {} + Anti-EGFR/CD16A Bispecific Antibody AFM24: {} + Anti-EGFR/DM1 Antibody-drug Conjugate AVID100: {} + Anti-EGFR/HER2/HER3 Monoclonal Antibody Mixture Sym013: {} + Anti-EGFR/PBD Antibody-drug Conjugate ABBV-321: {} + Anti-EGFR/c-Met Bispecific Antibody EMB-01: {} + Anti-EGFR/c-Met Bispecific Antibody JNJ-61186372: {} + Anti-EGFRvIII Antibody Drug Conjugate AMG 595: {} + Anti-EGFRvIII Immunotoxin MR1-1: {} + Anti-EGFRvIII/CD3 BiTE Antibody AMG 596: {} + Anti-EGP-2 Immunotoxin MOC31-PE: {} + Anti-ENPP3 Antibody-Drug Conjugate AGS-16C3F: {} + Anti-ENPP3/MMAF Antibody-Drug Conjugate AGS-16M8F: {} + Anti-ETBR/MMAE Antibody-Drug Conjugate DEDN6526A: {} + Anti-Ep-CAM Monoclonal Antibody ING-1: {} + Anti-EphA2 Antibody-directed Liposomal Docetaxel Prodrug MM-310: {} + Anti-EphA2 Monoclonal Antibody DS-8895a: {} + Anti-EphA2 Monoclonal Antibody-MMAF Immunoconjugate MEDI-547: {} + Anti-ErbB2/Anti-ErbB3 Bispecific Monoclonal Antibody MM-111: {} + Anti-ErbB3 Antibody ISU104: {} + Anti-ErbB3 Monoclonal Antibody AV-203: {} + Anti-ErbB3 Monoclonal Antibody CDX-3379: {} + Anti-ErbB3 Monoclonal Antibody REGN1400: {} + Anti-ErbB3/Anti-IGF-1R Bispecific Monoclonal Antibody MM-141: {} + Anti-FAP/Interleukin-2 Fusion Protein RO6874281: {} + Anti-FCRH5/CD3 BiTE Antibody BFCR4350A: {} + Anti-FGFR2 Antibody BAY1179470: {} + Anti-FGFR3 Antibody-drug Conjugate LY3076226: {} + Anti-FGFR4 Monoclonal Antibody U3-1784: {} + Anti-FLT3 Antibody-drug Conjugate AGS62P1: {} + Anti-FLT3 Monoclonal Antibody 4G8-SDIEM: {} + Anti-FLT3 Monoclonal Antibody IMC-EB10: {} + Anti-FLT3/CD3 BiTE Antibody AMG 427: {} + Anti-FRA/Eribulin Antibody-drug Conjugate MORAb-202: {} + Anti-Folate Receptor-alpha Antibody Drug Conjugate STRO-002: {} + Anti-GARP Monoclonal Antibody ABBV-151: {} + Anti-GCC Antibody-Drug Conjugate MLN0264: {} + Anti-GCC Antibody-Drug Conjugate TAK-164: {} + Anti-GD2 Monoclonal Antibody MORAb-028: {} + Anti-GD2 Monoclonal Antibody hu14.18K322A: {} + Anti-GD2 hu3F8/Anti-CD3 huOKT3 Bispecific Antibody: {} + Anti-GD3 Antibody-drug Conjugate PF-06688992: {} + Anti-GITR Agonistic Monoclonal Antibody ASP1951: {} + Anti-GITR Agonistic Monoclonal Antibody BMS-986156: {} + Anti-GITR Agonistic Monoclonal Antibody INCAGN01876: {} + Anti-GITR Monoclonal Antibody GWN 323: {} + Anti-GITR Monoclonal Antibody MK-4166: {} + Anti-GPR20/DXd Antibody-drug Conjugate DS-6157a: {} + Anti-GRP78 Monoclonal Antibody PAT-SM6: {} + Anti-Ganglioside GM2 Monoclonal Antibody BIW-8962: {} + Anti-Globo H Monoclonal Antibody OBI-888: {} + Anti-Globo H/MMAE Antibody-drug Conjugate OBI 999: {} + Anti-Glypican 3/CD3 Bispecific Antibody ERY974: {} + Anti-GnRH Vaccine PEP223: {} + Anti-HA Epitope Monoclonal Antibody MEDI8852: {} + Anti-HB-EGF Monoclonal Antibody KHK2866: {} + Anti-HBEGF Monoclonal Antibody U3-1565: {} + Anti-HER-2 Bispecific Antibody KN026: {} + Anti-HER2 ADC DS-8201a: {} + Anti-HER2 Antibody Conjugated Natural Killer Cells ACE1702: {} + Anti-HER2 Antibody-drug Conjugate A166: {} + Anti-HER2 Antibody-drug Conjugate ARX788: {} + Anti-HER2 Antibody-drug Conjugate BAT8001: {} + Anti-HER2 Antibody-drug Conjugate DP303c: {} + Anti-HER2 Antibody-drug Conjugate MEDI4276: {} + Anti-HER2 Antibody-drug Conjugate RC48: {} + Anti-HER2 Bi-specific Monoclonal Antibody ZW25: {} + Anti-HER2 Bispecific Antibody-drug Conjugate ZW49: {} + Anti-HER2 Immune Stimulator-antibody Conjugate NJH395: {} + Anti-HER2 Monoclonal Antibody B002: {} + Anti-HER2 Monoclonal Antibody CT-P6: {} + Anti-HER2 Monoclonal Antibody HLX22: {} + Anti-HER2 Monoclonal Antibody/Anti-CD137Anticalin Bispecific Fusion Protein PRS-343: {} + Anti-HER2-DM1 ADC B003: {} + Anti-HER2-DM1 Antibody-drug Conjugate GQ1001: {} + Anti-HER2-vc0101 ADC PF-06804103: {} + Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody BTRC 4017A: {} + Anti-HER2/Anti-CD3 Bispecific Monoclonal Antibody GBR 1302: {} + Anti-HER2/Anti-HER3 Bispecific Monoclonal Antibody MCLA-128: {} + Anti-HER2/Auristatin Payload Antibody-drug Conjugate XMT-1522: {} + Anti-HER2/MMAE Antibody-drug Conjugate MRG002: {} + Anti-HER2/PBD-MA Antibody-drug Conjugate DHES0815A: {} + Anti-HER3 Antibody-drug Conjugate U3 1402: {} + Anti-HER3 Monoclonal Antibody GSK2849330: {} + Anti-HGF Monoclonal Antibody TAK-701: {} + Anti-HIF-1alpha LNA Antisense Oligonucleotide EZN-2968: {} + Anti-HIV-1 Lentiviral Vector-expressing sh5/C46 Cal-1: {} + Anti-HLA-DR Monoclonal Antibody IMMU-114: {} + Anti-HLA-G Antibody TTX-080: {} + Anti-ICAM-1 Monoclonal Antibody BI-505: {} + Anti-ICOS Agonist Antibody GSK3359609: {} + Anti-ICOS Agonist Monoclonal Antibody BMS-986226: {} + Anti-ICOS Monoclonal Antibody KY1044: {} + Anti-ICOS Monoclonal Antibody MEDI-570: {} + Anti-IGF-1R Monoclonal Antibody AVE1642: {} + Anti-IGF-1R Recombinant Monoclonal Antibody BIIB022: {} + Anti-IL-1 alpha Monoclonal Antibody MABp1: {} + Anti-IL-13 Humanized Monoclonal Antibody TNX-650: {} + Anti-IL-15 Monoclonal Antibody AMG 714: {} + Anti-IL-8 Monoclonal Antibody BMS-986253: {} + Anti-IL-8 Monoclonal Antibody HuMax-IL8: {} + Anti-ILDR2 Monoclonal Antibody BAY 1905254: {} + Anti-ILT4 Monoclonal Antibody MK-4830: {} + Anti-IRF4 Antisense Oligonucleotide ION251: {} + Anti-Integrin Monoclonal Antibody-DM4 Immunoconjugate IMGN388: {} + Anti-KIR Monoclonal Antibody IPH 2101: {} + Anti-KSP/Anti-VEGF siRNAs ALN-VSP02: {} + Anti-LAG-3 Monoclonal Antibody IBI-110: {} + Anti-LAG-3 Monoclonal Antibody INCAGN02385: {} + Anti-LAG-3 Monoclonal Antibody LAG525: {} + Anti-LAG-3 Monoclonal Antibody REGN3767: {} + Anti-LAG-3/PD-L1 Bispecific Antibody FS118: {} + Anti-LAG3 Monoclonal Antibody BI 754111: {} + Anti-LAG3 Monoclonal Antibody MK-4280: {} + Anti-LAG3 Monoclonal Antibody TSR-033: {} + Anti-LAMP1 Antibody-drug Conjugate SAR428926: {} + Anti-LGR5 Monoclonal Antibody BNC101: {} + Anti-LIF Monoclonal Antibody MSC-1: {} + Anti-LILRB4 Monoclonal Antibody IO-202: {} + Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A: {} + Anti-Lewis B/Lewis Y Monoclonal Antibody GNX102: {} + Anti-Ly6E Antibody-Drug Conjugate RG 7841: {} + Anti-MAGE-A4 T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-C103C: {} + Anti-MMP-9 Monoclonal Antibody GS-5745: {} + Anti-MUC1 Monoclonal Antibody BTH1704: {} + Anti-MUC16/CD3 BiTE Antibody REGN4018: {} + Anti-MUC16/CD3 Bispecific Antibody REGN4018: {} + Anti-MUC16/MMAE Antibody-Drug Conjugate DMUC4064A: {} + Anti-MUC17/CD3 BiTE Antibody AMG 199: {} + Anti-Melanin Monoclonal Antibody PTI-6D2: {} + Anti-Met Monoclonal Antibody Mixture Sym015: {} + Anti-Met/EGFR Monoclonal Antibody LY3164530: {} + Anti-Myeloma Monoclonal Antibody-DM4 Immunoconjugate BT-062: {} + Anti-NRP1 Antibody ASP1948: {} + Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A: {} + Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso: {} + Anti-NaPi2b Antibody-drug Conjugate XMT-1592: {} + Anti-NaPi2b Monoclonal Antibody XMT-1535: {} + Anti-Neuropilin-1 Monoclonal Antibody MNRP1685A: {} + Anti-Nucleolin Aptamer AS1411: {} + Anti-OFA Immunotherapeutic BB-MPI-03: {} + Anti-OX40 Agonist Monoclonal Antibody ABBV-368: {} + Anti-OX40 Agonist Monoclonal Antibody BGB-A445: {} + Anti-OX40 Agonist Monoclonal Antibody PF-04518600: {} + Anti-OX40 Antibody BMS 986178: {} + Anti-OX40 Hexavalent Agonist Antibody INBRX-106: {} + Anti-OX40 Monoclonal Antibody GSK3174998: {} + Anti-OX40 Monoclonal Antibody IBI101: {} + Anti-PD-1 Antibody-interleukin-21 Mutein Fusion Protein AMG 256: {} + Anti-PD-1 Checkpoint Inhibitor PF-06801591: {} + Anti-PD-1 Fusion Protein AMP-224: {} + Anti-PD-1 Monoclonal Antibody 609A: {} + Anti-PD-1 Monoclonal Antibody AK105: {} + Anti-PD-1 Monoclonal Antibody AMG 404: {} + Anti-PD-1 Monoclonal Antibody BAT1306: {} + Anti-PD-1 Monoclonal Antibody BCD-100: {} + Anti-PD-1 Monoclonal Antibody BI 754091: {} + Anti-PD-1 Monoclonal Antibody CS1003: {} + Anti-PD-1 Monoclonal Antibody F520: {} + Anti-PD-1 Monoclonal Antibody GLS-010: {} + Anti-PD-1 Monoclonal Antibody HLX10: {} + Anti-PD-1 Monoclonal Antibody HX008: {} + Anti-PD-1 Monoclonal Antibody JTX-4014: {} + Anti-PD-1 Monoclonal Antibody LZM009: {} + Anti-PD-1 Monoclonal Antibody MEDI0680: {} + Anti-PD-1 Monoclonal Antibody MGA012: {} + Anti-PD-1 Monoclonal Antibody SCT-I10A: {} + Anti-PD-1 Monoclonal Antibody Sym021: {} + Anti-PD-1 Monoclonal Antibody TSR-042: {} + Anti-PD-1/Anti-CTLA4 DART Protein MGD019: {} + Anti-PD-1/Anti-HER2 Bispecific Antibody IBI315: {} + Anti-PD-1/Anti-LAG-3 Bispecific Antibody RO7247669: {} + Anti-PD-1/Anti-LAG-3 DART Protein MGD013: {} + Anti-PD-1/Anti-PD-L1 Bispecific Antibody IBI318: {} + Anti-PD-1/Anti-PD-L1 Bispecific Antibody LY3434172: {} + Anti-PD-1/CD47 Infusion Protein HX009: {} + Anti-PD-1/CTLA-4 Bispecific Antibody AK104: {} + Anti-PD-1/CTLA-4 Bispecific Antibody MEDI5752: {} + Anti-PD-1/TIM-3 Bispecific Antibody RO7121661: {} + Anti-PD-1/VEGF Bispecific Antibody AK112: {} + Anti-PD-L1 Monoclonal Antibody A167: {} + Anti-PD-L1 Monoclonal Antibody BCD-135: {} + Anti-PD-L1 Monoclonal Antibody BGB-A333: {} + Anti-PD-L1 Monoclonal Antibody CBT-502: {} + Anti-PD-L1 Monoclonal Antibody CK-301: {} + Anti-PD-L1 Monoclonal Antibody CS1001: {} + Anti-PD-L1 Monoclonal Antibody FAZ053: {} + Anti-PD-L1 Monoclonal Antibody GR1405: {} + Anti-PD-L1 Monoclonal Antibody HLX20: {} + Anti-PD-L1 Monoclonal Antibody IMC-001: {} + Anti-PD-L1 Monoclonal Antibody LY3300054: {} + Anti-PD-L1 Monoclonal Antibody MDX-1105: {} + Anti-PD-L1 Monoclonal Antibody MSB2311: {} + Anti-PD-L1 Monoclonal Antibody RC98: {} + Anti-PD-L1 Monoclonal Antibody SHR-1316: {} + Anti-PD-L1 Monoclonal Antibody TG-1501: {} + Anti-PD-L1 Monoclonal Antibody ZKAB001: {} + Anti-PD-L1/4-1BB Bispecific Antibody INBRX-105: {} + Anti-PD-L1/Anti-4-1BB Bispecific Monoclonal Antibody GEN1046: {} + Anti-PD-L1/CD137 Bispecific Antibody MCLA-145: {} + Anti-PD-L1/IL-15 Fusion Protein KD033: {} + Anti-PD-L1/TIM-3 Bispecific Antibody LY3415244: {} + Anti-PD1 Monoclonal Antibody AGEN2034: {} + Anti-PD1/CTLA4 Bispecific Antibody XmAb20717: {} + Anti-PGF Monoclonal Antibody RO5323441: {} + Anti-PKN3 siRNA Atu027: {} + Anti-PLGF Monoclonal Antibody TB-403: {} + Anti-PR1/HLA-A2 Monoclonal Antibody Hu8F4: {} + Anti-PRAME Immunotherapeutic GSK2302032A: {} + Anti-PRAME T-cell Receptor/Anti-CD3 scFv Fusion Protein IMC-F106C: {} + Anti-PRL-3 Monoclonal Antibody PRL3-zumab: {} + Anti-PSCA Monoclonal Antibody AGS-1C4D4: {} + Anti-PSMA Monoclonal Antibody MDX1201-A488: {} + Anti-PSMA Monoclonal Antibody MLN591-DM1 Immunoconjugate MLN2704: {} + Anti-PSMA Monoclonal Antibody-MMAE Conjugate: {} + Anti-PSMA/CD28 Bispecific Antibody REGN5678: {} + Anti-PSMA/CD3 Bispecific Antibody CCW702: {} + Anti-PSMA/CD3 Bispecific Antibody JNJ-63898081: {} + Anti-PSMA/CD3 Monoclonal Antibody MOR209/ES414: {} + Anti-PSMA/PBD ADC MEDI3726: {} + Anti-PTK7/Auristatin-0101 Antibody-drug Conjugate PF-06647020: {} + Anti-PVRIG Monoclonal Antibody COM701: {} + Anti-RANKL Monoclonal Antibody GB-223: {} + Anti-RANKL Monoclonal Antibody JMT103: {} + Anti-ROR1 ADC VLS-101: {} + Anti-ROR1/PNU-159682 Derivative Antibody-drug Conjugate NBE-002: {} + Anti-Ribonucleoprotein Antibody ATRC-101: {} + Anti-S15 Monoclonal Antibody NC318: {} + Anti-SIRPa Monoclonal Antibody CC-95251: {} + Anti-SLITRK6 Monoclonal Antibody-MMAE Conjugate AGS15E: {} + Anti-TAG-72 Monoclonal Antibody scFV CC-49/218: {} + Anti-TF Monoclonal Antibody ALT-836: {} + Anti-TGF-beta Monoclonal Antibody NIS793: {} + Anti-TGF-beta Monoclonal Antibody SAR-439459: {} + Anti-TGF-beta RII Monoclonal Antibody IMC-TR1: {} + Anti-TIGIT Monoclonal Antibody AB154: {} + Anti-TIGIT Monoclonal Antibody BGB-A1217: {} + Anti-TIGIT Monoclonal Antibody BMS-986207: {} + Anti-TIGIT Monoclonal Antibody COM902: {} + Anti-TIGIT Monoclonal Antibody OMP-313M32: {} + Anti-TIGIT Monoclonal Antibody SGN-TGT: {} + Anti-TIM-3 Antibody BMS-986258: {} + Anti-TIM-3 Monoclonal Antibody BGB-A425: {} + Anti-TIM-3 Monoclonal Antibody INCAGN02390: {} + Anti-TIM-3 Monoclonal Antibody MBG453: {} + Anti-TIM-3 Monoclonal Antibody Sym023: {} + Anti-TIM-3 Monoclonal Antibody TSR-022: {} + Anti-TIM3 Monoclonal Antibody LY3321367: {} + Anti-TIM3 Monoclonal Antibody SHR-1702: {} + Anti-TRAILR2/CDH17 Tetravalent Bispecific Antibody BI 905711: {} + Anti-TROP2 Antibody-drug Conjugate BAT8003: {} + Anti-TROP2 Antibody-drug Conjugate SKB264: {} + Anti-TROP2/DXd Antibody-drug Conjugate DS-1062a: {} + Anti-TWEAK Monoclonal Antibody RG7212: {} + Anti-Tissue Factor Monoclonal Antibody MORAb-066: {} + Anti-VEGF Anticalin PRS-050-PEG40: {} + Anti-VEGF Monoclonal Antibody hPV19: {} + Anti-VEGF/ANG2 Nanobody BI 836880: {} + Anti-VEGF/TGF-beta 1 Fusion Protein HB-002T: {} + Anti-VEGFC Monoclonal Antibody VGX-100: {} + Anti-VEGFR2 Monoclonal Antibody HLX06: {} + Anti-VEGFR2 Monoclonal Antibody MSB0254: {} + Anti-VEGFR3 Monoclonal Antibody IMC-3C5: {} + Anti-VISTA Monoclonal Antibody JNJ 61610588: {} + Anti-alpha BCMA/Anti-alpha CD3 T-cell Engaging Bispecific Antibody TNB-383B: {} + Anti-alpha5beta1 Integrin Antibody MINT1526A: {} + Anti-angiopoietin Monoclonal Antibody AMG 780: {} + Anti-c-KIT Monoclonal Antibody CDX 0158: {} + Anti-c-MET Monoclonal Antibody LY2875358: {} + Anti-c-Met Antibody-drug Conjugate HTI-1066: {} + Anti-c-Met Antibody-drug Conjugate TR1801: {} + Anti-c-Met Monoclonal Antibody ABT-700: {} + Anti-c-Met Monoclonal Antibody ARGX-111: {} + Anti-c-Met Monoclonal Antibody HLX55: {} + Anti-c-fms Monoclonal Antibody AMG 820: {} + Anti-claudin18.2 Monoclonal Antibody AB011: {} + Anti-fucosyl-GM1 Monoclonal Antibody BMS-986012: {} + Anti-gpA33/CD3 Monoclonal Antibody MGD007: {} + Anti-gremlin-1 Monoclonal Antibody UCB6114: {} + Anti-hepcidin Monoclonal Antibody LY2787106: {} + Anti-human GITR Monoclonal Antibody AMG 228: {} + Anti-human GITR Monoclonal Antibody TRX518: {} + Anti-integrin Beta-6/MMAE Antibody-drug Conjugate SGN-B6A: {} + Anti-latent TGF-beta 1 Monoclonal Antibody SRK-181: {} + Anti-mesothelin Antibody-drug Conjugate BMS-986148: {} + Anti-mesothelin-Pseudomonas Exotoxin 24 Cytolytic Fusion Protein LMB-100: {} + Anti-mesothelin/MMAE Antibody-Drug Conjugate DMOT4039A: {} + Anti-mesothelin/MMAE Antibody-drug Conjugate RC88: {} + Anti-myostatin Monoclonal Antibody LY2495655: {} + Anti-nectin-4 Monoclonal Antibody-Drug Conjugate AGS-22M6E: {} + Anti-nf-P2X7 Antibody Ointment BIL-010t: {} + Anti-prolactin Receptor Antibody LFA102: {} + Anti-sCLU Monoclonal Antibody AB-16B5: {} + Antiangiogenic Drug Combination TL-118: {} + Antibody-Drug Conjugate DFRF4539A: {} + Antibody-drug Conjugate ABBV-011: {} + Antibody-drug Conjugate ABBV-085: {} + Antibody-drug Conjugate ABBV-155: {} + Antibody-drug Conjugate ABBV-176: {} + Antibody-drug Conjugate ABBV-838: {} + Antibody-drug Conjugate ADC XMT-1536: {} + Antibody-drug Conjugate Anti-TIM-1-vcMMAE CDX-014: {} + Antibody-drug Conjugate MEDI7247: {} + Antibody-drug Conjugate PF-06647263: {} + Antibody-drug Conjugate PF-06664178: {} + Antibody-drug Conjugate SC-002: {} + Antibody-drug Conjugate SC-003: {} + Antibody-drug Conjugate SC-004: {} + Antibody-drug Conjugate SC-005: {} + Antibody-drug Conjugate SC-006: {} + Antibody-drug Conjugate SC-007: {} + Antibody-like CD95 Receptor/Fc-fusion Protein CAN-008: {} + Antigen-presenting Cells-expressing HPV16 E6/E7 SQZ-PBMC-HPV: {} + Antimetabolite FF-10502: {} + Antineoplastic Agent Combination SM-88: {} + Antineoplastic Vaccine: {} + Antineoplastic Vaccine GV-1301: {} + Antineoplaston A10: {} + Antineoplaston AS2-1: {} + Antisense Oligonucleotide GTI-2040: {} + Antisense Oligonucleotide QR-313: {} + Antitumor B Key Active Component-alpha: {} + Antrodia cinnamomea Supplement: {} + Antroquinonol Capsule: {} + Apalutamide: {} + Apatorsen: {} + Apaziquone: {} + Aphidicoline Glycinate: {} + Apilimod Dimesylate Capsule: {} + Apitolisib: {} + Apolizumab: {} + Apomab: {} + Apomine: {} + Apoptosis Inducer BZL101: {} + Apoptosis Inducer GCS-100: {} + Apoptosis Inducer MPC-2130: {} + Apricoxib: {} + Aprinocarsen: {} + Aprutumab: {} + Aprutumab Ixadotin: {} + Arabinoxylan Compound MGN3: {} + Aranose: {} + Archexin: {} + Arcitumomab: {} + Arfolitixorin: {} + Arginase Inhibitor INCB001158: {} + Arginine Butyrate: {} + Arnebia Indigo Jade Pearl Topical Cream: {} + Arsenic Trioxide: {} + Arsenic Trioxide Capsule Formulation ORH 2014: {} + Artemether Sublingual Spray: {} + Artemisinin Dimer: {} + Artesunate: {} + Arugula Seed Powder: {} + Aryl Hydrocarbon Receptor Antagonist BAY2416964: {} + Aryl Hydrocarbon Receptor Inhibitor IK-175: {} + Asaley: {} + Asciminib: {} + Ascrinvacumab: {} + Ashwagandha Root Powder Extract: {} + Aspacytarabine: {} + Asparaginase: {} + Asparaginase Erwinia chrysanthemi: {} + Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10: {} + Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10: {} + Astuprotimut-R: {} + Asulacrine: {} + Asulacrine Isethionate: {} + Asunercept: {} + At 211 Monoclonal Antibody 81C6: {} + Atamestane: {} + Atezolizumab: {} + Atiprimod: {} + Atiprimod Dihydrochloride: {} + Atiprimod Dimaleate: {} + Atorvastatin Calcium: {} + Atorvastatin Sodium: {} + Atrasentan Hydrochloride: {} + Attenuated Listeria monocytogenes CRS-100: {} + Attenuated Live Listeria Encoding HPV 16 E7 Vaccine ADXS11-001: {} + Attenuated Measles Virus Encoding SCD Transgene TMV-018: {} + Atuveciclib: {} + Audencel: {} + Auranofin: {} + Aurora A Kinase Inhibitor LY3295668: {} + Aurora A Kinase Inhibitor LY3295668 Erbumine: {} + Aurora A Kinase Inhibitor MK5108: {} + Aurora A Kinase Inhibitor TAS-119: {} + Aurora A Kinase/Tyrosine Kinase Inhibitor ENMD-2076: {} + Aurora B Serine/Threonine Kinase Inhibitor TAK-901: {} + Aurora B/C Kinase Inhibitor GSK1070916A: {} + Aurora Kinase Inhibitor AMG 900: {} + Aurora Kinase Inhibitor BI 811283: {} + Aurora Kinase Inhibitor MLN8054: {} + Aurora Kinase Inhibitor PF-03814735: {} + Aurora Kinase Inhibitor SNS-314: {} + Aurora Kinase Inhibitor TTP607: {} + Aurora Kinase/VEGFR2 Inhibitor CYC116: {} + Aurora kinase A/B inhibitor TT-00420: {} + Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707: {} + Autologous AFP Specific T Cell Receptor Transduced T Cells C-TCR055: {} + Autologous AXL-targeted CAR T-cells CCT301-38: {} + Autologous Anti-BCMA CAR T-cells PHE885: {} + Autologous Anti-BCMA CAR-transduced T-cells KITE-585: {} + Autologous Anti-BCMA CD8+ CAR T-cells Descartes-11: {} + Autologous Anti-BCMA-CAR Expressing Stem Memory T-cells P-BCMA-101: {} + Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing CD4+/CD8+ T-lymphocytes JCARH125: {} + Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing Memory T-lymphocytes bb21217: {} + Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells C-CAR088: {} + Autologous Anti-BCMA-CAR-4-1BB-CD3zeta-expressing T-cells CT053: {} + Autologous Anti-BCMA-CAR-expressing CD4+/CD8+ T-lymphocytes FCARH143: {} + Autologous Anti-CD123 CAR-T Cells: {} + Autologous Anti-CD19 CAR T-cells 19(T2)28z1xx: {} + Autologous Anti-CD19 CAR T-cells IM19: {} + Autologous Anti-CD19 CAR TCR-zeta/4-1BB-transduced T-lymphocytes huCART19: {} + Autologous Anti-CD19 CAR-4-1BB-CD3zeta-expressing T-cells CNCT19: {} + Autologous Anti-CD19 CAR-CD28 T-cells ET019002: {} + Autologous Anti-CD19 CAR-CD3zeta-4-1BB-expressing T-cells PZ01: {} + Autologous Anti-CD19 CAR-expressing T-lymphocytes CLIC-1901: {} + Autologous Anti-CD19 Chimeric Antigen Receptor T-cells AUTO1: {} + Autologous Anti-CD19 Chimeric Antigen Receptor T-cells SJCAR19: {} + Autologous Anti-CD19 T-cell Receptor T cells ET190L1: {} + Autologous Anti-CD19 TAC-T cells TAC01-CD19: {} + Autologous Anti-CD19/CD20 Bispecific Nanobody-based CAR-T cells: {} + Autologous Anti-CD19/CD22 CAR T-cells AUTO3: {} + Autologous Anti-CD19CAR-4-1BB-CD3zeta-EGFRt-expressing CD4+/CD8+ Central Memory T-lymphocytes JCAR014: {} + Autologous Anti-CD19CAR-HER2t/CD22CAR-EGFRt-expressing T-cells: {} + Autologous Anti-CD20 CAR Transduced CD4/CD8 Enriched T-cells MB-CART20.1: {} + Autologous Anti-CD22 CAR-4-1BB-TCRz-transduced T-lymphocytes CART22-65s: {} + Autologous Anti-EGFR CAR-transduced CXCR 5-modified T-lymphocytes: {} + Autologous Anti-FLT3 CAR T Cells AMG 553: {} + Autologous Anti-HLA-A*02/AFP TCRm-expressing T-cells ET140202: {} + Autologous Anti-HLA-A*0201/AFP CAR T-cells ET1402L1: {} + Autologous Anti-ICAM-1-CAR-CD28-4-1BB-CD3zeta-expressing T-cells AIC100: {} + Autologous Anti-NY-ESO-1/LAGE-1 TCR-transduced c259 T Lymphocytes GSK3377794: {} + Autologous Anti-PD-1 Antibody-activated Tumor-infiltrating Lymphocytes: {} + Autologous Anti-PSMA CAR-T Cells P-PSMA-101: {} + Autologous Anti-kappa Light Chain CAR-CD28-expressing T-lymphocytes: {} + Autologous B-cell/Monocyte-presenting HER2/neu Antigen Vaccine BVAC-B: {} + Autologous BCMA-targeted CAR T Cells CC-98633: {} + Autologous BCMA-targeted CAR T Cells LCAR-B4822M: {} + Autologous Bi-epitope BCMA-targeted CAR T-cells JNJ-68284528: {} + Autologous Bispecific BCMA/CD19-targeted CAR-T Cells GC012F: {} + Autologous Bispecific CD19/CD22-targeted CAR-T Cells GC022: {} + Autologous Bone Marrow-derived CD34/CXCR4-positive Stem Cells AMR-001: {} + Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3005: {} + Autologous CAR-mbIL15-Safety Switch T-cells PRGN-3006: {} + Autologous CD123-4SCAR-expressing T-cells 4SCAR123: {} + Autologous CD19 CAR-expressing CD4+/CD8+ T-cells MB-CART19.1: {} + Autologous CD19-targeted CAR T Cells CC-97540: {} + Autologous CD19-targeted CAR T Cells JWCAR029: {} + Autologous CD19-targeted CAR-T Cells GC007F: {} + Autologous CD19/PD-1 Bispecific CAR-T Cells: {} + Autologous CD20-4SCAR-expressing T-cells 4SCAR20: {} + Autologous CD22-4SCAR-expressing T-cells 4SCAR22: {} + Autologous CD38-4SCAR-expressing T-cells 4SCAR38: {} + Autologous CRISPR-edited Anti-CD19 CAR T Cells XYF19: {} + Autologous Clonal Neoantigen T Cells ATL001: {} + Autologous Deep IL-15 Primed T-cells TRQ15-01: {} + Autologous Dendritic Cell Vaccine ACT2001: {} + Autologous Dendritic Cell-based Immunotherapeutic AV0113: {} + Autologous FRa-4SCAR-expressing T-cells 4SCAR-FRa: {} + Autologous Genetically-modified MAGE-A4 C1032 CD8alpha T Cells: {} + Autologous Genetically-modified MAGE-A4 C1032 T Cells: {} + Autologous HPV16 E7-specific HLA-A*02:01-restricted TCR Gene Engineered Lymphocytes KITE-439: {} + Autologous Heat-Shock Protein 70 Peptide Vaccine AG-858: {} + Autologous LMP1/LMP2/EBNA1-specific HLA-A02:01/24:02/11:01-restricted TCR-expressing T-lymphocytes YT-E001: {} + Autologous MAGE-A3/A6-specific TCR Gene-engineered Lymphocytes KITE-718: {} + Autologous MCPyV-specific HLA-A02-restricted TCR-transduced CD4+ and CD8+ T-cells FH-MCVA2TCR: {} + Autologous Mesenchymal Stem Cells Apceth_101: {} + Autologous Mesothelin-specific Human mRNA CAR-transfected PBMCs MCY-M11: {} + Autologous Monocyte-derived Lysate-pulsed Dendritic Cell Vaccine PV-001-DC: {} + Autologous Multi-lineage Potential Cells: {} + Autologous NKG2D CAR T-cells CYAD-02: {} + Autologous NKG2D CAR-CD3zeta-DAP10-expressing T-Lymphocytes CYAD-01: {} + Autologous Nectin-4/FAP-targeted CAR-T Cells: {} + Autologous Pancreatic Adenocarcinoma Lysate and mRNA-loaded Dendritic Cell Vaccine: {} + Autologous Peripheral Blood Lymphocytes from Ibrutinib-treated Chronic Lymphocytic Leukemia Patients IOV-2001: {} + Autologous Prostate Cancer Antigen-expressing Dendritic Cell Vaccine BPX-101: {} + Autologous Prostate Stem Cell Antigen-specific CAR T Cells BPX-601: {} + Autologous ROR2-targeted CAR T-cells CCT301-59: {} + Autologous Rapamycin-resistant Th1/Tc1 Cells RAPA-201: {} + Autologous TAAs-loaded Autologous Dendritic Cells AV-GBM-1: {} + Autologous TCR-engineered T-cells IMA201: {} + Autologous TCR-engineered T-cells IMA202: {} + Autologous TCR-engineered T-cells IMA203: {} + Autologous TCRm-expressing T-cells ET140203: {} + Autologous Tetravalent Dendritic Cell Vaccine MIDRIX4-LUNG: {} + Autologous Tumor Infiltrating Lymphocytes LN-144: {} + Autologous Tumor Infiltrating Lymphocytes LN-145: {} + Autologous Tumor Infiltrating Lymphocytes LN-145-S1: {} + Autologous Tumor Infiltrating Lymphocytes MDA-TIL: {} + Autologous Universal CAR-expressing T-lymphocytes UniCAR02-T: {} + Avadomide: {} + Avadomide Hydrochloride: {} + Avapritinib: {} + Avdoralimab: {} + Avelumab: {} + Aviscumine: {} + Avitinib Maleate: {} + Axalimogene Filolisbac: {} + Axatilimab: {} + Axicabtagene Ciloleucel: {} + Axitinib: {} + Axl/Mer Inhibitor INCB081776: {} + Axl/Mer Inhibitor PF-07265807: {} + Azacitidine: {} + Azapicyl: {} + Azaribine: {} + Azaserine: {} + Azathioprine: {} + Azimexon: {} + Azintuxizumab Vedotin: {} + Aziridinylbenzoquinone RH1: {} + Azotomycin: {} + Azurin:50-77 Cell Penetrating Peptide p28: {} + B-Raf/VEGFR-2 Inhibitor RAF265: {} + BC-819 Plasmid/Polyethylenimine Complex: {} + BCG Solution: {} + BCG Tokyo-172 Strain Solution: {} + BCG Vaccine: {} + BCMA x CD3 T-cell Engaging Antibody CC-93269: {} + BCMA-CD19 Compound CAR T Cells: {} + BCMA/CD3e Tri-specific T-cell Activating Construct HPN217: {} + BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351: {} + BET Bromodomain Inhibitor ZEN-3694: {} + BET Inhibitor ABBV-744: {} + BET Inhibitor BAY1238097: {} + BET Inhibitor BMS-986158: {} + BET Inhibitor CC-90010: {} + BET Inhibitor CPI-0610: {} + BET Inhibitor FT-1101: {} + BET Inhibitor GS-5829: {} + BET Inhibitor GSK2820151: {} + BET Inhibitor INCB054329: {} + BET Inhibitor INCB057643: {} + BET Inhibitor RO6870810: {} + BET inhibitor BI 894999: {} + BET-bromodomain Inhibitor ODM-207: {} + BF-200 Gel Formulation: {} + BH3 Mimetic ABT-737: {} + BL22 Immunotoxin: {} + BMI1 Inhibitor PTC596: {} + BMS-184476: {} + BMS-188797: {} + BMS-214662: {} + BMS-275183: {} + BP-Cx1-Platinum Complex BP-C1: {} + BR96-Doxorubicin Immunoconjugate: {} + BRAF Inhibitor: {} + BRAF Inhibitor ARQ 736: {} + BRAF Inhibitor BGB-3245: {} + BRAF Inhibitor PLX8394: {} + BRAF(V600E) Kinase Inhibitor ABM-1310: {} + BRAF(V600E) Kinase Inhibitor RO5212054: {} + BRAF/EGFR Inhibitor BGB-283: {} + BRAFV600/PI3K Inhibitor ASN003: {} + BRD4 Inhibitor PLX2853: {} + BRD4 Inhibitor PLX51107: {} + BTK Inhibitor ARQ 531: {} + BTK Inhibitor CT-1530: {} + BTK Inhibitor DTRMWXHS-12: {} + BTK Inhibitor HZ-A-018: {} + BTK Inhibitor ICP-022: {} + BTK Inhibitor LOXO-305: {} + BTK Inhibitor M7583: {} + BTK inhibitor TG-1701: {} + BXQ-350 Nanovesicle Formulation: {} + Babaodan Capsule: {} + Bacillus Calmette-Guerin Substrain Connaught Live Antigen: {} + Bactobolin: {} + Bafetinib: {} + Balixafortide: {} + Balstilimab: {} + Baltaleucel-T: {} + Banoxantrone: {} + Barasertib: {} + Bardoxolone: {} + Bardoxolone Methyl: {} + Baricitinib: {} + Batabulin: {} + Batabulin Sodium: {} + Batimastat: {} + Bavituximab: {} + Bazedoxifene: {} + Bazlitoran: {} + Bcl-2 Inhibitor APG 2575: {} + Bcl-2 Inhibitor BCL201: {} + Bcl-2 Inhibitor BGB-11417: {} + Bcl-2 Inhibitor LP-108: {} + Bcl-2 Inhibitor S65487: {} + Bcl-Xs Adenovirus Vaccine: {} + Bcr-Abl Kinase Inhibitor K0706: {} + Bcr-Abl Kinase Inhibitor PF-114: {} + Beauvericin: {} + Becatecarin: {} + Belagenpumatucel-L: {} + Belantamab Mafodotin: {} + Belapectin: {} + Belimumab: {} + Belinostat: {} + Belotecan Hydrochloride: {} + Belvarafenib: {} + Belzutifan: {} + Bemarituzumab: {} + Bemcentinib: {} + Bempegaldesleukin: {} + Benaxibine: {} + Bendamustine: {} + Bendamustine Hydrochloride: {} + Bendamustine-containing Nanoparticle-based Formulation RXDX-107: {} + Benzaldehyde Dimethane Sulfonate: {} + Benzoylphenylurea: {} + Berberine Chloride: {} + Bermekimab: {} + Bersanlimab: {} + Berubicin Hydrochloride: {} + Berzosertib: {} + Beta Alethine: {} + Beta-Carotene: {} + Beta-Glucan: {} + Beta-Glucan MM-10-001: {} + Beta-Thioguanine Deoxyriboside: {} + Beta-elemene: {} + Beta-lapachone Prodrug ARQ 761: {} + Betaglucin Gel: {} + Betulinic Acid: {} + Bevacizumab: {} + Bexarotene: {} + Bexmarilimab: {} + Bi-functional Alkylating Agent VAL-083: {} + BiTE Antibody AMG 910: {} + Bicalutamide: {} + Bimiralisib: {} + Binetrakin: {} + Binimetinib: {} + Bintrafusp Alfa: {} + Birabresib: {} + Birinapant: {} + Bis(choline)tetrathiomolybdate: {} + Bisantrene: {} + Bisantrene Hydrochloride: {} + Bisnafide: {} + Bisnafide Dimesylate: {} + Bispecific Antibody 2B1: {} + Bispecific Antibody AGEN1223: {} + Bispecific Antibody AMG 509: {} + Bispecific Antibody GS-1423: {} + Bispecific Antibody MDX-H210: {} + Bispecific Antibody MDX447: {} + Bisthianostat: {} + Bivalent BRD4 Inhibitor AZD5153: {} + Bizalimogene Ralaplasmid: {} + Bizelesin: {} + Black Cohosh: {} + Black Raspberry Nectar: {} + Bleomycin: {} + Bleomycin A2: {} + Bleomycin B2: {} + Bleomycin Sulfate: {} + Blinatumomab: {} + Blueberry Powder Supplement: {} + Boanmycin Hydrochloride: {} + Bomedemstat: {} + Boronophenylalanine-Fructose Complex: {} + Bortezomib: {} + Bosutinib: {} + Bosutinib Monohydrate: {} + Botanical Agent BEL-X-HG: {} + Botanical Agent LEAC-102: {} + Bovine Cartilage: {} + Bozitinib: {} + Brachyury-expressing Yeast Vaccine GI-6301: {} + Breflate: {} + Brentuximab: {} + Brentuximab Vedotin: {} + Brequinar: {} + Brequinar Sodium: {} + Briciclib Sodium: {} + Brigatinib: {} + Brilanestrant: {} + Brimonidine Tartrate Nanoemulsion OCU-300: {} + Brivanib: {} + Brivanib Alaninate: {} + Brivudine: {} + Brivudine Phosphoramidate: {} + Broad-Spectrum Human Papillomavirus Vaccine V505: {} + Broccoli Sprout/Broccoli Seed Extract Supplement: {} + Bromacrylide: {} + Bromebric Acid: {} + Bromocriptine Mesylate: {} + Brontictuzumab: {} + Brostacillin Hydrochloride: {} + Brostallicin: {} + Broxuridine: {} + Bruceanol A: {} + Bruceanol B: {} + Bruceanol C: {} + Bruceanol D: {} + Bruceanol E: {} + Bruceanol F: {} + Bruceanol G: {} + Bruceanol H: {} + Bruceantin: {} + Bryostatin 1: {} + Budigalimab: {} + Budotitane: {} + Bufalin: {} + Buparlisib: {} + Burixafor: {} + Burixafor Hydrobromide: {} + Burosumab: {} + Buserelin: {} + Bushen Culuan Decoction: {} + Bushen-Jianpi Decoction: {} + Busulfan: {} + Buthionine Sulfoximine: {} + C-VISA BikDD:Liposome: {} + C-myb Antisense Oligonucleotide G4460: {} + C/EBP Beta Antagonist ST101: {} + CAB-ROR2-ADC BA3021: {} + CAIX Inhibitor DTP348: {} + CAIX Inhibitor SLC-0111: {} + CAR T-Cells AMG 119: {} + CBP/beta-catenin Antagonist PRI-724: {} + CBP/beta-catenin Modulator E7386: {} + CCR2 Antagonist CCX872-B: {} + CCR2 Antagonist PF-04136309: {} + CCR2/CCR5 Antagonist BMS-813160: {} + CCR4 Inhibitor FLX475: {} + CD11b Agonist GB1275: {} + CD123-CD33 Compound CAR T Cells: {} + CD123-specific Targeting Module TM123: {} + CD20-CD19 Compound CAR T Cells: {} + CD28/ICOS Antagonist ALPN-101: {} + CD4-specific Telomerase Peptide Vaccine UCPVax: {} + CD40 Agonist Monoclonal Antibody CP-870,893: {} + CD40 Agonistic Monoclonal Antibody APX005M: {} + CD44 Targeted Agent SPL-108: {} + CD44v6-specific CAR T-cells: {} + CD47 Antagonist ALX148: {} + CD73 Inhibitor AB680: {} + CD73 Inhibitor LY3475070: {} + CD80-Fc Fusion Protein ALPN-202: {} + CD80-Fc Fusion Protein FPT155: {} + CDC7 Inhibitor TAK-931: {} + CDC7 Kinase Inhibitor BMS-863233: {} + CDC7 Kinase Inhibitor LY3143921 Hydrate: {} + CDC7 Kinase Inhibitor NMS-1116354: {} + CDK Inhibitor AT7519: {} + CDK Inhibitor R547: {} + CDK Inhibitor SNS-032: {} + CDK/JAK2/FLT3 Inhibitor TG02 Citrate: {} + CDK1 Inhibitor BEY1107: {} + CDK1/2/4 Inhibitor AG-024322: {} + CDK2 Inhibitor PF-07104091: {} + CDK2/4/6/FLT3 Inhibitor FN-1501: {} + CDK2/5/9 Inhibitor CYC065: {} + CDK4 Inhibitor P1446A-05: {} + CDK4/6 Inhibitor: {} + CDK4/6 Inhibitor BPI-16350: {} + CDK4/6 Inhibitor CS3002: {} + CDK4/6 Inhibitor FCN-437: {} + CDK4/6 Inhibitor G1T38: {} + CDK4/6 Inhibitor HS-10342: {} + CDK4/6 Inhibitor SHR6390: {} + CDK4/6 Inhibitor TQB3616: {} + CDK7 Inhibitor CT7001: {} + CDK7 Inhibitor SY-1365: {} + CDK7 Inhibitor SY-5609: {} + CDK8/19 Inhibitor SEL 120: {} + CDK9 Inhibitor AZD4573: {} + CEA-MUC-1-TRICOM Vaccine CV301: {} + CEA-targeting Agent RG6123: {} + CEBPA-targeting saRNA MTL-CEBPA Liposome: {} + CENP-E Inhibitor GSK-923295: {} + CHK1 Inhibitor MK-8776: {} + CHK1 Inhibitor PF-477736: {} + CHP-NY-ESO-1 Peptide Vaccine IMF-001: {} + CK1alpha/CDK7/CDK9 Inhibitor BTX-A51: {} + CK2-targeting Synthetic Peptide CIGB-300: {} + CL 246738: {} + CSF-1R Inhibitor BLZ945: {} + CSF1R Inhibitor ABSK021: {} + CSF1R Inhibitor DCC-3014: {} + CSF1R Inhibitor PLX73086: {} + CT2584 HMS: {} + CTLA-4-directed Probody BMS-986249: {} + CXC Chemokine Receptor 2 Antagonist AZD5069: {} + CXCR1/2 Inhibitor SX-682: {} + CXCR2 Antagonist QBM076: {} + CXCR4 Antagonist BL-8040: {} + CXCR4 Antagonist USL311: {} + CXCR4 Inhibitor Q-122: {} + CXCR4 Peptide Antagonist LY2510924: {} + CXCR4/E-selectin Antagonist GMI-1359: {} + CYL-02 Plasmid DNA: {} + CYP11A1 Inhibitor ODM-209: {} + CYP11A1 inhibitor ODM-208: {} + CYP17 Inhibitor CFG920: {} + CYP17 Lyase Inhibitor ASN001: {} + CYP17/Androgen Receptor Inhibitor ODM 204: {} + CYP17/CYP11B2 Inhibitor LAE001: {} + Cabazitaxel: {} + Cabiralizumab: {} + Cabozantinib: {} + Cabozantinib S-malate: {} + Cactinomycin: {} + Caffeic Acid Phenethyl Ester: {} + Calaspargase Pegol-mknl: {} + Calcitriol: {} + Calcium Release-activated Channel Inhibitor CM4620: {} + Calcium Release-activated Channels Inhibitor RP4010: {} + Calcium Saccharate: {} + Calculus bovis/Moschus/Olibanum/Myrrha Capsule: {} + Calicheamicin Gamma 1I: {} + Camidanlumab Tesirine: {} + Camptothecin: {} + Camptothecin Analogue TLC388: {} + Camptothecin Glycoconjugate BAY 38-3441: {} + Camptothecin Sodium: {} + Camptothecin-20(S)-O-Propionate Hydrate: {} + Camrelizumab: {} + Camsirubicin: {} + Cancell: {} + Cancer Peptide Vaccine S-588410: {} + Canerpaturev: {} + Canertinib Dihydrochloride: {} + Canfosfamide: {} + Canfosfamide Hydrochloride: {} + Cannabidiol: {} + Cantrixil: {} + Cantuzumab Ravtansine: {} + Capecitabine: {} + Capecitabine Rapidly Disintegrating Tablet: {} + Capivasertib: {} + Capmatinib: {} + Captopril: {} + Caracemide: {} + Carbendazim: {} + Carbetimer: {} + Carbogen: {} + Carbon C 14-pamiparib: {} + Carboplatin: {} + Carboquone: {} + Carboxyamidotriazole: {} + Carboxyamidotriazole Orotate: {} + Carboxyphenyl Retinamide: {} + Carfilzomib: {} + Caricotamide/Tretazicar: {} + Carlumab: {} + Carmofur: {} + Carmustine: {} + Carmustine Implant: {} + Carmustine Sustained-Release Implant Wafer: {} + Carmustine in Ethanol: {} + Carotuximab: {} + Carubicin: {} + Carubicin Hydrochloride: {} + Carzelesin: {} + Carzinophilin: {} + Cathelicidin LL-37: {} + Cationic Liposome-Encapsulated Paclitaxel: {} + Cationic Peptide Cream Cypep-1: {} + Catumaxomab: {} + Cedazuridine: {} + Cedazuridine/Azacitidine Combination Agent ASTX030: {} + Cedazuridine/Decitabine Combination Agent ASTX727: {} + Cedefingol: {} + Cediranib: {} + Cediranib Maleate: {} + Celecoxib: {} + Cell Cycle Checkpoint/DNA Repair Antagonist IC83: {} + Cemadotin: {} + Cemadotin Hydrochloride: {} + Cemiplimab: {} + Cenersen: {} + Cenisertib: {} + Ceralasertib: {} + Ceramide Nanoliposome: {} + Cerdulatinib: {} + Cereblon E3 Ubiquitin Ligase Modulating Agent CC-92480: {} + Cereblon E3 Ubiquitin Ligase Modulating Agent CC-99282: {} + Cereblon Modulator CC-90009: {} + Cergutuzumab Amunaleukin: {} + Ceritinib: {} + Cesalin: {} + Cetrelimab: {} + Cetuximab: {} + Cetuximab Sarotalocan: {} + Cetuximab-IR700 Conjugate RM-1929: {} + Cetuximab-loaded Ethylcellulose Polymeric Nanoparticles Decorated with Octreotide (SY): {} + Cevipabulin: {} + Cevipabulin Fumarate: {} + Cevipabulin Succinate: {} + Cevostamab: {} + Chaparrin: {} + Chaparrinone: {} + Checkpoint Kinase Inhibitor AZD7762: {} + Checkpoint Kinase Inhibitor XL844: {} + Chemotherapy: {} + ChiNing Decoction: {} + Chiauranib: {} + Chimeric Monoclonal Antibody 81C6: {} + Chk1 Inhibitor CCT245737: {} + Chk1 Inhibitor GDC-0425: {} + Chk1 Inhibitor GDC-0575: {} + Chlorambucil: {} + Chlorodihydropyrimidine: {} + Chloroquine: {} + Chloroquinoxaline Sulfonamide: {} + Chlorotoxin: {} + Chlorotoxin (EQ)-CD28-CD3zeta-CD19t-expressing CAR T-lymphocytes: {} + Chlorozotocin: {} + Choline Kinase Alpha Inhibitor TCD-717: {} + Chromomycin A3: {} + ? Chrysanthemum morifolium/Ganoderma lucidum/Glycyrrhiza glabra/Isatis indigotica/Panax + pseudoginseng/Rabdosia rubescens/Scutellaria baicalensis/Serona repens Supplement + : {} + Cibisatamab: {} + Ciclopirox Prodrug CPX-POM: {} + Cidan Herbal Capsule: {} + Ciforadenant: {} + Cilengitide: {} + Ciltacabtagene Autoleucel: {} + Cimetidine: {} + Cinacalcet Hydrochloride: {} + Cinobufagin: {} + Cinobufotalin: {} + Cinrebafusp Alfa: {} + Cintirorgon: {} + Cintredekin Besudotox: {} + Cirmtuzumab: {} + Cisplatin: {} + Cisplatin Liposomal: {} + Cisplatin-E Therapeutic Implant: {} + Cisplatin/Vinblastine/Cell Penetration Enhancer Formulation INT230-6: {} + Citarinostat: {} + Citatuzumab Bogatox: {} + Cixutumumab: {} + Cladribine: {} + Clanfenur: {} + Clarithromycin: {} + Class 1/4 Histone Deacetylase Inhibitor OKI-179: {} + Clinical Trial: {} + Clinical Trial Agent: {} + Clioquinol: {} + Clivatuzumab: {} + Clodronate Disodium: {} + Clodronic Acid: {} + Clofarabine: {} + Clomesone: {} + Clomiphene: {} + Clomiphene Citrate: {} + Clostridium Novyi-NT Spores: {} + Cobimetinib: {} + Cobolimab: {} + Cobomarsen: {} + Codrituzumab: {} + Coenzyme Q10: {} + Cofetuzumab Pelidotin: {} + Colchicine-Site Binding Agent ABT-751: {} + Cold Contaminant-free Iobenguane I-131: {} + Colloidal Gold-Bound Tumor Necrosis Factor: {} + Colorectal Cancer Peptide Vaccine PolyPEPI1018: {} + Colorectal Tumor-Associated Peptides Vaccine IMA910: {} + Coltuximab Ravtansine: {} + Combretastatin: {} + Combretastatin A-1: {} + Combretastatin A1 Diphosphate: {} + Commensal Bacterial Strain Formulation VE800: {} + Compound Kushen Injection: {} + Conatumumab: {} + Conbercept: {} + Concentrated Lingzhi Mushroom Extract: {} + Conditionally Active Biologic Anti-AXL Antibody-drug Conjugate BA3011: {} + Copanlisib: {} + Copanlisib Hydrochloride: {} + Copper Cu 64-ATSM: {} + Copper Cu 67 Tyr3-octreotate: {} + Copper Gluconate: {} + Cord Blood Derived CAR T-Cells: {} + Cord Blood-derived Expanded Natural Killer Cells PNK-007: {} + Cordycepin: {} + Cordycepin Triphosphate: {} + Coriolus Versicolor Extract: {} + Corticorelin Acetate: {} + Cortisone Acetate: {} + Cosibelimab: {} + Cositecan: {} + Coxsackievirus A21: {} + Coxsackievirus V937: {} + CpG Oligodeoxynucleotide GNKG168: {} + Crenolanib: {} + Crenolanib Besylate: {} + Crizotinib: {} + Crolibulin: {} + Cryptophycin: {} + Cryptophycin 52: {} + Crystalline Genistein Formulation AXP107-11: {} + Curcumin: {} + Curcumin/Doxorubicin-encapsulating Nanoparticle IMX-110: {} + Cusatuzumab: {} + Custirsen Sodium: {} + Cyclin-dependent Kinase 8/19 Inhibitor BCD 115: {} + Cyclin-dependent Kinase Inhibitor PF-06873600: {} + Cyclodextrin-Based Polymer-Camptothecin CRLX101: {} + Cyclodisone: {} + Cycloleucine: {} + Cyclopentenyl Cytosine: {} + Cyclophosphamide: {} + Cyclophosphamide Anhydrous: {} + Cyclosporine: {} + Cyproterone: {} + Cyproterone Acetate: {} + Cytarabine: {} + Cytarabine Monophosphate Prodrug MB07133: {} + Cytarabine-asparagine Prodrug BST-236: {} + Cytidine Analog RX-3117: {} + Cytochlor: {} + Cytokine-based Biologic Agent IRX-2: {} + D-methionine Formulation MRX-1024: {} + DAB389 Epidermal Growth Factor: {} + DACH Polymer Platinate AP5346: {} + DACH-Platin Micelle NC-4016: {} + DEC-205/NY-ESO-1 Fusion Protein CDX-1401: {} + DHA-Paclitaxel: {} + DHEA Mustard: {} + DI-Leu16-IL2 Immunocytokine: {} + DKK1-Neutralizing Monoclonal Antibody DKN-01: {} + DM-CHOC-PEN: {} + DM4-Conjugated Anti-Cripto Monoclonal Antibody BIIB015: {} + DNA Interference Oligonucleotide PNT2258: {} + DNA Minor Groove Binding Agent SG2000: {} + DNA Plasmid Encoding Interleukin-12 INO-9012: {} + DNA Plasmid-encoding Interleukin-12 INO-9012/PSA/PSMA DNA Plasmids INO-5150 Formulation INO-5151: {} + DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457: {} + DNA Vaccine VB10.16: {} + DNA-PK inhibitor AZD7648: {} + DNA-PK/PI3K-delta Inhibitor BR101801: {} + DNA-PK/TOR Kinase Inhibitor CC-115: {} + DNA-dependent Protein Kinase Inhibitor VX-984: {} + DNMT1 Inhibitor NTX-301: {} + DNMT1 Mixed-Backbone Antisense Oligonucleotide MG 98: {} + DPT/BCG/Measles/Serratia/Pneumococcus Vaccine: {} + DPT/Typhoid/Staphylococcus aureus/Paratyphoid A/Paratyphoid B Vaccine: {} + DPX-E7 HPV Vaccine: {} + DR5 HexaBody Agonist GEN1029: {} + DR5-targeting Tetrameric Nanobody Agonist TAS266: {} + DTRMWXHS-12/Everolimus/Pomalidomide Combination Agent DTRM-555: {} + Dabrafenib: {} + Dabrafenib Mesylate: {} + Dacarbazine: {} + Dacetuzumab: {} + Daclizumab: {} + Dacomitinib: {} + Dacplatinum: {} + Dactinomycin: {} + Dactolisib: {} + Dactolisib Tosylate: {} + Dalantercept: {} + Dalotuzumab: {} + Daniquidone: {} + Danusertib: {} + Danvatirsen: {} + Daporinad: {} + Daratumumab: {} + Daratumumab and Hyaluronidase-fihj: {} + Daratumumab/rHuPH20: {} + Darinaparsin: {} + Darleukin: {} + Darolutamide: {} + Daromun: {} + Dasatinib: {} + Daunorubicin: {} + Daunorubicin Citrate: {} + Daunorubicin Hydrochloride: {} + Decitabine: {} + Decitabine and Cedazuridine: {} + Defactinib: {} + Defactinib Hydrochloride: {} + Deferoxamine: {} + Deferoxamine Mesylate: {} + Degarelix: {} + Degarelix Acetate: {} + Delanzomib: {} + Delolimogene Mupadenorepvec: {} + Demcizumab: {} + Demecolcine: {} + Demplatin Pegraglumer: {} + Dendrimer-conjugated Bcl-2/Bcl-XL Inhibitor AZD0466: {} + Dendritic Cell Vaccine: {} + Dendritic Cell-Autologous Lung Tumor Vaccine: {} + Dendritic Cell-targeting Lentiviral Vector ID-LV305: {} + Denenicokin: {} + Dengue Virus Adjuvant PV-001-DV: {} + Denibulin: {} + Denibulin Hydrochloride: {} + Denileukin Diftitox: {} + Denintuzumab Mafodotin: {} + Denosumab: {} + Deoxycytidine Analogue TAS-109: {} + Deoxycytidine Analogue TAS-109 Hydrochloride: {} + Depatuxizumab: {} + Depatuxizumab Mafodotin: {} + Derazantinib: {} + Deslorelin: {} + Deslorelin Acetate: {} + Detirelix: {} + Detorubicin: {} + Deuteporfin: {} + Deuterated Enzalutamide: {} + Devimistat: {} + Dexamethason: {} + Dexamethasone: {} + Dexamethasone Phosphate: {} + Dexamethasone Sodium Phosphate: {} + Dexanabinol: {} + Dexrazoxane: {} + Dexrazoxane Hydrochloride: {} + Dezaguanine: {} + Dezaguanine Mesylate: {} + Dezapelisib: {} + Dianhydrogalactitol: {} + Diarylsulfonylurea Compound ILX-295501: {} + Diazepinomicin: {} + Diaziquone: {} + Diazooxonorleucine: {} + Dibrospidium Chloride: {} + Dichloroallyl Lawsone: {} + Dicycloplatin: {} + Didox: {} + Dienogest: {} + Diethylnorspermine: {} + Digitoxin: {} + Digoxin: {} + Dihydro-5-Azacytidine: {} + Dihydrolenperone: {} + Dihydroorotate Dehydrogenase Inhibitor AG-636: {} + Dihydroorotate Dehydrogenase Inhibitor BAY2402234: {} + Diindolylmethane: {} + Dilpacimab: {} + Dimethylmyleran: {} + Dinaciclib: {} + Dinutuximab: {} + Dioscorea nipponica Makino Extract DNE3: {} + Diphencyprone: {} + Diphtheria Toxin Fragment-Interleukin-2 Fusion Protein E7777: {} + Ditiocarb: {} + Docetaxel: {} + Docetaxel Anhydrous: {} + Docetaxel Emulsion ANX-514: {} + Docetaxel Formulation CKD-810: {} + Docetaxel Lipid Microspheres: {} + Docetaxel Nanoparticle CPC634: {} + Docetaxel Polymeric Micelles: {} + Docetaxel-PNP: {} + Docetaxel-loaded Nanopharmaceutical CRLX301: {} + Docetaxel/Ritonavir: {} + Dociparstat sodium: {} + Dolastatin 10: {} + Dolastatin 15: {} + Domatinostat: {} + Donafenib: {} + Dopamine-Somatostatin Chimeric Molecule BIM-23A760: {} + Dostarlimab: {} + Double-armed TMZ-CD40L/4-1BBL Oncolytic Ad5/35 Adenovirus LOAd703: {} + Dovitinib: {} + Dovitinib Lactate: {} + Doxazosin: {} + Doxercalciferol: {} + Doxifluridine: {} + Doxorubicin: {} + Doxorubicin Hydrochloride: {} + Doxorubicin Prodrug L-377,202: {} + Doxorubicin Prodrug/Prodrug-activating Biomaterial SQ3370: {} + Doxorubicin-Eluting Beads: {} + Doxorubicin-HPMA Conjugate: {} + Doxorubicin-Magnetic Targeted Carrier Complex: {} + Doxorubicin-loaded EGFR-targeting Nanocells: {} + Dromostanolone Propionate: {} + Drozitumab: {} + Dual IGF-1R/InsR Inhibitor BMS-754807: {} + Dual Variable Domain Immunoglobulin ABT-165: {} + Dual-affinity B7-H3/CD3-targeted Protein MGD009: {} + Dubermatinib: {} + Duborimycin: {} + Dulanermin: {} + Duligotuzumab: {} + Dupilumab: {} + Durvalumab: {} + Dusigitumab: {} + Duvelisib: {} + Duvortuxizumab: {} + Dynemicin: {} + Dynemicin A: {} + E2F1 Pathway Activator ARQ 171: {} + EBNA-1 inhibitor VK-2019: {} + EED Inhibitor MAK683: {} + EGFR Antagonist Hemay022: {} + EGFR Antisense DNA BB-401: {} + EGFR Inhibitor AZD3759: {} + EGFR Inhibitor BIBX 1382: {} + EGFR Inhibitor DBPR112: {} + EGFR Inhibitor PD-168393: {} + EGFR Inhibitor TY-9591: {} + EGFR Mutant-selective Inhibitor TQB3804: {} + EGFR Mutant-specific Inhibitor BPI-7711: {} + EGFR Mutant-specific Inhibitor CK-101: {} + EGFR Mutant-specific Inhibitor D-0316: {} + EGFR Mutant-specific Inhibitor ZN-e4: {} + EGFR T790M Antagonist BPI-15086: {} + EGFR T790M Inhibitor HS-10296: {} + EGFR/EGFRvIII Inhibitor WSD0922-FU: {} + EGFR/FLT3/Abl Inhibitor SKLB1028: {} + EGFR/HER1/HER2 Inhibitor PKI166: {} + EGFR/HER2 Inhibitor AP32788: {} + EGFR/HER2 Inhibitor AV-412: {} + EGFR/HER2 Inhibitor DZD9008: {} + EGFR/HER2 Kinase Inhibitor TAK-285: {} + EGFR/TGFb Fusion Monoclonal Antibody BCA101: {} + EGFR/VEGFR/RET Inhibitor HA121-28: {} + EGb761: {} + EP2/EP4 Antagonist TPST-1495: {} + EP4 Antagonist INV-1120: {} + EP4 Antagonist ONO-4578: {} + ER alpha Proteolysis-targeting Chimera Protein Degrader ARV-471: {} + ERK 1/2 Inhibitor ASTX029: {} + ERK Inhibitor CC-90003: {} + ERK Inhibitor GDC-0994: {} + ERK Inhibitor LTT462: {} + ERK Inhibitor MK-8353: {} + ERK1/2 Inhibitor ASN007: {} + ERK1/2 Inhibitor HH2710: {} + ERK1/2 Inhibitor JSI-1187: {} + ERK1/2 Inhibitor KO-947: {} + ERK1/2 Inhibitor LY3214996: {} + ERa36 Modulator Icaritin: {} + EZH1/2 Inhibitor DS-3201: {} + EZH1/2 Inhibitor HH2853: {} + EZH2 Inhibitor CPI-1205: {} + EZH2 Inhibitor PF-06821497: {} + EZH2 Inhibitor SHR2554: {} + EZH2 inhibitor CPI-0209: {} + Echinomycin: {} + Ecromeximab: {} + Edatrexate: {} + Edelfosine: {} + Edicotinib: {} + Edodekin alfa: {} + Edotecarin: {} + Edrecolomab: {} + Efatutazone: {} + Efatutazone Dihydrochloride: {} + Efizonerimod: {} + Eflornithine: {} + Eflornithine Hydrochloride: {} + Eftilagimod Alpha: {} + Eftozanermin Alfa: {} + Eg5 Kinesin-Related Motor Protein Inhibitor 4SC-205: {} + Eg5 Kinesin-Related Motor Protein Inhibitor ARQ 621: {} + Eicosapentaenoic Acid: {} + Elacestrant: {} + Elacytarabine: {} + Elagolix: {} + Elbasvir/Grazoprevir: {} + Elesclomol: {} + Elesclomol Sodium: {} + Elgemtumab: {} + Elinafide: {} + Elisidepsin: {} + Elliptinium: {} + Elliptinium Acetate: {} + Elmustine: {} + Elotuzumab: {} + Elpamotide: {} + Elsamitrucin: {} + Eltanexor: {} + Emactuzumab: {} + Emapalumab: {} + Emepepimut-S: {} + Emibetuzumab: {} + Emitefur: {} + Emofolin Sodium: {} + Empesertib: {} + Enadenotucirev: {} + Enadenotucirev-expressing Anti-CD40 Agonistic Monoclonal Antibody NG-350A: {} + Enadenotucirev-expressing FAP/CD3 Bispecific FAP-TAc NG-641: {} + Enasidenib: {} + Enasidenib Mesylate: {} + Enavatuzumab: {} + Encapsulated Rapamycin: {} + Encelimab: {} + Enclomiphene: {} + Enclomiphene Citrate: {} + Encorafenib: {} + Endothelin B Receptor Blocker ENB 003: {} + Endothelin Receptor Type A Antagonist YM598: {} + Enfortumab Vedotin: {} + Engineered Human Umbilical Vein Endothelial Cells AB-205: {} + Engineered Red Blood Cells Co-expressing 4-1BBL and IL-15TP RTX-240: {} + Engineered Toxin Body Targeting CD38 TAK-169: {} + Engineered Toxin Body Targeting HER2 MT-5111: {} + Eniluracil/5-FU Combination Tablet: {} + Enloplatin: {} + Enoblituzumab: {} + Enobosarm: {} + Enoticumab: {} + Enpromate: {} + Ensartinib: {} + Ensituximab: {} + Enteric-Coated TRPM8 Agonist D-3263 Hydrochloride: {} + Enterococcus gallinarum Strain MRx0518: {} + Entinostat: {} + Entolimod: {} + Entospletinib: {} + Entrectinib: {} + Envafolimab: {} + Enzalutamide: {} + Enzastaurin: {} + Enzastaurin Hydrochloride: {} + Epacadostat: {} + Epcoritamab: {} + EphA2-targeting Bicycle Toxin Conjugate BT5528: {} + Epipodophyllotoxin Analog GL331: {} + Epipropidine: {} + Epirubicin: {} + Epirubicin Hydrochloride: {} + Epitinib Succinate: {} + Epitiostanol: {} + Epothilone Analog UTD1: {} + Epothilone KOS-1584: {} + Epratuzumab: {} + Epratuzumab-cys-tesirine: {} + Erastin Analogue PRLX 93936: {} + Erbulozole: {} + Erdafitinib: {} + Eribulin: {} + Eribulin Mesylate: {} + Erlotinib: {} + Erlotinib Hydrochloride: {} + Ertumaxomab: {} + Erythrocyte-encapsulated L-asparaginase Suspension: {} + Esorubicin: {} + Esorubicin Hydrochloride: {} + Esperamicin A1: {} + Essiac: {} + Esterified Estrogens: {} + Estradiol Valerate: {} + Estramustine: {} + Estramustine Phosphate Sodium: {} + Estrogen Receptor Agonist GTx-758: {} + Estrogens, Conjugated: {} + Etalocib: {} + Etanercept: {} + Etanidazole: {} + Etaracizumab: {} + Etarotene: {} + Ethaselen: {} + Ethinyl Estradiol: {} + Ethyleneimine: {} + Ethylnitrosourea: {} + Etidronate-Cytarabine Conjugate MBC-11: {} + Etigilimab: {} + Etirinotecan Pegol: {} + Etoglucid: {} + Etoposide: {} + Etoposide Phosphate: {} + Etoposide Toniribate: {} + Etoprine: {} + Etoricoxib: {} + Ets-family Transcription Factor Inhibitor TK216: {} + Everolimus: {} + Everolimus Tablets for Oral Suspension: {} + Evofosfamide: {} + Ex Vivo-expanded Autologous T Cells IMA101: {} + Exatecan Mesylate: {} + Exatecan Mesylate Anhydrous: {} + Exemestane: {} + Exicorilant: {} + Exisulind: {} + Extended Release Flucytosine: {} + Extended Release Metformin Hydrochloride: {} + Extended-release Onapristone: {} + Ezabenlimab: {} + F16-IL2 Fusion Protein: {} + FACT Complex-targeting Curaxin CBL0137: {} + FAK Inhibitor GSK2256098: {} + FAK Inhibitor PF-00562271: {} + FAK Inhibitor VS-4718: {} + FAK/ALK/ROS1 Inhibitor APG-2449: {} + FAP/4-1BB-targeting DARPin MP0310: {} + FAP/4-1BB-targeting Fusion Protein RO7122290: {} + FASN Inhibitor TVB-2640: {} + FGF Receptor Antagonist HGS1036: {} + FGF/FGFR Pathway Inhibitor E7090: {} + FGFR Inhibitor ASP5878: {} + FGFR Inhibitor AZD4547: {} + FGFR Inhibitor CPL304110: {} + FGFR Inhibitor Debio 1347: {} + FGFR Inhibitor TAS-120: {} + FGFR/CSF-1R Inhibitor 3D185: {} + FGFR/VEGFR/PDGFR/FLT3/SRC Inhibitor XL999: {} + FGFR1/2/3 Inhibitor HMPL-453: {} + FGFR2 Inhibitor RLY-4008: {} + FGFR4 Antagonist INCB062079: {} + FGFR4 Inhibitor BLU 9931: {} + FGFR4 Inhibitor FGF401: {} + FGFR4 Inhibitor H3B-6527: {} + FGFR4 Inhibitor ICP-105: {} + FLT3 Inhibitor FF-10101 Succinate: {} + FLT3 Inhibitor HM43239: {} + FLT3 Inhibitor SKI-G-801: {} + FLT3 Tyrosine Kinase Inhibitor TTT-3002: {} + FLT3/ABL/Aurora Kinase Inhibitor KW-2449: {} + FLT3/CDK4/6 Inhibitor FLX925: {} + FLT3/FGFR Dual Kinase Inhibitor MAX-40279: {} + FLT3/KIT Kinase Inhibitor AKN-028: {} + FLT3/KIT/CSF1R Inhibitor NMS-03592088: {} + FMS Inhibitor JNJ-40346527: {} + FPV Vaccine CV301: {} + FPV-Brachyury-TRICOM Vaccine: {} + Factor VII-targeting Immunoconjugate Protein ICON-1: {} + Factor VIIa Inhibitor PCI-27483: {} + Fadraciclib: {} + Fadrozole Hydrochloride: {} + Falimarev: {} + Famitinib: {} + Farletuzumab: {} + Farnesyltransferase/Geranylgeranyltransferase Inhibitor L-778,123: {} + Fas Ligand-treated Allogeneic Mobilized Peripheral Blood Cells: {} + Fas Receptor Agonist APO010: {} + Fascin Inhibitor NP-G2-044: {} + Favezelimab: {} + Fazarabine: {} + Fc-engineered Anti-CD40 Agonist Antibody 2141-V11: {} + Febuxostat: {} + Fedratinib: {} + Fedratinib Hydrochloride: {} + Feladilimab: {} + Felzartamab: {} + Fenebrutinib: {} + Fenretinide: {} + Fenretinide Lipid Matrix: {} + Fenretinide Phospholipid Suspension ST-001: {} + Fianlimab: {} + Fibromun: {} + Ficlatuzumab: {} + Figitumumab: {} + Filanesib: {} + Filgotinib: {} + Filgrastim: {} + Fimaporfin A: {} + Fimepinostat: {} + Firtecan Pegol: {} + Fisogatinib: {} + Flanvotumab: {} + Flotetuzumab: {} + Floxuridine: {} + Flt3 Ligand/Anti-CTLA-4 Antibody/IL-12 Engineered Oncolytic Vaccinia Virus RIVAL-01: {} + Flt3/MerTK Inhibitor MRX-2843: {} + Fludarabine: {} + Fludarabine Phosphate: {} + Flumatinib: {} + Flumatinib Mesylate: {} + Fluorine F 18 Ara-G: {} + Fluorodopan: {} + Fluorouracil: {} + Fluorouracil Implant: {} + Fluorouracil-E Therapeutic Implant: {} + Fluoxymesterone: {} + Flutamide: {} + Fluvastatin: {} + Fluvastatin Sodium: {} + Fluzoparib: {} + Fms/Trk Tyrosine Kinase Inhibitor PLX7486 Tosylate: {} + Folate Receptor Targeted Epothilone BMS753493: {} + Folate Receptor-Targeted Tubulysin Conjugate EC1456: {} + Folate Receptor-Targeted Vinca Alkaloid EC0489: {} + Folate Receptor-Targeted Vinca Alkaloid/Mitomycin C EC0225: {} + Folate-FITC: {} + Folic Acid: {} + Folitixorin: {} + Foretinib: {} + Foritinib Succinate: {} + Formestane: {} + Forodesine Hydrochloride: {} + Fosaprepitant: {} + Fosbretabulin: {} + Fosbretabulin Disodium: {} + Fosbretabulin Tromethamine: {} + Fosgemcitabine Palabenamide: {} + Fosifloxuridine Nafalbenamide: {} + Foslinanib: {} + Foslinanib Disodium: {} + Fosquidone: {} + Fostriecin: {} + Fotemustine: {} + Fotretamine: {} + Fresolimumab: {} + Fruquintinib: {} + Fulvestrant: {} + Fumagillin-Derived Polymer Conjugate XMT-1107: {} + Fursultiamine: {} + Futibatinib: {} + Futuximab: {} + Futuximab/Modotuximab Mixture: {} + G Protein-coupled Estrogen Receptor Agonist LNS8801: {} + G-Quadruplex Stabilizer BMVC: {} + GBM Antigens and Alloantigens Immunotherapeutic Vaccine: {} + GI-4000 Vaccine: {} + GITR Agonist MEDI1873: {} + GM-CSF-encoding Oncolytic Adenovirus CGTG-102: {} + GS/pan-Notch Inhibitor AL101: {} + GS/pan-Notch Inhibitor BMS-986115: {} + GSK-3 Inhibitor 9-ING-41: {} + GSK-3 Inhibitor LY2090314: {} + Galamustine: {} + Galarubicin: {} + Galectin Inhibitor GR-MD-02: {} + Galectin-1 Inhibitor OTX008: {} + Galeterone: {} + Galiximab: {} + Gallium-based Bone Resorption Inhibitor AP-002: {} + Galocitabine: {} + Galunisertib: {} + Gamboge Resin Extract TSB-9-W1: {} + Gamma-Secretase Inhibitor LY3039478: {} + Gamma-Secretase Inhibitor RO4929097: {} + Gamma-delta Tocotrienol: {} + Gandotinib: {} + Ganetespib: {} + Ganglioside GD2: {} + Ganglioside GM2: {} + Ganitumab: {} + Ganoderma lucidum Spores Powder Capsule: {} + Garlic: {} + Gastrin Immunotoxin: {} + Gastrin/cholecystokinin Type B Receptor Inhibitor Z-360: {} + Gataparsen Sodium: {} + Gatipotuzumab: {} + Gedatolisib: {} + Gefitinib: {} + Geldanamycin: {} + Gelonin: {} + Gemcitabine: {} + Gemcitabine Elaidate: {} + Gemcitabine Hydrochloride: {} + Gemcitabine Hydrochloride Emulsion: {} + Gemcitabine Prodrug LY2334737: {} + Gemcitabine-Phosphoramidate Hydrochloride NUC-1031: {} + Gemcitabine-Releasing Intravesical System: {} + Gemtuzumab Ozogamicin: {} + Genetically Modified Interleukin-12 Transgene-encoding Bifidobacterium longum: {} + Genistein: {} + Gentuximab: {} + Geranylgeranyltransferase I Inhibitor: {} + Giloralimab: {} + Gilteritinib: {} + Gilteritinib Fumarate: {} + Gimatecan: {} + Gimeracil: {} + Ginsenoside Rg3 Capsule: {} + Giredestrant: {} + Girentuximab: {} + Girodazole: {} + Givinostat: {} + Glasdegib: {} + Glasdegib Maleate: {} + Glaucarubolone: {} + Glecaprevir/Pibrentasvir: {} + Glembatumumab Vedotin: {} + Glesatinib: {} + Glioblastoma Cancer Vaccine ERC1671: {} + Glioblastoma Multiforme Multipeptide Vaccine IMA950: {} + Glioma Lysate Vaccine GBM6-AD: {} + Glioma-associated Peptide-loaded Dendritic Cell Vaccine SL-701: {} + Globo H-DT Vaccine OBI-833: {} + Glofitamab: {} + Glucarpidase: {} + Glucocorticoid Receptor Antagonist ORIC-101: {} + Glufosfamide: {} + Glumetinib: {} + Glutaminase Inhibitor CB-839: {} + Glutaminase Inhibitor CB-839 Hydrochloride: {} + Glutaminase Inhibitor IPN60090: {} + Glutamine Antagonist DRP-104: {} + Glutathione Pegylated Liposomal Doxorubicin Hydrochloride Formulation 2B3-101: {} + Glyco-engineered Anti-CD20 Monoclonal Antibody CHO H01: {} + Glycooptimized Trastuzumab-GEX: {} + Gold Sodium Thiomalate: {} + Golnerminogene Pradenovec: {} + Golotimod: {} + Golvatinib: {} + Gonadotropin-releasing Hormone Analog: {} + Goserelin: {} + Goserelin Acetate: {} + Goserelin Acetate Extended-release Microspheres LY01005: {} + Gossypol: {} + Gossypol Acetic Acid: {} + Grapiprant: {} + Green Tea Extract-based Antioxidant Supplement: {} + Guadecitabine: {} + Guanabenz Acetate: {} + Guselkumab: {} + Gusperimus Trihydrochloride: {} + Gutolactone: {} + H-ras Antisense Oligodeoxynucleotide ISIS 2503: {} + H1299 Tumor Cell Lysate Vaccine: {} + HAAH Lambda phage Vaccine SNS-301: {} + HCV DNA Vaccine INO-8000: {} + HDAC Class I/IIb Inhibitor HG146: {} + HDAC Inhibitor AR-42: {} + HDAC Inhibitor CHR-2845: {} + HDAC Inhibitor CKD-581: {} + HDAC Inhibitor CXD101: {} + HDAC Inhibitor MPT0E028: {} + HDAC Inhibitor OBP-801: {} + HDAC inhibitor CG200745: {} + HDAC/EGFR/HER2 Inhibitor CUDC-101: {} + HDAC6 Inhibitor KA2507: {} + HDAC8 Inhibitor NBM-BMX: {} + HDM2 Inhibitor HDM201: {} + HDM2 Inhibitor MK-8242: {} + HER-2-positive B-cell Peptide Antigen P467-DT-CRM197/Montanide Vaccine IMU-131: {} + HER2 ECD+TM Virus-like Replicon Particles Vaccine AVX901: {} + HER2 Inhibitor CP-724,714: {} + HER2 Inhibitor DZD1516: {} + HER2 Inhibitor TAS0728: {} + HER2 Tri-specific Natural Killer Cell Engager DF1001: {} + HER2-directed TLR8 Agonist SBT6050: {} + HER2-targeted DARPin MP0274: {} + HER2-targeted Liposomal Doxorubicin Hydrochloride MM-302: {} + HER2-targeting Antibody Fc Fragment FS102: {} + HIF-1alpha Inhibitor PX-478: {} + HIF-2alpha Inhibitor PT2385: {} + HIF-2alpha Inhibitor PT2977: {} + HIF2a RNAi ARO-HIF2: {} + HLA-A*0201 Restricted TERT(572Y)/TERT(572) Peptides Vaccine Vx-001: {} + HLA-A*2402-Restricted Multipeptide Vaccine S-488410: {} + HLA-A2-restricted Melanoma-specific Peptides Vaccine GRN-1201: {} + HM2/MMAE Antibody-Drug Conjugate ALT-P7: {} + HPPH: {} + HPV 16 E6/E7-encoding Arenavirus Vaccine HB-202: {} + HPV 16 E7 Antigen-expressing Lactobacillis casei Vaccine BLS-ILB-E710c: {} + HPV DNA Plasmids Therapeutic Vaccine VGX-3100: {} + HPV E6/E7 DNA Vaccine GX-188E: {} + HPV E6/E7-encoding Arenavirus Vaccine HB-201: {} + HPV Types 16/18 E6/E7-Adenoviral Transduced Autologous Lymphocytes/alpha-Galactosylceramide Vaccine BVAC-C: {} + HPV-16 E6 Peptides Vaccine/Candida albicans Extract: {} + HPV-6-targeting Immunotherapeutic Vaccine INO-3106: {} + HPV16 E7-specific HLA-A*02:01-restricted IgG1-Fc Fusion Protein CUE-101: {} + HPV16 L2/E6/E7 Fusion Protein Vaccine TA-CIN: {} + HPV6/11-targeted DNA Plasmid Vaccine INO-3107: {} + HSP90-targeted SN-38 Conjugate PEN-866: {} + HSP90alpha/beta Inhibitor TAS-116: {} + Hafnium Oxide-containing Nanoparticles NBTXR3: {} + Halichondrin Analogue E7130: {} + Halichondrin B: {} + Halofuginone: {} + Halofuginone Hydrobromide: {} + Hedgehog Inhibitor IPI-609: {} + Hematoporphyrin Derivative: {} + Hemiasterlin Analog E7974: {} + Henatinib Maleate: {} + Heparan Sulfate Glycosaminoglycan Mimetic M402: {} + Heparin Derivative SST0001: {} + Herba Scutellaria Barbata: {} + Herbimycin: {} + Heterodimeric Interleukin-15: {} + Hexamethylene Bisacetamide: {} + Hexaminolevulinate: {} + Hexylresorcinol: {} + Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126: {} + Histrelin Acetate: {} + Hodgkin's Antigens-GM-CSF-Expressing Cell Vaccine: {} + Holmium Ho 166 Poly(L-Lactic Acid) Microspheres: {} + Hormone Therapy: {} + Hsp90 Antagonist KW-2478: {} + Hsp90 Inhibitor AB-010: {} + Hsp90 Inhibitor BIIB021: {} + Hsp90 Inhibitor BIIB028: {} + Hsp90 Inhibitor DS-2248: {} + Hsp90 Inhibitor Debio 0932: {} + Hsp90 Inhibitor HSP990: {} + Hsp90 Inhibitor MPC-3100: {} + Hsp90 Inhibitor PU-H71: {} + Hsp90 Inhibitor SNX-5422 Mesylate: {} + Hsp90 Inhibitor SNX-5542 Mesylate: {} + Hsp90 Inhibitor TQB3474: {} + Hsp90 Inhibitor XL888: {} + Hsp90-targeted Photosensitizer HS-201: {} + Hu14.18-IL2 Fusion Protein EMD 273063: {} + HuaChanSu: {} + Huaier Extract Granule: {} + Huang Lian: {} + Human Combinatorial Antibody Library-based Monoclonal Antibody VAY736: {} + Human MHC Non-Restricted Cytotoxic T-Cell Line TALL-104: {} + Human MOAB LICO 28a32: {} + Human Monoclonal Antibody 216: {} + Human Monoclonal Antibody B11-hCG Beta Fusion Protein CDX-1307: {} + Human Papillomavirus 16 E7 Peptide/Padre 965.10: {} + Hyaluronidase-zzxf/Pertuzumab/Trastuzumab: {} + Hycanthone: {} + Hydralazine Hydrochloride: {} + Hydrocortisone Sodium Succinate: {} + Hydroxychloroquine: {} + Hydroxyprogesterone Caproate: {} + Hydroxytyrosol: {} + Hydroxyurea: {} + Hypericin: {} + Hypoxia-activated Prodrug TH-4000: {} + I 131 Antiferritin Immunoglobulin: {} + I 131 Monoclonal Antibody A33: {} + I 131 Monoclonal Antibody CC49: {} + I 131 Monoclonal Antibody F19: {} + I 131 Monoclonal Antibody Lym-1: {} + IAP Inhibitor APG-1387: {} + IAP Inhibitor AT-406: {} + IAP Inhibitor HGS1029: {} + ICT-121 Dendritic Cell Vaccine: {} + IDH1 Mutant Inhibitor LY3410738: {} + IDH1(R132) Inhibitor IDH305: {} + IDH1R132H-Specific Peptide Vaccine PEPIDH1M: {} + IDO Peptide Vaccine IO102: {} + IDO-1 Inhibitor LY3381916: {} + IDO/TDO Inhibitor HTI-1090: {} + IDO/TDO Inhibitor LY-01013: {} + IDO1 Inhibitor KHK2455: {} + IDO1 Inhibitor MK-7162: {} + IDO1 Inhibitor PF-06840003: {} + IDO1/TDO2 Inhibitor DN1406131: {} + IDO1/TDO2 Inhibitor M4112: {} + IGF-1R Inhibitor: {} + IGF-1R Inhibitor PL225B: {} + IGF-1R/IR Inhibitor KW-2450: {} + IGF-methotrexate Conjugate: {} + IL-10 Immunomodulator MK-1966: {} + IL-12-expressing HSV-1 NSC 733972: {} + IL-12-expressing Mesenchymal Stem Cell Vaccine GX-051: {} + IL-12sc, IL-15sushi, IFNa and GM-CSF mRNA-based Immunotherapeutic Agent SAR441000: {} + IL-2 Recombinant Fusion Protein ALT-801: {} + IL-2/9/15 Gamma Chain Receptor Inhibitor BNZ-1: {} + IL4-Pseudomonas Exotoxin Fusion Protein MDNA55: {} + IMT-1012 Immunotherapeutic Vaccine: {} + INO-1001: {} + IRAK4 Inhibitor CA-4948: {} + ISS 1018 CpG Oligodeoxynucleotide: {} + ITK Inhibitor CPI-818: {} + Iadademstat: {} + Ianalumab: {} + Ibandronate Sodium: {} + Iberdomide: {} + Iboctadekin: {} + Ibritumomab Tiuxetan: {} + Ibrutinib: {} + Icotinib Hydrochloride: {} + Icrucumab: {} + Idarubicin: {} + Idarubicin Hydrochloride: {} + Idarubicin-Eluting Beads: {} + Idasanutlin: {} + Idecabtagene Vicleucel: {} + Idelalisib: {} + Idetrexed: {} + Idiotype-Pulsed Autologous Dendritic Cell Vaccine APC8020: {} + Idronoxil: {} + Idronoxil Suppository NOX66: {} + Ieramilimab: {} + Ifabotuzumab: {} + Ifetroban: {} + Ifosfamide: {} + Ilginatinib: {} + Ilixadencel: {} + Iloprost: {} + Ilorasertib: {} + Imalumab: {} + Imaradenant: {} + Imatinib: {} + Imatinib Mesylate: {} + Imetelstat: {} + Imetelstat Sodium: {} + Imexon: {} + Imgatuzumab: {} + Imidazole Mustard: {} + Imidazole-Pyrazole: {} + Imifoplatin: {} + Imipramine Blue: {} + Imiquimod: {} + Immediate-release Onapristone: {} + Immediate-release Tablet Afuresertib: {} + Immune Checkpoint Inhibitor ASP8374: {} + Immunoconjugate RO5479599: {} + Immunocytokine NHS-IL12: {} + Immunocytokine NHS-IL2-LT: {} + Immunomodulator LAM-003: {} + Immunomodulator OHR/AVR118: {} + Immunomodulatory Agent CC-11006: {} + Immunomodulatory Oligonucleotide HYB2055: {} + Immunotherapeutic Combination Product CMB305: {} + Immunotherapeutic GSK1572932A: {} + Immunotherapy Regimen MKC-1106-MT: {} + Immunotoxin CMD-193: {} + Inactivated Oncolytic Virus Particle GEN0101: {} + Inalimarev: {} + Incyclinide: {} + Indatuximab Ravtansine: {} + Indibulin: {} + Indicine-N-Oxide: {} + Indisulam: {} + Individualized MVA-based Vaccine TG4050: {} + Indocyanine Green-labeled Polymeric Micelles ONM-100: {} + Indole-3-Carbinol: {} + Indomethacin: {} + Indoximod: {} + Indoximod Prodrug NLG802: {} + Indusatumab Vedotin: {} + Inebilizumab: {} + Inecalcitol: {} + Infigratinib: {} + Infigratinib Mesylate: {} + Infliximab: {} + Ingenol Mebutate: {} + Ingenol Mebutate Gel: {} + Iniparib: {} + Innate Immunostimulator rBBX-01: {} + Inodiftagene Vixteplasmid: {} + Inosine 5'-monophosphate Dehydrogenase Inhibitor FF-10501-01: {} + Inosine Monophosphate Dehydrogenase Inhibitor AVN944: {} + Inositol: {} + Inotuzumab Ozogamicin: {} + Inproquone: {} + Integrin Receptor Antagonist GLPG0187: {} + Integrin alpha-2 Inhibitor E7820: {} + Interferon: {} + Interferon Alfa-2B: {} + Interferon Alfa-N1: {} + Interferon Alfa-N3: {} + Interferon Alfacon-1: {} + Interferon Beta-1A: {} + Interferon Gamma-1b: {} + Interferon-gamma-expressing Adenovirus Vaccine ASN-002: {} + Interleukin Therapy: {} + Interleukin-12-Fc Fusion Protein DF6002: {} + Interleukin-15 Agonist Fusion Protein SHR1501: {} + Interleukin-15 Fusion Protein BJ-001: {} + Interleukin-15/Interleukin-15 Receptor Alpha Complex-Fc Fusion Protein XmAb24306: {} + Interleukin-15/Interleukin-15 Receptor Alpha Sushi+ Domain Fusion Protein SO-C101: {} + Interleukin-2 Liposome: {} + Intermediate-affinity Interleukin-2 Receptor Agonist ALKS 4230: {} + Intetumumab: {} + Intiquinatine: {} + Intoplicine: {} + Inulin: {} + Iobenguane I-131: {} + Iodine I 124 Monoclonal Antibody A33: {} + Iodine I 124 Monoclonal Antibody M5A: {} + Iodine I 125-Anti-EGFR-425 Monoclonal Antibody: {} + Iodine I 131 Anti-Fibronectin Antibody Fragment L19-SIP: {} + Iodine I 131 Apamistamab: {} + Iodine I 131 Derlotuximab Biotin: {} + Iodine I 131 Ethiodized Oil: {} + Iodine I 131 IPA: {} + Iodine I 131 MIP-1095: {} + Iodine I 131 Monoclonal Antibody 81C6: {} + Iodine I 131 Monoclonal Antibody BC8: {} + Iodine I 131 Monoclonal Antibody CC49-deltaCH2: {} + Iodine I 131 Monoclonal Antibody F16SIP: {} + Iodine I 131 Monoclonal Antibody G-250: {} + Iodine I 131 Monoclonal Antibody muJ591: {} + Iodine I 131 Omburtamab: {} + Iodine I 131 Rituximab: {} + Iodine I 131 TM-601: {} + Iodine I 131 Tenatumomab: {} + Iodine I 131 Tositumomab: {} + Iodine I-131: {} + Ioflubenzamide I-131: {} + Ionomycin: {} + Ipafricept: {} + Ipatasertib: {} + Ipilimumab: {} + Ipomeanol: {} + Iproplatin: {} + Iratumumab: {} + Iridium Ir 192: {} + Irinotecan: {} + Irinotecan Hydrochloride: {} + Irinotecan Sucrosofate: {} + Irinotecan-Eluting Beads: {} + Irinotecan/P-glycoprotein Inhibitor HM30181AK Combination Tablet: {} + Irofulven: {} + Iroplact: {} + Irosustat: {} + Irradiated Allogeneic Human Lung Cancer Cells Expressing OX40L-Ig Vaccine HS-130: {} + Isatuximab: {} + Iso-fludelone: {} + Isobrucein B: {} + Isocoumarin NM-3: {} + Isotretinoin: {} + Ispinesib: {} + Ispinesib Mesylate: {} + Istiratumab: {} + Itacitinib: {} + Itacitinib Adipate: {} + Itraconazole: {} + Itraconazole Dispersion In Polymer Matrix: {} + Ivaltinostat: {} + Ivosidenib: {} + Ivuxolimab: {} + Ixabepilone: {} + Ixazomib: {} + Ixazomib Citrate: {} + JAK Inhibitor: {} + JAK Inhibitor INCB047986: {} + JAK1 Inhibitor AZD4205: {} + JAK1 Inhibitor INCB052793: {} + JAK2 Inhibitor AZD1480: {} + JAK2 Inhibitor BMS-911543: {} + JAK2 Inhibitor XL019: {} + JAK2/Src Inhibitor NS-018: {} + JNK Inhibitor CC-401: {} + Jin Fu Kang: {} + KRAS G12C Inhibitor GDC-6036: {} + KRAS G12C Inhibitor LY3499446: {} + KRAS G12C Inhibitor MRTX849: {} + KRAS Mutant-targeting AMG 510: {} + KRAS-MAPK Signaling Pathway Inhibitor JAB-3312: {} + KRASG12C Inhibitor JNJ-74699157: {} + KRN5500: {} + KSP Inhibitor AZD4877: {} + KSP Inhibitor SB-743921: {} + Kanglaite: {} + Kanitinib: {} + Ketoconazole: {} + Ketotrexate: {} + Kunecatechins Ointment: {} + L-Gossypol: {} + L-methylfolate: {} + LAIR-2 Fusion Protein NC410: {} + LMB-1 Immunotoxin: {} + LMB-2 Immunotoxin: {} + LMB-7 Immunotoxin: {} + LMB-9 Immunotoxin: {} + LMP-2:340-349 Peptide Vaccine: {} + LMP-2:419-427 Peptide Vaccine: {} + LMP2-specific T Cell Receptor-transduced Autologous T-lymphocytes: {} + LMP7 Inhibitor M3258: {} + LOXL2 Inhibitor PAT-1251: {} + LRP5 Antagonist BI 905681: {} + LRP5/6 Antagonist BI 905677: {} + LSD1 Inhibitor CC-90011: {} + LSD1 Inhibitor GSK2879552: {} + LSD1 Inhibitor IMG-7289: {} + LSD1 Inhibitor RO7051790: {} + LSD1 Inhibitor SYHA1807: {} + LV.IL-2/B7.1-Transduced AML Blast Vaccine RFUSIN2-AML1: {} + Labetuzumab Govitecan: {} + Lactoferrin-derived Lytic Peptide LTX-315: {} + Lacutamab: {} + Ladiratuzumab Vedotin: {} + Ladirubicin: {} + Laetrile: {} + Landogrozumab: {} + Laniquidar: {} + Lanreotide Acetate: {} + Lapachone: {} + Lapatinib: {} + Lapatinib Ditosylate: {} + Laprituximab Emtansine: {} + Lapuleucel-T: {} + Laromustine: {} + Larotaxel: {} + Larotinib Mesylate: {} + Larotrectinib: {} + Larotrectinib Sulfate: {} + Lavendustin A: {} + Lazertinib: {} + Lead Pb 212 TCMC-trastuzumab: {} + Lefitolimod: {} + Leflunomide: {} + Lenalidomide: {} + Lenalidomide Analog KPG-121: {} + Lentinan: {} + Lenvatinib: {} + Lenvatinib Mesylate: {} + Lenzilumab: {} + Lerociclib: {} + Lestaurtinib: {} + Letetresgene Autoleucel: {} + Letolizumab: {} + Letrozole: {} + Leucovorin: {} + Leucovorin Calcium: {} + Leuprolide: {} + Leuprolide Acetate: {} + Leuprolide Mesylate Injectable Suspension: {} + Leurubicin: {} + Levetiracetam: {} + Levoleucovorin Calcium: {} + Levothyroxine: {} + Levothyroxine Sodium: {} + Lexatumumab: {} + Lexibulin: {} + Liarozole: {} + Liarozole Fumarate: {} + Liarozole Hydrochloride: {} + Licartin: {} + Licorice: {} + Lifastuzumab Vedotin: {} + Lifileucel: {} + Lifirafenib: {} + Light-Emitting Oncolytic Vaccinia Virus GL-ONC1: {} + Light-activated AU-011: {} + Lilotomab: {} + Limonene, (+)-: {} + Limonene, (+/-)-: {} + Linifanib: {} + Linoleyl Carbonate-Paclitaxel: {} + Linperlisib: {} + Linrodostat: {} + Linsitinib: {} + Lintuzumab: {} + Liothyronine I-131: {} + Liothyronine Sodium: {} + Lipid Encapsulated Anti-PLK1 siRNA TKM-PLK1: {} + Lipid Nanoparticle Encapsulated OX40L mRNA-2416: {} + Lipid Nanoparticle Encapsulated mRNAs Encoding Human IL-12A/IL-12B MEDI-1191: {} + Lipid Nanoparticle Encapsulating Glutathione S-transferase P siRNA NBF-006: {} + Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L/IL-23/IL-36gamma mRNA-2752: {} + Liposomal Bcl-2 Antisense Oligonucleotide BP1002: {} + Liposomal Curcumin: {} + Liposomal Cytarabine: {} + Liposomal Daunorubicin Citrate: {} + Liposomal Docetaxel: {} + Liposomal Eribulin Mesylate: {} + Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101: {} + Liposomal Irinotecan: {} + Liposomal MUC1/PET-lipid A Vaccine ONT-10: {} + Liposomal Mitoxantrone Hydrochloride: {} + Liposomal NDDP: {} + Liposomal Rhenium Re 186: {} + Liposomal SN-38: {} + Liposomal Topotecan FF-10850: {} + Liposomal Vinorelbine: {} + Liposomal Vinorelbine Tartrate: {} + Liposomal c-raf Antisense Oligonucleotide: {} + Liposome: {} + Liposome-Encapsulated Doxorubicin Citrate: {} + Liposome-encapsulated Daunorubicin-Cytarabine: {} + Liposome-encapsulated OSI-7904: {} + Liposome-encapsulated RB94 Plasmid DNA Gene Therapy Agent SGT-94: {} + Liposome-encapsulated TAAs mRNA Vaccine W_ova1: {} + Liposome-encapsulated miR-34 Mimic MRX34: {} + Lirilumab: {} + Lisavanbulin: {} + Lisocabtagene Maraleucel: {} + Listeria monocytogenes-LLO-PSA Vaccine ADXS31-142: {} + Litronesib: {} + Live-Attenuated Listeria Encoding Human Mesothelin Vaccine CRS-207: {} + Live-attenuated Double-deleted Listeria monocytogenes Bacteria JNJ-64041809: {} + Live-attenuated Listeria monocytogenes-encoding EGFRvIII-NY-ESO-1 Vaccine ADU-623: {} + Liver X Receptor beta Agonist RGX-104: {} + Lm-tLLO-neoantigens Vaccine ADXS-NEO: {} + LmddA-LLO-chHER2 Fusion Protein-secreting Live-attenuated Listeria Cancer Vaccine ADXS31-164: {} + Lobaplatin: {} + Lodapolimab: {} + Lometrexol: {} + Lometrexol Sodium: {} + Lomustine: {} + Lonafarnib: {} + Loncastuximab Tesirine: {} + Long Peptide Vaccine 7: {} + Long-acting Release Pasireotide: {} + Lontucirev: {} + Lorlatinib: {} + Lorukafusp alfa: {} + Lorvotuzumab Mertansine: {} + Losatuxizumab Vedotin: {} + Losoxantrone: {} + Losoxantrone Hydrochloride: {} + Lovastatin: {} + Lucanthone: {} + Lucatumumab: {} + Lucitanib: {} + Luminespib: {} + Luminespib Mesylate: {} + Lumretuzumab: {} + Lung-targeted Immunomodulator QBKPN: {} + Lupartumab Amadotin: {} + Lurbinectedin: {} + Lurtotecan: {} + Lurtotecan Liposome: {} + Lutetium Lu 177 Anti-CA19-9 Monoclonal Antibody 5B1: {} + Lutetium Lu 177 DOTA-N3-CTT1403: {} + Lutetium Lu 177 DOTA-Tetulomab: {} + Lutetium Lu 177 DOTA-biotin: {} + Lutetium Lu 177 Dotatate: {} + Lutetium Lu 177 Lilotomab-satetraxetan: {} + Lutetium Lu 177 Monoclonal Antibody CC49: {} + Lutetium Lu 177 Monoclonal Antibody J591: {} + Lutetium Lu 177 PP-F11N: {} + Lutetium Lu 177 Satoreotide Tetraxetan: {} + Lutetium Lu 177-DOTA-EB-TATE: {} + Lutetium Lu 177-DTPA-omburtamab: {} + Lutetium Lu 177-Edotreotide: {} + Lutetium Lu 177-NeoB: {} + Lutetium Lu 177-PSMA-617: {} + Lutetium Lu-177 Capromab: {} + Lutetium Lu-177 Girentuximab: {} + Lutetium Lu-177 PSMA-R2: {} + Lutetium Lu-177 Rituximab: {} + Lyophilized Black Raspberry Lozenge: {} + Lyophilized Black Raspberry Saliva Substitute: {} + Lysine-specific Demethylase 1 Inhibitor INCB059872: {} + Lyso-Thermosensitive Liposome Doxorubicin: {} + MAGE-10.A2: {} + MAGE-A1-specific T Cell Receptor-transduced Autologous T-cells: {} + MAGE-A3 Multipeptide Vaccine GL-0817: {} + MAGE-A3 Peptide Vaccine: {} + MAGE-A3-specific Immunotherapeutic GSK 2132231A: {} + MAGE-A4-specific TCR Gene-transduced Autologous T Lymphocytes TBI-1201: {} + MALT1 Inhibitor JNJ-67856633: {} + MARCKS Protein Inhibitor BIO-11006: {} + MAT2A Inhibitor AG-270: {} + MCL-1 Inhibitor ABBV-467: {} + MCL-1 Inhibitor AMG 176: {} + MCL-1 inhibitor AMG 397: {} + MDM2 Antagonist ASTX295: {} + MDM2 Antagonist RO5045337: {} + MDM2 Antagonist RO6839921: {} + MDM2 Inhibitor AMG-232: {} + MDM2 Inhibitor AMGMDS3: {} + MDM2 Inhibitor BI 907828: {} + MDM2 Inhibitor KRT-232: {} + MDM2/MDMX Inhibitor ALRN-6924: {} + MDR Modulator CBT-1: {} + MEK 1/2 Inhibitor AS703988/MSC2015103B: {} + MEK 1/2 Inhibitor FCN-159: {} + MEK Inhibitor AZD8330: {} + MEK Inhibitor CI-1040: {} + MEK Inhibitor GDC-0623: {} + MEK Inhibitor HL-085: {} + MEK Inhibitor PD0325901: {} + MEK Inhibitor RO4987655: {} + MEK Inhibitor SHR 7390: {} + MEK Inhibitor TAK-733: {} + MEK Inhibitor WX-554: {} + MEK inhibitor CS3006: {} + MEK-1/MEKK-1 Inhibitor E6201: {} + MEK/Aurora Kinase Inhibitor BI 847325: {} + MELK Inhibitor OTS167: {} + MET Kinase Inhibitor OMO-1: {} + MET Tyrosine Kinase Inhibitor BMS-777607: {} + MET Tyrosine Kinase Inhibitor EMD 1204831: {} + MET Tyrosine Kinase Inhibitor PF-04217903: {} + MET Tyrosine Kinase Inhibitor SAR125844: {} + MET Tyrosine Kinase Inhibitor SGX523: {} + MET x MET Bispecific Antibody REGN5093: {} + MK0731: {} + MKC-1: {} + MKNK1 Inhibitor BAY 1143269: {} + MMP Inhibitor S-3304: {} + MNK1/2 Inhibitor ETC-1907206: {} + MOF Compound RiMO-301: {} + MOv-gamma Chimeric Receptor Gene: {} + MTF-1 Inhibitor APTO-253 HCl: {} + MUC-1/WT1 Peptide-primed Autologous Dendritic Cells: {} + MUC1-targeted Peptide GO-203-2C: {} + MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP: {} + MVA-BN Smallpox Vaccine: {} + MVA-FCU1 TG4023: {} + MVX-1-loaded Macrocapsule/autologous Tumor Cell Vaccine MVX-ONCO-1: {} + MYC-targeting siRNA DCR-MYC: {} + Maackia amurensis Seed Lectin: {} + Macimorelin: {} + Macitentan: {} + Macrocycle-bridged STING Agonist E7766: {} + Maekmoondong-tang: {} + Mafosfamide: {} + Magnesium Valproate: {} + Magrolimab: {} + Manelimab: {} + Mannosulfan: {} + Mannosylerythritol Lipid: {} + Mapatumumab: {} + Maraba Oncolytic Virus Expressing Mutant HPV E6/E7: {} + Marcellomycin: {} + Margetuximab: {} + Marimastat: {} + Marizomib: {} + Masitinib Mesylate: {} + Masoprocol: {} + Matrix Metalloproteinase Inhibitor MMI270: {} + Matuzumab: {} + Mavelertinib: {} + Mavorixafor: {} + Maytansine: {} + Mcl-1 Inhibitor AZD5991: {} + Mcl-1 Inhibitor MIK665: {} + Mechlorethamine: {} + Mechlorethamine Hydrochloride: {} + Mechlorethamine Hydrochloride Gel: {} + Medorubicin: {} + Medroxyprogesterone: {} + Medroxyprogesterone Acetate: {} + Megestrol Acetate: {} + Melanoma Monoclonal Antibody hIgG2A: {} + Melanoma TRP2 CTL Epitope Vaccine SCIB1: {} + Melapuldencel-T: {} + Melphalan: {} + Melphalan Flufenamide: {} + Melphalan Hydrochloride: {} + Melphalan Hydrochloride/Sulfobutyl Ether Beta-Cyclodextrin Complex: {} + Membrane-Disrupting Peptide EP-100: {} + Menatetrenone: {} + Menin-MLL Interaction Inhibitor SNDX-5613: {} + Menogaril: {} + Merbarone: {} + Mercaptopurine: {} + Mercaptopurine Anhydrous: {} + Mercaptopurine Oral Suspension: {} + Merestinib: {} + Mesna: {} + Mesothelin/CD3e Tri-specific T-cell Activating Construct HPN536: {} + MetAP2 Inhibitor APL-1202: {} + MetAP2 Inhibitor SDX-7320: {} + Metamelfalan: {} + Metarrestin: {} + Metatinib Tromethamine: {} + Metformin: {} + Metformin Hydrochloride: {} + Methanol Extraction Residue of BCG: {} + Methazolamide: {} + Methionine Aminopeptidase 2 Inhibitor M8891: {} + Methionine Aminopeptidase 2 Inhibitor PPI-2458: {} + Methotrexate: {} + Methotrexate Sodium: {} + Methotrexate-E Therapeutic Implant: {} + Methotrexate-Encapsulating Autologous Tumor-Derived Microparticles: {} + Methoxsalen: {} + Methoxyamine: {} + Methoxyamine Hydrochloride: {} + Methyl-5-Aminolevulinate Hydrochloride Cream: {} + Methylcantharidimide: {} + Methylmercaptopurine Riboside: {} + Methylprednisolone: {} + Methylprednisolone Acetate: {} + Methylprednisolone Sodium Succinate: {} + Methylselenocysteine: {} + Methyltestosterone: {} + Metoprine: {} + Mevociclib: {} + Mezagitamab: {} + Mibefradil: {} + Mibefradil Dihydrochloride: {} + Micellar Nanoparticle-encapsulated Epirubicin: {} + Micro Needle Array-Doxorubicin: {} + Microbiome GEN-001: {} + Microbiome-derived Peptide Vaccine EO2401: {} + Microparticle-encapsulated CYP1B1-encoding DNA Vaccine ZYC300: {} + Microtubule Inhibitor SCB01A: {} + Midostaurin: {} + Mifamurtide: {} + Mifepristone: {} + Milademetan Tosylate: {} + Milataxel: {} + Milatuzumab: {} + Milatuzumab-Doxorubicin Antibody-Drug Conjugate IMMU-110: {} + Milciclib Maleate: {} + Milk Thistle: {} + Miltefosine: {} + Minretumomab: {} + Mipsagargin: {} + Miptenalimab: {} + Mirabegron: {} + Miransertib: {} + Mirdametinib: {} + Mirvetuximab Soravtansine: {} + Mirzotamab Clezutoclax: {} + Misonidazole: {} + Mistletoe Extract: {} + Mitazalimab: {} + Mitindomide: {} + Mitobronitol: {} + Mitochondrial Oxidative Phosphorylation Inhibitor ATR-101: {} + Mitoclomine: {} + Mitoflaxone: {} + Mitoguazone: {} + Mitoguazone Dihydrochloride: {} + Mitolactol: {} + Mitomycin: {} + Mitomycin A: {} + Mitomycin B: {} + Mitomycin C Analog KW-2149: {} + Mitosis Inhibitor T 1101 Tosylate: {} + Mitotane: {} + Mitotenamine: {} + Mitoxantrone: {} + Mitoxantrone Hydrochloride: {} + Mitozolomide: {} + Mivavotinib: {} + Mivebresib: {} + Mivobulin: {} + Mivobulin Isethionate: {} + Mixed Bacteria Vaccine: {} + Mobocertinib: {} + Mocetinostat: {} + Modakafusp Alfa: {} + Modified Vaccinia Ankara-vectored HPV16/18 Vaccine JNJ-65195208: {} + Modified Vitamin D Binding Protein Macrophage Activator EF-022: {} + Modotuximab: {} + Mofarotene: {} + Mogamulizumab: {} + Molibresib: {} + Molibresib Besylate: {} + Momelotinib: {} + Monalizumab: {} + Monocarboxylate Transporter 1 Inhibitor AZD3965: {} + Monoclonal Antibody 105AD7 Anti-idiotype Vaccine: {} + Monoclonal Antibody 11D10: {} + Monoclonal Antibody 11D10 Anti-Idiotype Vaccine: {} + Monoclonal Antibody 14G2A: {} + Monoclonal Antibody 1F5: {} + Monoclonal Antibody 3622W94: {} + Monoclonal Antibody 3F8: {} + Monoclonal Antibody 3H1 Anti-Idiotype Vaccine: {} + Monoclonal Antibody 4B5 Anti-Idiotype Vaccine: {} + Monoclonal Antibody 7C11: {} + Monoclonal Antibody 81C6: {} + Monoclonal Antibody A1G4 Anti-Idiotype Vaccine: {} + Monoclonal Antibody A27.15: {} + Monoclonal Antibody A33: {} + Monoclonal Antibody AK002: {} + Monoclonal Antibody ASP1948: {} + Monoclonal Antibody AbGn-7: {} + Monoclonal Antibody CAL: {} + Monoclonal Antibody CC49-delta CH2: {} + Monoclonal Antibody CEP-37250/KHK2804: {} + Monoclonal Antibody D6.12: {} + Monoclonal Antibody E2.3: {} + Monoclonal Antibody F19: {} + Monoclonal Antibody GD2 Anti-Idiotype Vaccine: {} + Monoclonal Antibody HeFi-1: {} + Monoclonal Antibody Hu3S193: {} + Monoclonal Antibody HuAFP31: {} + Monoclonal Antibody HuHMFG1: {} + Monoclonal Antibody HuPAM4: {} + Monoclonal Antibody IMMU-14: {} + Monoclonal Antibody L6: {} + Monoclonal Antibody Lym-1: {} + Monoclonal Antibody MX35 F(ab')2: {} + Monoclonal Antibody Me1-14 F(ab')2: {} + Monoclonal Antibody NEO-201: {} + Monoclonal Antibody R24: {} + Monoclonal Antibody RAV12: {} + Monoclonal Antibody SGN-14: {} + Monoclonal Antibody TRK-950: {} + Monoclonal Antibody huJ591: {} + Monoclonal Antibody m170: {} + Monoclonal Antibody muJ591: {} + Monoclonal Microbial EDP1503: {} + Monoclonal T-cell Receptor Anti-CD3 scFv Fusion Protein IMCgp100: {} + Monomethyl Auristatin E: {} + Morinda Citrifolia Fruit Extract: {} + Morpholinodoxorubicin: {} + Mosedipimod: {} + Mosunetuzumab: {} + Motesanib: {} + Motesanib Diphosphate: {} + Motexafin Gadolinium: {} + Motexafin Lutetium: {} + Motixafortide: {} + Motolimod: {} + Moxetumomab Pasudotox: {} + Mps1 Inhibitor BAY 1217389: {} + Mps1 Inhibitor BOS172722: {} + Mucoadhesive Paclitaxel Formulation: {} + Multi-AGC Kinase Inhibitor AT13148: {} + Multi-epitope Anti-folate Receptor Peptide Vaccine TPIV 200: {} + Multi-epitope HER2 Peptide Vaccine H2NVAC: {} + Multi-epitope HER2 Peptide Vaccine TPIV100: {} + Multi-glioblastoma-peptide-targeting Autologous Dendritic Cell Vaccine ICT-107: {} + Multi-kinase Inhibitor TPX-0022: {} + Multi-kinase Inhibitor XL092: {} + Multi-mode Kinase Inhibitor EOC317: {} + Multi-neo-epitope Vaccine OSE 2101: {} + Multifunctional/Multitargeted Anticancer Agent OMN54: {} + Multikinase Inhibitor 4SC-203: {} + Multikinase Inhibitor AEE788: {} + Multikinase Inhibitor AT9283: {} + Multikinase Inhibitor SAR103168: {} + Multipeptide Vaccine S-588210: {} + Multitargeted Tyrosine Kinase Inhibitor JNJ-26483327: {} + Muparfostat: {} + Mureletecan: {} + Murizatoclax: {} + Muscadine Grape Extract: {} + Mutant IDH1 Inhibitor DS-1001: {} + Mutant p53 Activator COTI-2: {} + Mutant-selective EGFR Inhibitor PF-06459988: {} + Mycobacterium tuberculosis Arabinomannan Z-100: {} + Mycobacterium w: {} + Mycophenolic Acid: {} + N,N-Dibenzyl Daunomycin: {} + N-(5-tert-butyl-3-isoxazolyl)-N-(4-(4-pyridinyl)oxyphenyl) Urea: {} + N-Methylformamide: {} + N-dihydrogalactochitosan: {} + NA17-A Antigen: {} + NA17.A2 Peptide Vaccine: {} + NAMPT Inhibitor OT-82: {} + NEDD8 Activating Enzyme E1 Inhibitor TAS4464: {} + NG-nitro-L-arginine: {} + NLRP3 Agonist BMS-986299: {} + NTRK/ROS1 Inhibitor DS-6051b: {} + NY-ESO-1 Plasmid DNA Cancer Vaccine pPJV7611: {} + NY-ESO-1-specific TCR Gene-transduced T Lymphocytes TBI-1301: {} + NY-ESO-1/GLA-SE Vaccine ID-G305: {} + NY-ESO-B: {} + Nab-paclitaxel: {} + Nab-paclitaxel/Rituximab-coated Nanoparticle AR160: {} + Nadofaragene Firadenovec: {} + Nagrestipen: {} + Namirotene: {} + Namodenoson: {} + Nanafrocin: {} + Nanatinostat: {} + Nanocell-encapsulated miR-16-based microRNA Mimic: {} + Nanoparticle Albumin-Bound Docetaxel: {} + Nanoparticle Albumin-Bound Rapamycin: {} + Nanoparticle Albumin-bound Thiocolchicine Dimer nab-5404: {} + Nanoparticle Paclitaxel Ointment SOR007: {} + Nanoparticle-based Paclitaxel Suspension: {} + Nanoparticle-encapsulated Doxorubicin Hydrochloride: {} + Nanoscale Coordination Polymer Nanoparticles CPI-100: {} + Nanosomal Docetaxel Lipid Suspension: {} + Napabucasin: {} + Naphthalimide Analogue UNBS5162: {} + Naptumomab Estafenatox: {} + Naquotinib: {} + Naratuximab Emtansine: {} + Narnatumab: {} + Natalizumab: {} + Natural IFN-alpha OPC-18: {} + Natural Killer Cells ZRx101: {} + Navarixin: {} + Navicixizumab: {} + Navitoclax: {} + Navoximod: {} + Navy Bean Powder: {} + Naxitamab: {} + Nazartinib: {} + Necitumumab: {} + Nedaplatin: {} + Nedisertib: {} + Nelarabine: {} + Nelipepimut-S: {} + Nelipepimut-S Plus GM-CSF Vaccine: {} + Nemorubicin: {} + Nemorubicin Hydrochloride: {} + Neoantigen Vaccine GEN-009: {} + Neoantigen-HSP70 Peptide Cancer Vaccine AGEN2017: {} + Neoantigen-based Glioblastoma Vaccine: {} + Neoantigen-based Melanoma-Poly-ICLC Vaccine: {} + Neoantigen-based Renal Cell Carcinoma-Poly-ICLC Vaccine: {} + Neoantigen-based Therapeutic Cancer Vaccine GRT-C903: {} + Neoantigen-based Therapeutic Cancer Vaccine GRT-R904: {} + Neratinib: {} + Neratinib Maleate: {} + Nesvacumab: {} + Niacinamide: {} + Niclosamide: {} + Nicotinamide Riboside: {} + Nidanilimab: {} + Nifurtimox: {} + Nilotinib: {} + Nilotinib Hydrochloride Anhydrous: {} + Nilotinib Hydrochloride Monohydrate: {} + Nilutamide: {} + Nimesulide-Hyaluronic Acid Conjugate CA102N: {} + Nimodipine: {} + Nimotuzumab: {} + Nimustine: {} + Nimustine Hydrochloride: {} + Ningetinib Tosylate: {} + Nintedanib: {} + Niraparib: {} + Niraparib Tosylate Monohydrate: {} + Nirogacestat: {} + Nitric Oxide-Releasing Acetylsalicylic Acid Derivative: {} + Nitrogen Mustard Prodrug PR-104: {} + Nitroglycerin Transdermal Patch: {} + Nivolumab: {} + Nocodazole: {} + Nogalamycin: {} + Nogapendekin Alfa: {} + Nolatrexed Dihydrochloride: {} + Non-Small Cell Lung Cancer mRNA-Derived Vaccine CV9201: {} + Norgestrel: {} + North American Ginseng Extract AFX-2: {} + Nortopixantrone: {} + Noscapine: {} + Noscapine Hydrochloride: {} + Not Otherwise Specified: {} + Not Reported: {} + Notch Signaling Inhibitor PF-06650808: {} + Notch Signaling Pathway Inhibitor MK0752: {} + Nucleolin Antagonist IPP-204106N: {} + Nucleoside Analog DFP-10917: {} + Nucleotide Analog Prodrug NUC-3373: {} + Nucleotide Analogue GS 9219: {} + Numidargistat: {} + Nurulimab: {} + Nutlin-3a: {} + Nutraceutical TBL-12: {} + O-Chloroacetylcarbamoylfumagillol: {} + O6-Benzylguanine: {} + OPCs/Green Tea/Spirullina/Curcumin/Antrodia Camphorate/Fermented Soymilk Extract Capsule: {} + OX40L-expressing Oncolytic Adenovirus DNX-2440: {} + Obatoclax Mesylate: {} + Obinutuzumab: {} + Oblimersen Sodium: {} + Ocaratuzumab: {} + Ocrelizumab: {} + Octreotide: {} + Octreotide Acetate: {} + Octreotide Pamoate: {} + Odronextamab: {} + Ofatumumab: {} + Ofranergene Obadenovec: {} + Oglufanide Disodium: {} + Olaparib: {} + Olaptesed Pegol: {} + Olaratumab: {} + Oleandrin: {} + Oleclumab: {} + Oligo-fucoidan: {} + Oligonucleotide SPC2996: {} + Olinvacimab: {} + Olivomycin: {} + Olmutinib: {} + Oltipraz: {} + Olutasidenib: {} + Olvimulogene Nanivacirepvec: {} + Omacetaxine Mepesuccinate: {} + Ombrabulin: {} + Omipalisib: {} + Onalespib: {} + Onalespib Lactate: {} + Onartuzumab: {} + Onatasertib: {} + Oncolytic Adenovirus Ad5-DNX-2401: {} + Oncolytic Adenovirus ORCA-010: {} + Oncolytic HSV-1 C134: {} + Oncolytic HSV-1 Expressing IL-12 and Anti-PD-1 Antibody T3011: {} + Oncolytic HSV-1 G207: {} + Oncolytic HSV-1 NV1020: {} + Oncolytic HSV-1 rQNestin34.5v.2: {} + Oncolytic HSV-1 rRp450: {} + Oncolytic HSV1716: {} + Oncolytic Herpes Simplex Virus-1 ONCR-177: {} + Oncolytic Measles Virus Encoding Helicobacter pylori Neutrophil-activating Protein: {} + Oncolytic Newcastle Disease Virus MEDI5395: {} + Oncolytic Newcastle Disease Virus MTH-68H: {} + Oncolytic Newcastle Disease Virus Strain PV701: {} + Oncolytic Virus ASP9801: {} + Oncolytic Virus RP1: {} + Ondansetron Hydrochloride: {} + Ontorpacept: {} + Ontuxizumab: {} + Onvansertib: {} + Onvatilimab: {} + Opaganib: {} + Opioid Growth Factor: {} + Opolimogene Capmilisbac: {} + Oportuzumab Monatox: {} + Oprozomib: {} + Opucolimab: {} + Oral Aminolevulinic Acid Hydrochloride: {} + Oral Azacitidine: {} + Oral Cancer Vaccine V3-OVA: {} + Oral Docetaxel: {} + Oral Fludarabine Phosphate: {} + Oral Hsp90 Inhibitor IPI-493: {} + Oral Ixabepilone: {} + Oral Microencapsulated Diindolylmethane: {} + Oral Milataxel: {} + Oral Myoma Vaccine V3-myoma: {} + Oral Pancreatic Cancer Vaccine V3-P: {} + Oral Picoplatin: {} + Oral Sodium Phenylbutyrate: {} + Oral Topotecan Hydrochloride: {} + Orantinib: {} + Oraxol: {} + Oregovomab: {} + Orelabrutinib: {} + Ormaplatin: {} + Ortataxel: {} + Orteronel: {} + Orvacabtagene Autoleucel: {} + Osilodrostat: {} + Osimertinib: {} + Other: {} + Otlertuzumab: {} + Ovapuldencel-T: {} + Ovarian Cancer Stem Cell/hTERT/Survivin mRNAs-loaded Autologous Dendritic Cell Vaccine DC-006: {} + Ovine Submaxillary Mucin: {} + OxPhos Inhibitor VLX600: {} + Oxaliplatin: {} + Oxaliplatin Eluting Beads: {} + Oxaliplatin-Encapsulated Transferrin-Conjugated N-glutaryl Phosphatidylethanolamine Liposome: {} + Oxcarbazepine: {} + Oxeclosporin: {} + Oxidative Phosphorylation Inhibitor IACS-010759: {} + Oxidative Phosphorylation Inhibitor IM156: {} + Oxidopamine: {} + Ozarelix: {} + P-TEFb Inhibitor BAY1143572: {} + P-cadherin Antagonist PF-03732010: {} + P-cadherin Inhibitor PCA062: {} + P-cadherin-targeting Agent PF-06671008: {} + P-p68 Inhibitor RX-5902: {} + PAK4 Inhibitor PF-03758309: {} + PAK4/NAMPT Inhibitor KPT-9274: {} + PARP 1/2 Inhibitor IMP4297: {} + PARP 1/2 Inhibitor NOV1401: {} + PARP Inhibitor AZD2461: {} + PARP Inhibitor CEP-9722: {} + PARP Inhibitor E7016: {} + PARP Inhibitor NMS-03305293: {} + PARP-1/2 Inhibitor ABT-767: {} + PARP/Tankyrase Inhibitor 2X-121: {} + PARP7 Inhibitor RBN-2397: {} + PBN Derivative OKN-007: {} + PCNU: {} + PD-1 Directed Probody CX-188: {} + PD-1 Inhibitor: {} + PD-L1 Inhibitor GS-4224: {} + PD-L1 Inhibitor INCB086550: {} + PD-L1/4-1BB/HSA Trispecific Fusion Protein NM21-1480: {} + PD-L1/PD-L2/VISTA Antagonist CA-170: {} + PDK1 Inhibitor AR-12: {} + PE/HPV16 E7/KDEL Fusion Protein/GPI-0100 TVGV-1: {} + PEG-PEI-cholesterol Lipopolymer-encased IL-12 DNA Plasmid Vector GEN-1: {} + PEG-Proline-Interferon Alfa-2b: {} + PEG-interleukin-2: {} + PEOX-based Polymer Encapsulated Paclitaxel FID-007: {} + PEP-3-KLH Conjugate Vaccine: {} + PGG Beta-Glucan: {} + PGLA/PEG Copolymer-Based Paclitaxel: {} + PH20 Hyaluronidase-expressing Adenovirus VCN-01: {} + PI3K Alpha/Beta Inhibitor BAY1082439: {} + PI3K Alpha/mTOR Inhibitor PWT33597 Mesylate: {} + PI3K Inhibitor ACP-319: {} + PI3K Inhibitor BGT226: {} + PI3K Inhibitor GDC-0084: {} + PI3K Inhibitor GDC0077: {} + PI3K Inhibitor GSK1059615: {} + PI3K Inhibitor WX-037: {} + PI3K Inhibitor ZSTK474: {} + PI3K p110beta/delta Inhibitor KA2237: {} + PI3K-alpha Inhibitor MEN1611: {} + PI3K-beta Inhibitor GSK2636771: {} + PI3K-beta Inhibitor SAR260301: {} + PI3K-delta Inhibitor AMG 319: {} + PI3K-delta Inhibitor HMPL 689: {} + PI3K-delta Inhibitor INCB050465: {} + PI3K-delta Inhibitor PWT143: {} + PI3K-delta Inhibitor SHC014748M: {} + PI3K-delta Inhibitor YY-20394: {} + PI3K-gamma Inhibitor IPI-549: {} + PI3K/BET Inhibitor LY294002: {} + PI3K/mTOR Kinase Inhibitor DS-7423: {} + PI3K/mTOR Kinase Inhibitor PF-04691502: {} + PI3K/mTOR Kinase Inhibitor VS-5584: {} + PI3K/mTOR Kinase Inhibitor WXFL10030390: {} + PI3K/mTOR/ALK-1/DNA-PK Inhibitor P7170: {} + PI3K/mTORC1/mTORC2 Inhibitor DCBCI0901: {} + PI3Ka/mTOR Inhibitor PKI-179: {} + PI3Kalpha Inhibitor AZD8835: {} + PI3Kbeta Inhibitor AZD8186: {} + PI3Kdelta Inhibitor GS-9901: {} + PIM Kinase Inhibitor LGH447: {} + PIM Kinase Inhibitor SGI-1776: {} + PIM Kinase Inhibitor TP-3654: {} + PIM/FLT3 Kinase Inhibitor SEL24: {} + PKA Regulatory Subunit RIalpha Mixed-Backbone Antisense Oligonucleotide GEM 231: {} + PKC-alpha Antisense Oligodeoxynucleotide ISIS 3521: {} + PKC-beta Inhibitor MS-553: {} + PLK1 Inhibitor CYC140: {} + PLK1 Inhibitor TAK-960: {} + PPAR Alpha Antagonist TPST-1120: {} + PR1 Leukemia Peptide Vaccine: {} + PRAME-targeting T-cell Receptor/Inducible Caspase 9 BPX-701: {} + PRIMA-1 Analog APR-246: {} + PRMT1 Inhibitor GSK3368715: {} + PRMT5 Inhibitor JNJ-64619178: {} + PRMT5 Inhibitor PRT811: {} + PSA/IL-2/GM-CSF Vaccine: {} + PSA/PSMA DNA Plasmid INO-5150: {} + PSMA-targeted Docetaxel Nanoparticles BIND-014: {} + PSMA-targeted Tubulysin B-containing Conjugate EC1169: {} + PSMA/CD3 Tri-specific T-cell Activating Construct HPN424: {} + PTEF-b/CDK9 Inhibitor BAY1251152: {} + PV-10: {} + PVA Microporous Hydrospheres/Doxorubicin Hydrochloride: {} + Paclitaxel: {} + Paclitaxel Ceribate: {} + Paclitaxel Injection Concentrate for Nanodispersion: {} + Paclitaxel Liposome: {} + Paclitaxel PPE Microspheres: {} + Paclitaxel Poliglumex: {} + Paclitaxel Polymeric Micelle Formulation NANT-008: {} + Paclitaxel Trevatide: {} + Paclitaxel Vitamin E-Based Emulsion: {} + Paclitaxel-Loaded Polymeric Micelle: {} + Pacmilimab: {} + Pacritinib: {} + Padeliporfin: {} + Padoporfin: {} + Palbociclib: {} + Palbociclib Isethionate: {} + Palifosfamide: {} + Palifosfamide Tromethamine: {} + Palladium Pd-103: {} + Palonosetron Hydrochloride: {} + Pamidronate Disodium: {} + Pamidronic Acid: {} + Pamiparib: {} + Pamrevlumab: {} + Pan HER/VEGFR2 Receptor Tyrosine Kinase Inhibitor BMS-690514: {} + Pan-AKT Inhibitor ARQ751: {} + Pan-AKT Kinase Inhibitor GSK690693: {} + Pan-FGFR Inhibitor LY2874455: {} + Pan-FLT3/Pan-BTK Multi-kinase Inhibitor CG-806: {} + Pan-IDH Mutant Inhibitor AG-881: {} + Pan-KRAS Inhibitor BI 1701963: {} + Pan-Mutant-IDH1 Inhibitor Bay-1436032: {} + Pan-PIM Inhibitor INCB053914: {} + Pan-RAF Inhibitor LY3009120: {} + Pan-RAR Agonist/AP-1 Inhibitor LGD 1550: {} + Pan-TRK Inhibitor NOV1601: {} + Pan-TRK Inhibitor ONO-7579: {} + Pan-VEGFR/TIE2 Tyrosine Kinase Inhibitor CEP-11981: {} + Pan-mutation-selective EGFR Inhibitor CLN-081: {} + Pancratistatin: {} + Panitumumab: {} + Panobinostat: {} + Panobinostat Nanoparticle Formulation MTX110: {} + Panulisib: {} + Paricalcitol: {} + Parsaclisib: {} + Parsaclisib Hydrochloride: {} + Parsatuzumab: {} + Partially Engineered T-regulatory Cell Donor Graft TRGFT-201: {} + Parvovirus H-1: {} + Pasireotide: {} + Pasotuxizumab: {} + Patidegib: {} + Patidegib Topical Gel: {} + Patritumab: {} + Patritumab Deruxtecan: {} + Patupilone: {} + Paxalisib: {} + Pazopanib: {} + Pazopanib Hydrochloride: {} + Pegargiminase: {} + Pegaspargase: {} + Pegdinetanib: {} + Pegfilgrastim: {} + Pegilodecakin: {} + Peginterferon Alfa-2a: {} + Peginterferon Alfa-2b: {} + Pegvisomant: {} + Pegvorhyaluronidase Alfa: {} + Pegylated Deoxycytidine Analogue DFP-14927: {} + Pegylated Interferon Alfa: {} + Pegylated Liposomal Belotecan: {} + Pegylated Liposomal Doxorubicin Hydrochloride: {} + Pegylated Liposomal Irinotecan: {} + Pegylated Liposomal Mitomycin C Lipid-based Prodrug: {} + Pegylated Liposomal Mitoxantrone Hydrochloride: {} + Pegylated Liposomal Nanoparticle-based Docetaxel Prodrug MNK-010: {} + Pegylated Paclitaxel: {} + Pegylated Recombinant Human Arginase I BCT-100: {} + Pegylated Recombinant Human Hyaluronidase PH20: {} + Pegylated Recombinant Interleukin-2 THOR-707: {} + Pegylated Recombinant L-asparaginase Erwinia chrysanthemi: {} + Pegylated SN-38 Conjugate PLX038: {} + Pegzilarginase: {} + Pelabresib: {} + Pelareorep: {} + Peldesine: {} + Pelitinib: {} + Pelitrexol: {} + Pembrolizumab: {} + Pemetrexed: {} + Pemetrexed Disodium: {} + Pemigatinib: {} + Pemlimogene Merolisbac: {} + Penberol: {} + Penclomedine: {} + Penicillamine: {} + Pentamethylmelamine: {} + Pentamustine: {} + Pentostatin: {} + Pentoxifylline: {} + Pepinemab: {} + Peplomycin: {} + Peplomycin Sulfate: {} + Peposertib: {} + Peptichemio: {} + Peptide 946 Melanoma Vaccine: {} + Peptide 946-Tetanus Peptide Conjugate Melanoma Vaccine: {} + Peretinoin: {} + Perflenapent Emulsion: {} + Perfosfamide: {} + Perifosine: {} + Perillyl Alcohol: {} + Personalized ALL-specific Multi-HLA-binding Peptide Vaccine: {} + Personalized Cancer Vaccine RO7198457: {} + Personalized Neoantigen DNA Vaccine GNOS-PV01: {} + Personalized Neoantigen DNA Vaccine GNOS-PVO2: {} + Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01: {} + Personalized Neoepitope Yeast Vaccine YE-NEO-001: {} + Personalized Peptide Cancer Vaccine NEO-PV-01: {} + Personalized and Adjusted Neoantigen Peptide Vaccine PANDA-VAC: {} + Pertuzumab: {} + Pevonedistat: {} + Pexastimogene Devacirepvec: {} + Pexidartinib: {} + Pexmetinib: {} + Phaleria macrocarpa Extract DLBS-1425: {} + Pharmacological Ascorbate: {} + Phellodendron amurense Bark Extract: {} + Phenesterin: {} + Phenethyl Isothiocyanate: {} + Phenethyl Isothiocyanate-containing Watercress Juice: {} + Phenyl Acetate: {} + Phenytoin Sodium: {} + Phosphaplatin PT-112: {} + Phosphatidylcholine-Bound Silybin: {} + Phospholipid Ether-drug Conjugate CLR 131: {} + Phosphoramide Mustard: {} + Phosphorodiamidate Morpholino Oligomer AVI-4126: {} + Phosphorus P-32: {} + Photodynamic Compound TLD-1433: {} + Photosensitizer LUZ 11: {} + Phytochlorin Sodium-Polyvinylpyrrolidone Complex: {} + Pibenzimol: {} + Pibrozelesin: {} + Pibrozelesin Hydrobromide: {} + Picibanil: {} + Picoplatin: {} + Picrasinoside H: {} + Picropodophyllin: {} + Pictilisib: {} + Pictilisib Bismesylate: {} + Pidilizumab: {} + Pilaralisib: {} + Pimasertib: {} + Pimitespib: {} + Pimurutamab: {} + Pinatuzumab Vedotin: {} + Pingyangmycin: {} + Pinometostat: {} + Pioglitazone: {} + Pioglitazone Hydrochloride: {} + Pipendoxifene: {} + Piperazinedione: {} + Piperine Extract (Standardized): {} + Pipobroman: {} + Piposulfan: {} + Pirarubicin: {} + Pirarubicin Hydrochloride: {} + Pirfenidone: {} + Piritrexim: {} + Piritrexim Isethionate: {} + Pirotinib: {} + Piroxantrone: {} + Piroxantrone Hydrochloride: {} + Pixantrone: {} + Pixantrone Dimaleate: {} + Pixatimod: {} + Placebo: {} + Pladienolide Derivative E7107: {} + Plamotamab: {} + Plasmid DNA Vaccine pING-hHER3FL: {} + Platinum: {} + Platinum Acetylacetonate-Titanium Dioxide Nanoparticles: {} + Platinum Compound: {} + Plevitrexed: {} + Plicamycin: {} + Plinabulin: {} + Plitidepsin: {} + Plk1 Inhibitor BI 2536: {} + Plocabulin: {} + Plozalizumab: {} + Pol I Inhibitor CX5461: {} + Polatuzumab Vedotin: {} + Polidocanol: {} + Poliglusam: {} + Polo-like Kinase 1 Inhibitor GSK461364: {} + Polo-like Kinase 1 Inhibitor MK1496: {} + Polo-like Kinase 1 Inhibitor NMS-1286937: {} + Polo-like Kinase 4 Inhibitor CFI-400945 Fumarate: {} + Poly-alendronate Dextran-Guanidine Conjugate: {} + Poly-gamma Glutamic Acid: {} + Polyamine Analog SL11093: {} + Polyamine Analogue PG11047: {} + Polyamine Analogue SBP-101: {} + Polyamine Transport Inhibitor AMXT-1501 Dicaprate: {} + Polyandrol: {} + Polyethylene Glycol Recombinant Endostatin: {} + Polyethyleneglycol-7-ethyl-10-hydroxycamptothecin DFP-13318: {} + Polymer-conjugated IL-15 Receptor Agonist NKTR-255: {} + Polymer-encapsulated Luteolin Nanoparticle: {} + Polymeric Camptothecin Prodrug XMT-1001: {} + Polypodium leucotomos Extract: {} + Polysaccharide-K: {} + Polysialic Acid: {} + Polyunsaturated Fatty Acid: {} + Polyvalent Melanoma Vaccine: {} + Pomalidomide: {} + Pomegranate Juice: {} + Pomegranate Liquid Extract: {} + Ponatinib: {} + Ponatinib Hydrochloride: {} + Porcupine Inhibitor CGX1321: {} + Porcupine Inhibitor ETC-1922159: {} + Porcupine Inhibitor RXC004: {} + Porcupine Inhibitor WNT974: {} + Porcupine Inhibitor XNW7201: {} + Porfimer Sodium: {} + Porfiromycin: {} + Poziotinib: {} + Pracinostat: {} + Pralatrexate: {} + Pralsetinib: {} + Praluzatamab Ravtansine: {} + Pravastatin Sodium: {} + Prednimustine: {} + Prednisolone: {} + Prednisolone Acetate: {} + Prednisolone Sodium Phosphate: {} + Prednisone: {} + Prexasertib: {} + Prexigebersen: {} + Prime Cancer Vaccine MVA-BN-CV301: {} + Prinomastat: {} + Proapoptotic Sulindac Analog CP-461: {} + Procarbazine: {} + Procarbazine Hydrochloride: {} + Procaspase Activating Compound-1 VO-100: {} + Progestational IUD: {} + Prohibitin-Targeting Peptide 1: {} + Prolgolimab: {} + Prostaglandin E2 EP4 Receptor Inhibitor AN0025: {} + Prostaglandin E2 EP4 Receptor Inhibitor E7046: {} + Prostate Cancer Vaccine ONY-P1: {} + Prostate Health Cocktail Dietary Supplement: {} + Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024: {} + Protease-activated Anti-PD-L1 Antibody Prodrug CX-072: {} + Protein Arginine Methyltransferase 5 Inhibitor GSK3326595: {} + Protein Arginine Methyltransferase 5 Inhibitor PF-06939999: {} + Protein Arginine Methyltransferase 5 Inhibitor PRT543: {} + Protein Kinase C Inhibitor IDE196: {} + Protein Phosphatase 2A Inhibitor LB-100: {} + Protein Stabilized Liposomal Docetaxel Nanoparticles: {} + Protein Tyrosine Kinase 2 Inhibitor IN10018: {} + Proxalutamide: {} + Pseudoisocytidine: {} + Pterostilbene: {} + Pumitepa: {} + Puquitinib: {} + Puquitinib Mesylate: {} + Puromycin: {} + Puromycin Hydrochloride: {} + Pyrazinamide: {} + Pyrazoloacridine: {} + Pyridyl Cyanoguanidine CHS 828: {} + Pyrotinib: {} + Pyrotinib Dimaleate: {} + Pyroxamide: {} + Pyruvate Kinase Inhibitor TLN-232: {} + Pyruvate Kinase M2 Isoform Activator TP-1454: {} + Qilisheng Immunoregulatory Oral Solution: {} + Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine: {} + Quarfloxin: {} + Quinacrine Hydrochloride: {} + Quinine: {} + Quisinostat: {} + Quizartinib: {} + R-(-)-Gossypol Acetic Acid: {} + RAD51 Inhibitor CYT-0851: {} + RAF Kinase Inhibitor L-779450: {} + RAF Kinase Inhibitor XL281: {} + RARalpha Agonist IRX5183: {} + RET Inhibitor DS-5010: {} + RET Mutation/Fusion Inhibitor BLU-667: {} + RET/SRC Inhibitor TPX-0046: {} + RFT5-dgA Immunotoxin IMTOX25: {} + RIPK1 Inhibitor GSK3145095: {} + RNR Inhibitor COH29: {} + ROBO1-targeted BiCAR-NKT Cells: {} + RORgamma Agonist LYC-55716: {} + RSK1-4 Inhibitor PMD-026: {} + Rabusertib: {} + Racemetyrosine/Methoxsalen/Phenytoin/Sirolimus SM-88: {} + Racotumomab: {} + Radgocitabine: {} + Radgocitabine Hydrochloride: {} + Radioactive Iodine: {} + Radiolabeled CC49: {} + Radium Ra 223 Dichloride: {} + Radium Ra 224-labeled Calcium Carbonate Microparticles: {} + Radix Angelicae Sinensis/Radix Astragali Herbal Supplement: {} + Radotinib Hydrochloride: {} + Raf Kinase Inhibitor HM95573: {} + Ragifilimab: {} + Ralaniten Acetate: {} + Ralimetinib Mesylate: {} + Raloxifene: {} + Raloxifene Hydrochloride: {} + Raltitrexed: {} + Ramucirumab: {} + Ranibizumab: {} + Ranimustine: {} + Ranolazine: {} + Ranpirnase: {} + Ras Inhibitor: {} + Ras Peptide ASP: {} + Ras Peptide CYS: {} + Ras Peptide VAL: {} + Razoxane: {} + Realgar-Indigo naturalis Formulation: {} + Rebastinib Tosylate: {} + Rebeccamycin: {} + Rebimastat: {} + Receptor Tyrosine Kinase Inhibitor R1530: {} + Recombinant Adenovirus-p53 SCH-58500: {} + Recombinant Anti-WT1 Immunotherapeutic GSK2302024A: {} + Recombinant Bacterial Minicells VAX014: {} + Recombinant Bispecific Single-Chain Antibody rM28: {} + Recombinant CD40-Ligand: {} + Recombinant Erwinia asparaginase JZP-458: {} + Recombinant Erythropoietin: {} + Recombinant Fas Ligand: {} + Recombinant Fractalkine: {} + Recombinant Granulocyte-Macrophage Colony-Stimulating Factor: {} + Recombinant Human 6Ckine: {} + Recombinant Human Adenovirus Type 5 H101: {} + Recombinant Human Angiotensin Converting Enzyme 2 APN01: {} + Recombinant Human Apolipoprotein(a) Kringle V MG1102: {} + Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine: {} + Recombinant Human Endostatin: {} + Recombinant Human Hsp110-gp100 Chaperone Complex Vaccine: {} + Recombinant Human Papillomavirus 11-valent Vaccine: {} + Recombinant Human Papillomavirus Bivalent Vaccine: {} + Recombinant Human Papillomavirus Nonavalent Vaccine: {} + Recombinant Human Plasminogen Kringle 5 Domain ABT 828: {} + Recombinant Human TRAIL-Trimer Fusion Protein SCB-313: {} + Recombinant Humanized Anti-HER-2 Bispecific Monoclonal Antibody MBS301: {} + Recombinant Interferon: {} + Recombinant Interferon Alfa: {} + Recombinant Interferon Alfa-1b: {} + Recombinant Interferon Alfa-2a: {} + Recombinant Interferon Alfa-2b: {} + Recombinant Interferon Alpha 2b-like Protein: {} + Recombinant Interferon Beta: {} + Recombinant Interferon Gamma: {} + Recombinant Interleukin-12: {} + Recombinant Interleukin-13: {} + Recombinant Interleukin-18: {} + Recombinant Interleukin-2: {} + Recombinant Interleukin-6: {} + Recombinant KSA Glycoprotein CO17-1A: {} + Recombinant Leukocyte Interleukin: {} + Recombinant Leukoregulin: {} + Recombinant Luteinizing Hormone: {} + Recombinant MAGE-3.1 Antigen: {} + Recombinant MIP1-alpha Variant ECI301: {} + Recombinant Macrophage Colony-Stimulating Factor: {} + Recombinant Modified Vaccinia Ankara-5T4 Vaccine: {} + Recombinant Oncolytic Poliovirus PVS-RIPO: {} + Recombinant PRAME Protein Plus AS15 Adjuvant GSK2302025A: {} + Recombinant Platelet Factor 4: {} + Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207: {} + Recombinant Super-compound Interferon: {} + Recombinant Thyroglobulin: {} + Recombinant Thyrotropin Alfa: {} + Recombinant Transforming Growth Factor-Beta: {} + Recombinant Transforming Growth Factor-Beta-2: {} + Recombinant Tumor Necrosis Factor-Alpha: {} + Recombinant Tyrosinase-Related Protein-2: {} + Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter: {} + Redaporfin: {} + Refametinib: {} + Regorafenib: {} + Relacorilant: {} + Relatlimab: {} + Relugolix: {} + Remetinostat: {} + Renal Cell Carcinoma Peptides Vaccine IMA901: {} + Reparixin: {} + Repotrectinib: {} + Resiquimod: {} + Resiquimod Topical Gel: {} + Resistant Starch: {} + Resminostat: {} + Resveratrol: {} + Resveratrol Formulation SRT501: {} + Retaspimycin: {} + Retaspimycin Hydrochloride: {} + Retelliptine: {} + Retifanlimab: {} + Retinoic Acid Agent Ro 16-9100: {} + Retinoid 9cUAB30: {} + Retinol: {} + Retinyl Acetate: {} + Retinyl Palmitate: {} + Retrovector Encoding Mutant Anti-Cyclin G1: {} + Revdofilimab: {} + Rexinoid NRX 194204: {} + Rezivertinib: {} + Rhenium Re 188 BMEDA-labeled Liposomes: {} + Rhenium Re-186 Hydroxyethylidene Diphosphonate: {} + Rhenium Re-188 Ethiodized Oil: {} + Rhenium Re-188 Etidronate: {} + Rhizoxin: {} + RhoC Peptide Vaccine RV001V: {} + Ribociclib: {} + Ribociclib/Letrozole: {} + Ribonuclease QBI-139: {} + Ribosome-Inactivating Protein CY503: {} + Ribozyme RPI.4610: {} + Rice Bran: {} + Ricolinostat: {} + Ridaforolimus: {} + Rigosertib: {} + Rigosertib Sodium: {} + Rilimogene Galvacirepvec: {} + Rilimogene Galvacirepvec/Rilimogene Glafolivec: {} + Rilimogene Glafolivec: {} + Rilotumumab: {} + Rindopepimut: {} + Ripertamab: {} + Ripretinib: {} + Risperidone Formulation in Rumenic Acid: {} + Ritrosulfan: {} + Rituximab: {} + Rituximab Conjugate CON-4619: {} + Rituximab and Hyaluronidase Human: {} + Riviciclib: {} + Rivoceranib: {} + Rivoceranib Mesylate: {} + Robatumumab: {} + Roblitinib: {} + Rocakinogene Sifuplasmid: {} + Rocapuldencel-T: {} + Rociletinib: {} + Rodorubicin: {} + Roducitabine: {} + Rofecoxib: {} + Roflumilast: {} + Rogaratinib: {} + Rogletimide: {} + Rolinsatamab Talirine: {} + Romidepsin: {} + Roneparstat: {} + Roniciclib: {} + Ropeginterferon Alfa-2B: {} + Ropidoxuridine: {} + Ropocamptide: {} + Roquinimex: {} + Rosabulin: {} + Rose Bengal Solution PV-10: {} + Rosiglitazone Maleate: {} + Rosmantuzumab: {} + Rosopatamab: {} + Rosuvastatin: {} + Rovalpituzumab Tesirine: {} + Rubitecan: {} + Rucaparib: {} + Rucaparib Camsylate: {} + Rucaparib Phosphate: {} + Ruthenium Ru-106: {} + Ruthenium-based Small Molecule Therapeutic BOLD-100: {} + Ruthenium-based Transferrin Targeting Agent NKP-1339: {} + Ruxolitinib: {} + Ruxolitinib Phosphate: {} + Ruxotemitide: {} + S-Adenosylmethionine: {} + S-equol: {} + S1P Receptor Agonist KRP203: {} + SBIL-2: {} + SDF-1 Receptor Antagonist PTX-9908: {} + SERD D-0502: {} + SERD G1T48: {} + SERD GDC-9545: {} + SERD SAR439859: {} + SERD SHR9549: {} + SERD ZN-c5: {} + SHP-1 Agonist SC-43: {} + SHP2 Inhibitor JAB-3068: {} + SHP2 Inhibitor RLY-1971: {} + SHP2 Inhibitor RMC-4630: {} + SHP2 Inhibitor TNO155: {} + SIRPa-4-1BBL Fusion Protein DSP107: {} + SIRPa-Fc Fusion Protein TTI-621: {} + SIRPa-Fc-CD40L Fusion Protein SL-172154: {} + SIRPa-IgG4-Fc Fusion Protein TTI-622: {} + SLC6A8 Inhibitor RGX-202: {} + SLCT Inhibitor GNS561: {} + SMAC Mimetic BI 891065: {} + SMO Protein Inhibitor ZSP1602: {} + SN-38-Loaded Polymeric Micelles NK012: {} + SNS01-T Nanoparticles: {} + SR-BP1/HSI Inhibitor SR31747A: {} + SR-T100 Gel: {} + SRPK1/ABCG2 Inhibitor SCO-101: {} + SSTR2-targeting Protein/DM1 Conjugate PEN-221: {} + STAT Inhibitor OPB-111077: {} + STAT3 Inhibitor DSP-0337: {} + STAT3 Inhibitor OPB-31121: {} + STAT3 Inhibitor OPB-51602: {} + STAT3 Inhibitor TTI-101: {} + STAT3 Inhibitor WP1066: {} + STING Agonist BMS-986301: {} + STING Agonist GSK3745417: {} + STING Agonist IMSA101: {} + STING Agonist MK-1454: {} + STING Agonist SB 11285: {} + STING Agonist TAK-676: {} + STING-activating Cyclic Dinucleotide Agonist MIW815: {} + STING-expressing E. coli SYNB1891: {} + Sabarubicin: {} + Sabatolimab: {} + Sacituzumab Govitecan: {} + Sacubitril/Valsartan: {} + Safingol: {} + Sagopilone: {} + Salirasib: {} + Salmonella VNP20009: {} + Sam68 Modulator CWP232291: {} + Samalizumab: {} + Samarium Sm 153-DOTMP: {} + Samotolisib: {} + Samrotamab Vedotin: {} + Samuraciclib: {} + Sapacitabine: {} + Sapanisertib: {} + Sapitinib: {} + SarCNU: {} + Saracatinib: {} + Saracatinib Difumarate: {} + Sardomozide: {} + Sargramostim: {} + Sasanlimab: {} + Satraplatin: {} + Savolitinib: {} + Scopoletin: {} + Seclidemstat: {} + Sedoxantrone Trihydrochloride: {} + Selatinib Ditosilate: {} + Selective Androgen Receptor Modulator RAD140: {} + Selective Cytokine Inhibitory Drug CC-1088: {} + Selective Estrogen Receptor Degrader AZD9496: {} + Selective Estrogen Receptor Degrader AZD9833: {} + Selective Estrogen Receptor Degrader LSZ102: {} + Selective Estrogen Receptor Degrader LX-039: {} + Selective Estrogen Receptor Degrader LY3484356: {} + Selective Estrogen Receptor Degrader SRN-927: {} + Selective Estrogen Receptor Modulator CC-8490: {} + Selective Estrogen Receptor Modulator TAS-108: {} + Selective Glucocorticoid Receptor Antagonist CORT125281: {} + Selective Human Estrogen-receptor Alpha Partial Agonist TTC-352: {} + Seliciclib: {} + Selicrelumab: {} + Selinexor: {} + Selitrectinib: {} + Selonsertib: {} + Selpercatinib: {} + Selumetinib: {} + Selumetinib Sulfate: {} + Semaxanib: {} + Semuloparin: {} + Semustine: {} + Seneca Valley Virus-001: {} + Seocalcitol: {} + Sepantronium Bromide: {} + Serabelisib: {} + Serclutamab Talirine: {} + Serdemetan: {} + Sergiolide: {} + Seribantumab: {} + Serine/Threonine Kinase Inhibitor CBP501: {} + Serine/Threonine Kinase Inhibitor XL418: {} + Serplulimab: {} + Sevacizumab: {} + Seviteronel: {} + Shared Anti-Idiotype-AB-S006: {} + Shared Anti-Idiotype-AB-S024A: {} + Shark Cartilage: {} + Shark Cartilage Extract AE-941: {} + Shenqi Fuzheng Injection SQ001: {} + Sho-Saiko-To: {} + Short Chain Fatty Acid HQK-1004: {} + Shu Yu Wan Formula: {} + Sialyl Tn Antigen: {} + Sialyl Tn-KLH Vaccine: {} + Sibrotuzumab: {} + Silatecan AR-67: {} + Silibinin: {} + Silicon Phthalocyanine 4: {} + Silmitasertib Sodium: {} + Siltuximab: {} + Simalikalactone D: {} + Simeprevir: {} + Simlukafusp Alfa: {} + Simmitinib: {} + Simotaxel: {} + Simtuzumab: {} + Simurosertib: {} + Sintilimab: {} + Siplizumab: {} + Sipuleucel-T: {} + Siremadlin: {} + Sirolimus: {} + Sitimagene Ceradenovec: {} + Sitravatinib: {} + Sivifene: {} + Sizofiran: {} + Smac Mimetic GDC-0152: {} + Smac Mimetic GDC-0917: {} + Smac Mimetic LCL161: {} + Smoothened Antagonist BMS-833923: {} + Smoothened Antagonist LDE225 Topical: {} + Smoothened Antagonist LEQ506: {} + Smoothened Antagonist TAK-441: {} + Sobuzoxane: {} + Sodium Borocaptate: {} + Sodium Butyrate: {} + Sodium Dichloroacetate: {} + Sodium Iodide I-131: {} + Sodium Metaarsenite: {} + Sodium Phenylbutyrate: {} + Sodium Salicylate: {} + Sodium Selenite: {} + Sodium Stibogluconate: {} + Sodium-Potassium Adenosine Triphosphatase Inhibitor RX108: {} + Sofituzumab Vedotin: {} + Solitomab: {} + Sonepcizumab: {} + Sonidegib: {} + Sonolisib: {} + Sorafenib: {} + Sorafenib Tosylate: {} + Sorghum bicolor Supplement: {} + Sotigalimab: {} + Sotorasib: {} + Sotrastaurin: {} + Sotrastaurin Acetate: {} + Soy Isoflavones: {} + Soy Protein Isolate: {} + Spanlecortemlocel: {} + Sparfosate Sodium: {} + Sparfosic Acid: {} + Spartalizumab: {} + Spebrutinib: {} + Spherical Nucleic Acid Nanoparticle NU-0129: {} + Spirogermanium: {} + Spiromustine: {} + Spiroplatin: {} + Splicing Inhibitor H3B-8800: {} + Spongistatin: {} + Squalamine Lactate: {} + Src Kinase Inhibitor AP 23846: {} + Src Kinase Inhibitor KX2-391: {} + Src Kinase Inhibitor KX2-391 Ointment: {} + Src Kinase Inhibitor M475271: {} + Src/Abl Kinase Inhibitor AZD0424: {} + Src/tubulin Inhibitor KX02: {} + St. John's Wort: {} + Stallimycin: {} + Staphylococcal Enterotoxin A: {} + Staphylococcal Enterotoxin B: {} + Staurosporine: {} + Streptonigrin: {} + Streptozocin: {} + Strontium Chloride Sr-89: {} + Submicron Particle Paclitaxel Sterile Suspension: {} + Sugemalimab: {} + Sulfatinib: {} + Sulforaphane: {} + Sulindac: {} + Sulofenur: {} + Sumoylation Inhibitor TAK-981: {} + Sunitinib: {} + Sunitinib Malate: {} + Super Enhancer Inhibitor GZ17-6.02: {} + Superagonist Interleukin-15:Interleukin-15 Receptor alphaSu/Fc Fusion Complex ALT-803: {} + Superoxide Dismutase Mimetic GC4711: {} + Suramin: {} + Suramin Sodium: {} + Survivin Antigen: {} + Survivin Antigen Vaccine DPX-Survivac: {} + Survivin mRNA Antagonist EZN-3042: {} + Survivin-expressing CVD908ssb-TXSVN Vaccine: {} + Sustained-release Lipid Inhaled Cisplatin: {} + Sustained-release Mitomycin C Hydrogel Formulation UGN-101: {} + Sustained-release Mitomycin C Hydrogel Formulation UGN-102: {} + Syk Inhibitor HMPL-523: {} + Synchrotope TA2M Plasmid DNA Vaccine: {} + Synchrovax SEM Plasmid DNA Vaccine: {} + Synthetic Alkaloid PM00104: {} + Synthetic Glioblastoma Mutated Tumor-specific Peptides Vaccine Therapy APVAC2: {} + Synthetic Glioblastoma Tumor-associated Peptides Vaccine Therapy APVAC1: {} + Synthetic Hypericin: {} + Synthetic Long E6 Peptide-Toll-like Receptor Ligand Conjugate Vaccine ISA201: {} + Synthetic Long E6/E7 Peptides Vaccine HPV-01: {} + Synthetic Long HPV16 E6/E7 Peptides Vaccine ISA101b: {} + Synthetic Plumbagin PCUR-101: {} + Synthetic hTERT DNA Vaccine INO-1400: {} + Synthetic hTERT DNA Vaccine INO-1401: {} + T900607: {} + TAM/c-Met Inhibitor RXDX-106: {} + TGF-beta Receptor 1 Inhibitor PF-06952229: {} + TGF-beta Receptor 1 Kinase Inhibitor SH3051: {} + TGF-beta Receptor 1 Kinase Inhibitor YL-13027: {} + TGFa-PE38 Immunotoxin: {} + TGFbeta Inhibitor LY3200882: {} + TGFbeta Receptor Ectodomain-IgG Fc Fusion Protein AVID200: {} + THL-P: {} + TIGIT Inhibitor M6223: {} + TIGIT-targeting Agent MK-7684: {} + TLC ELL-12: {} + TLR Agonist BDB001: {} + TLR Agonist BSG-001: {} + TLR Agonist CADI-05: {} + TLR-Directed Cationic Lipid-DNA Complex JVRS-100: {} + TLR7 Agonist 852A: {} + TLR7 Agonist LHC165: {} + TLR7 agonist BNT411: {} + TLR7/8/9 Antagonist IMO-8400: {} + TLR8 Agonist DN1508052: {} + TLR9 Agonist AST-008: {} + TM4SF1-CAR/EpCAM-CAR-expressing Autologous T Cells: {} + TORC1/2 Kinase Inhibitor DS-3078a: {} + TP40 Immunotoxin: {} + TRAIL Receptor Agonist ABBV-621: {} + TRK Inhibitor AZD6918: {} + TRK Inhibitor TQB3558: {} + TRPM8 Agonist D-3263: {} + TRPV6 Calcium Channel Inhibitor SOR-C13: {} + TSP-1 Mimetic ABT-510: {} + TSP-1 Mimetic Fusion Protein CVX-045: {} + Tabalumab: {} + Tabelecleucel: {} + Tacedinaline: {} + Tafasitamab: {} + Tagraxofusp-erzs: {} + Talabostat: {} + Talabostat Mesylate: {} + Talacotuzumab: {} + Talactoferrin Alfa: {} + Taladegib: {} + Talampanel: {} + Talaporfin Sodium: {} + Talazoparib: {} + Taletrectinib: {} + Talimogene Laherparepvec: {} + Tallimustine: {} + Talmapimod: {} + Talotrexin: {} + Talotrexin Ammonium: {} + Taltobulin: {} + Tamibarotene: {} + Taminadenant: {} + Tamoxifen: {} + Tamoxifen Citrate: {} + Tamrintamab Pamozirine: {} + Tandutinib: {} + Tanespimycin: {} + Tanibirumab: {} + Tankyrase Inhibitor STP1002: {} + Tanomastat: {} + Tapotoclax: {} + Tarenflurbil: {} + Tarextumab: {} + Tariquidar: {} + Tasadenoturev: {} + Taselisib: {} + Tasidotin: {} + Tasisulam: {} + Tasisulam Sodium: {} + Tasquinimod: {} + Taurolidine: {} + Tauromustine: {} + Taurultam: {} + Taurultam Analogue GP-2250: {} + Tavokinogene Telseplasmid: {} + Tavolimab: {} + Taxane Analogue TPI 287: {} + Taxane Compound: {} + Taxol Analogue SID 530: {} + Tazarotene: {} + Tazemetostat: {} + Tebentafusp: {} + Teclistamab: {} + Tecogalan Sodium: {} + Tefinostat: {} + Tegafur: {} + Tegafur-Gimeracil-Oteracil Potassium-Leucovorin Calcium Oral Formulation: {} + Tegafur-Uracil: {} + Tegafur-gimeracil-oteracil Potassium: {} + Tegavivint: {} + Teglarinad: {} + Teglarinad Chloride: {} + Telaglenastat: {} + Telaglenastat Hydrochloride: {} + Telapristone: {} + Telapristone Acetate: {} + Telatinib Mesylate: {} + Telisotuzumab: {} + Telisotuzumab Vedotin: {} + Telomerase Inhibitor FJ5002: {} + Telomerase-specific Type 5 Adenovirus OBP-301: {} + Teloxantrone: {} + Teloxantrone Hydrochloride: {} + Telratolimod: {} + Temarotene: {} + Temoporfin: {} + Temozolomide: {} + Temsirolimus: {} + Tenalisib: {} + Tenifatecan: {} + Teniposide: {} + Tepoditamab: {} + Tepotinib: {} + Teprotumumab: {} + Terameprocol: {} + Terfluranol: {} + Tergenpumatucel-L: {} + Teroxirone: {} + Tertomotide: {} + Tesetaxel: {} + Tesevatinib: {} + Tesidolumab: {} + Testolactone: {} + Testosterone Enanthate: {} + Tetanus Toxoid Vaccine: {} + Tetradecanoylphorbol Acetate: {} + Tetrahydrouridine: {} + Tetraphenyl Chlorin Disulfonate: {} + Tetrathiomolybdate: {} + Tezacitabine: {} + Tezacitabine Anhydrous: {} + Thalicarpine: {} + Thalidomide: {} + Theliatinib: {} + Theramide: {} + Therapeutic Angiotensin-(1-7): {} + Therapeutic Breast/Ovarian/Prostate Peptide Cancer Vaccine DPX-0907: {} + Therapeutic Cancer Vaccine ATP128: {} + Therapeutic Estradiol: {} + Therapeutic Hydrocortisone: {} + Therapeutic Liver Cancer Peptide Vaccine IMA970A: {} + Thiarabine: {} + Thiodiglycol: {} + Thioguanine: {} + Thioguanine Anhydrous: {} + Thioinosine: {} + Thioredoxin-1 Inhibitor PX-12: {} + Thiotepa: {} + Thioureidobutyronitrile: {} + Thorium Th 227 Anetumab: {} + Thorium Th 227 Anetumab Corixetan: {} + Thorium Th 227 Anti-HER2 Monoclonal Antibody BAY2701439: {} + Thorium Th 227 Anti-PSMA Monoclonal Antibody BAY 2315497: {} + Threonine Tyrosine Kinase Inhibitor CFI-402257: {} + Thymidylate Synthase Inhibitor CX1106: {} + Thymidylate Synthase Inhibitor DFP-11207: {} + Thymopentin: {} + Thyroid Extract: {} + Tiazofurin: {} + Tidutamab: {} + Tigapotide: {} + Tigatuzumab: {} + Tilarginine: {} + Tilogotamab: {} + Tilsotolimod Sodium: {} + Timonacic: {} + Tin Ethyl Etiopurpurin: {} + Tinostamustine: {} + Tinzaparin Sodium: {} + Tiomolibdate Choline: {} + Tiomolibdate Diammonium: {} + Tipapkinogene Sovacivec: {} + Tipifarnib: {} + Tipiracil: {} + Tipiracil Hydrochloride: {} + Tirabrutinib: {} + Tiragolumab: {} + Tirapazamine: {} + Tirbanibulin: {} + Tisagenlecleucel: {} + Tislelizumab: {} + Tisotumab Vedotin: {} + Tivantinib: {} + Tivozanib: {} + Tocilizumab: {} + Tocladesine: {} + Tocotrienol: {} + Tocotrienol-rich Fraction: {} + Tolebrutinib: {} + Toll-like Receptor 7 Agonist DSP-0509: {} + Tolnidamine: {} + Tomaralimab: {} + Tomato-Soy Juice: {} + Tomivosertib: {} + Topical Betulinic Acid: {} + Topical Celecoxib: {} + Topical Fluorouracil: {} + Topical Gemcitabine Hydrochloride: {} + Topical Potassium Dobesilate: {} + Topical Trichloroacetic Acid: {} + Topixantrone: {} + Topoisomerase I Inhibitor Genz-644282: {} + Topoisomerase I Inhibitor LMP400: {} + Topoisomerase I Inhibitor LMP776: {} + Topoisomerase I/II Inhibitor NEV-801: {} + Topoisomerase-1 Inhibitor LMP744: {} + Topoisomerase-II Inhibitor Racemic XK469: {} + Topoisomerase-II-beta Inhibitor Racemic XK469: {} + Topotecan: {} + Topotecan Hydrochloride: {} + Topotecan Hydrochloride Liposomes: {} + Topotecan Sustained-release Episcleral Plaque: {} + Topsalysin: {} + Toremifene: {} + Toremifene Citrate: {} + Toripalimab: {} + Tosedostat: {} + Tositumomab: {} + Total Androgen Blockade: {} + Tovetumab: {} + Tozasertib Lactate: {} + Trabectedin: {} + Trabedersen: {} + Trametinib: {} + Trametinib Dimethyl Sulfoxide: {} + Trans Sodium Crocetinate: {} + Transdermal 17beta-Estradiol Gel BHR-200: {} + Transdermal 4-Hydroxytestosterone: {} + Transferrin Receptor-Targeted Anti-RRM2 siRNA CALAA-01: {} + Transferrin Receptor-Targeted Liposomal p53 cDNA: {} + Transferrin-CRM107: {} + Tranylcypromine Sulfate: {} + Trapoxin: {} + Trastuzumab: {} + Trastuzumab Conjugate BI-CON-02: {} + Trastuzumab Deruxtecan: {} + Trastuzumab Duocarmazine: {} + Trastuzumab Emtansine: {} + Trastuzumab Monomethyl Auristatin F: {} + Trastuzumab-TLR 7/8 Agonist BDC-1001: {} + Trastuzumab/Hyaluronidase-oysk: {} + Trastuzumab/Tesirine Antibody-drug Conjugate ADCT-502: {} + Trebananib: {} + Tremelimumab: {} + Treosulfan: {} + Tretazicar: {} + Tretinoin: {} + Tretinoin Liposome: {} + Triamcinolone Acetonide: {} + Triamcinolone Hexacetonide: {} + Triapine: {} + Triazene Derivative CB10-277: {} + Triazene Derivative TriN2755: {} + Triazinate: {} + Triaziquone: {} + Tributyrin: {} + Triciribine Phosphate: {} + Trientine Hydrochloride: {} + Triethylenemelamine: {} + Trifluridine: {} + Trifluridine and Tipiracil Hydrochloride: {} + Trigriluzole: {} + Trilaciclib: {} + Trimelamol: {} + Trimeric GITRL-Fc OMP-336B11: {} + Trimethylcolchicinic Acid: {} + Trimetrexate: {} + Trimetrexate Glucuronate: {} + Trioxifene: {} + Triplatin Tetranitrate: {} + Triptolide Analog: {} + Triptorelin: {} + Triptorelin Pamoate: {} + Tris-acryl Gelatin Microspheres: {} + Tritylcysteine: {} + TrkA Inhibitor VMD-928: {} + Trodusquemine: {} + Trofosfamide: {} + Troglitazone: {} + Tropomyosin Receptor Kinase Inhibitor AZD7451: {} + Troriluzole: {} + Troxacitabine: {} + Troxacitabine Nucleotide Prodrug MIV-818: {} + Tubercidin: {} + Tubulin Binding Agent TTI-237: {} + Tubulin Inhibitor ALB 109564 Dihydrochloride: {} + Tubulin Inhibitor ALB-109564: {} + Tubulin Polymerization Inhibitor AEZS 112: {} + Tubulin Polymerization Inhibitor CKD-516: {} + Tubulin Polymerization Inhibitor VERU-111: {} + Tubulin-Binding Agent SSR97225: {} + Tucatinib: {} + Tucidinostat: {} + Tucotuzumab Celmoleukin: {} + Tyroserleutide: {} + Tyrosinase Peptide: {} + Tyrosinase-KLH: {} + Tyrosinase:146-156 Peptide: {} + Tyrosine Kinase Inhibitor: {} + Tyrosine Kinase Inhibitor OSI-930: {} + Tyrosine Kinase Inhibitor SU5402: {} + Tyrosine Kinase Inhibitor TL-895: {} + Tyrosine Kinase Inhibitor XL228: {} + UAE Inhibitor TAK-243: {} + USP14/UCHL5 Inhibitor VLX1570: {} + Ubenimex: {} + Ubidecarenone Nanodispersion BPM31510n: {} + Ublituximab: {} + Ulinastatin: {} + Ulixertinib: {} + Ulocuplumab: {} + Umbralisib: {} + Uncaria tomentosa Extract: {} + Unknown: {} + Upamostat: {} + Upifitamab: {} + Uproleselan: {} + Uprosertib: {} + Urabrelimab: {} + Uracil Ointment: {} + Urelumab: {} + Uroacitides: {} + Urokinase-Derived Peptide A6: {} + Ursolic Acid: {} + Utomilumab: {} + Uzansertib: {} + V930 Vaccine: {} + VEGF Inhibitor PTC299: {} + VEGF/HGF-targeting DARPin MP0250: {} + VEGFR Inhibitor KRN951: {} + VEGFR-2 DNA Vaccine VXM01: {} + VEGFR/FGFR Inhibitor ODM-203: {} + VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593: {} + VEGFR2 Tyrosine Kinase Inhibitor PF-00337210: {} + VEGFR2/PDGFR/c-Kit/Flt-3 Inhibitor SU014813: {} + VGEF Mixed-Backbone Antisense Oligonucleotide GEM 220: {} + VGEFR/c-kit/PDGFR Tyrosine Kinase Inhibitor XL820: {} + VLP-encapsulated TLR9 Agonist CMP-001: {} + Vaccine-Sensitized Draining Lymph Node Cells: {} + Vaccinium myrtillus/Macleaya cordata/Echinacea angustifolia Extract Granules: {} + Vactosertib: {} + Vadacabtagene Leraleucel: {} + Vadastuximab Talirine: {} + Vadimezan: {} + Valecobulin: {} + Valemetostat: {} + Valproic Acid: {} + Valrubicin: {} + Valspodar: {} + Vandetanib: {} + Vandetanib-eluting Radiopaque Bead BTG-002814: {} + Vandortuzumab Vedotin: {} + Vantictumab: {} + Vanucizumab: {} + Vapreotide: {} + Varlilumab: {} + Varlitinib: {} + Varlitinib Tosylate: {} + Vascular Disrupting Agent BNC105: {} + Vascular Disrupting Agent BNC105P: {} + Vascular Disrupting Agent ZD6126: {} + Vatalanib: {} + Vatalanib Succinate: {} + Vecabrutinib: {} + Vector-peptide Conjugated Paclitaxel: {} + Vedolizumab: {} + Veliparib: {} + Veltuzumab: {} + Vemurafenib: {} + Venetoclax: {} + Verapamil: {} + Verpasep Caltespen: {} + Verubulin: {} + Verubulin Hydrochloride: {} + Vesencumab: {} + Vesigenurtucel-L: {} + Viagenpumatucel-L: {} + Vibecotamab: {} + Vibostolimab: {} + Vilaprisan: {} + Vinblastine: {} + Vinblastine Sulfate: {} + Vincristine: {} + Vincristine Liposomal: {} + Vincristine Sulfate: {} + Vincristine Sulfate Liposome: {} + Vindesine: {} + Vinepidine: {} + Vinflunine: {} + Vinflunine Ditartrate: {} + Vinfosiltine: {} + Vinorelbine: {} + Vinorelbine Tartrate: {} + Vinorelbine Tartrate Emulsion: {} + Vinorelbine Tartrate Oral: {} + Vintafolide: {} + Vinzolidine: {} + Vinzolidine Sulfate: {} + Virulizin: {} + Vismodegib: {} + Vistusertib: {} + Vitamin D3 Analogue ILX23-7553: {} + Vitamin E Compound: {} + Vitespen: {} + Vocimagene Amiretrorepvec: {} + Vofatamab: {} + Volasertib: {} + Volociximab: {} + Vonlerolizumab: {} + Vopratelimab: {} + Vorasidenib: {} + Vorinostat: {} + Vorolanib: {} + Vorsetzumab Mafodotin: {} + Vosaroxin: {} + Vosilasarm: {} + Voxtalisib: {} + Vulinacimab: {} + WT1 Peptide Vaccine OCV-501: {} + WT1 Peptide Vaccine WT2725: {} + WT1 Protein-derived Peptide Vaccine DSP-7888: {} + WT1-A10/AS01B Immunotherapeutic GSK2130579A: {} + WT1/PSMA/hTERT-encoding Plasmid DNA INO-5401: {} + Warfarin Sodium: {} + Wee1 Inhibitor ZN-c3: {} + Wee1 Kinase Inhibitor Debio 0123: {} + White Carrot: {} + Wnt Signaling Inhibitor SM04755: {} + Wnt Signaling Pathway Inhibitor SM08502: {} + Wnt-5a Mimic Hexapeptide Foxy-5: {} + Wobe-Mugos E: {} + XBP1-US/XBP1-SP/CD138/CS1 Multipeptide Vaccine PVX-410: {} + XIAP Antisense Oligonucleotide AEG35156: {} + XIAP/cIAP1 Antagonist ASTX660: {} + XPO1 Inhibitor SL-801: {} + Xanthohumol: {} + Xeloda: {} + Xentuzumab: {} + Xevinapant: {} + Xiaoai Jiedu Decoction: {} + Xiliertinib: {} + Xisomab 3G3: {} + Y 90 Monoclonal Antibody CC49: {} + Y 90 Monoclonal Antibody HMFG1: {} + Y 90 Monoclonal Antibody Lym-1: {} + Y 90 Monoclonal Antibody M195: {} + Y 90 Monoclonal Antibody m170: {} + Yang Yin Fu Zheng: {} + Yangzheng Xiaoji Extract: {} + Yiqi-yangyin-jiedu Herbal Decoction: {} + Yttrium Y 90 Anti-CD19 Monoclonal Antibody BU12: {} + Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12: {} + Yttrium Y 90 Anti-CD45 Monoclonal Antibody BC8: {} + Yttrium Y 90 Anti-CDH3 Monoclonal Antibody FF-21101: {} + Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66: {} + Yttrium Y 90 Basiliximab: {} + Yttrium Y 90 Colloid: {} + Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A: {} + Yttrium Y 90 Daclizumab: {} + Yttrium Y 90 Glass Microspheres: {} + Yttrium Y 90 Monoclonal Antibody B3: {} + Yttrium Y 90 Monoclonal Antibody BrE-3: {} + Yttrium Y 90 Monoclonal Antibody Hu3S193: {} + Yttrium Y 90 Monoclonal Antibody MN-14: {} + Yttrium Y 90 Resin Microspheres: {} + Yttrium Y 90 Tabituximab Barzuxetan: {} + Yttrium Y 90-DOTA-Biotin: {} + Yttrium Y 90-DOTA-di-HSG Peptide IMP-288: {} + Yttrium Y 90-Edotreotide: {} + Yttrium Y 90-labeled Anti-FZD10 Monoclonal Antibody OTSA101: {} + Yttrium Y-90 Clivatuzumab Tetraxetan: {} + Yttrium Y-90 Epratuzumab Tetraxetan: {} + Yttrium Y-90 Ibritumomab Tiuxetan: {} + Yttrium Y-90 Tacatuzumab Tetraxetan: {} + Yttrium-90 Polycarbonate Brachytherapy Plaque: {} + Z-Endoxifen Hydrochloride: {} + Zalcitabine: {} + Zalifrelimab: {} + Zalutumumab: {} + Zandelisib: {} + Zanidatamab: {} + Zanolimumab: {} + Zanubrutinib: {} + Zebularine: {} + Zelavespib: {} + Zibotentan: {} + Zinc Finger Nuclease ZFN-603: {} + Zinc Finger Nuclease ZFN-758: {} + Zinostatin: {} + Zinostatin Stimalamer: {} + Zirconium Zr 89 Panitumumab: {} + Ziv-Aflibercept: {} + Zolbetuximab: {} + Zoledronic Acid: {} + Zoptarelin Doxorubicin: {} + Zorifertinib: {} + Zorubicin: {} + Zorubicin Hydrochloride: {} + Zotatifin: {} + Zotiraciclib Citrate: {} + Zuclomiphene Citrate: {} + alpha-Folate Receptor-targeting Thymidylate Synthase Inhibitor ONX-0801: {} + c-Kit Inhibitor PLX9486: {} + c-Met Inhibitor ABN401: {} + c-Met Inhibitor AL2846: {} + c-Met Inhibitor AMG 208: {} + c-Met Inhibitor AMG 337: {} + c-Met Inhibitor GST-HG161: {} + c-Met Inhibitor HS-10241: {} + c-Met Inhibitor JNJ-38877605: {} + c-Met Inhibitor MK2461: {} + c-Met Inhibitor MK8033: {} + c-Met Inhibitor MSC2156119J: {} + c-raf Antisense Oligonucleotide ISIS 5132: {} + cEt KRAS Antisense Oligonucleotide AZD4785: {} + cFMS Tyrosine Kinase Inhibitor ARRY-382: {} + cis-Urocanic Acid: {} + dUTPase/DPD Inhibitor TAS-114: {} + eIF4E Antisense Oligonucleotide ISIS 183750: {} + hTERT Multipeptide/Montanide ISA-51 VG/Imiquimod Vaccine GX 301: {} + hTERT Vaccine V934/V935: {} + hTERT-encoding DNA Vaccine INVAC-1: {} + huBC1-huIL12 Fusion Protein AS1409: {} + iNKT Cell Agonist ABX196: {} + iNOS Dimerization Inhibitor ASP9853: {} + iPSC-derived CD16-expressing Natural Killer Cells FT516: {} + iPSC-derived CD16/IL-15RF-expressing Anti-CD19 CAR-NK Cells FT596: {} + iPSC-derived Natural Killer Cells FT500: {} + mRNA-Derived Prostate Cancer Vaccine CV9103: {} + mRNA-based Personalized Cancer Vaccine NCI-4650: {} + mRNA-based Personalized Cancer Vaccine mRNA-4157: {} + mRNA-based TriMix Melanoma Vaccine ECI-006: {} + mRNA-based Tumor-specific Neoantigen Boosting Vaccine GRT-R902: {} + mRNA-derived KRAS-targeted Vaccine V941: {} + mRNA-derived Lung Cancer Vaccine BI 1361849: {} + mRNA-derived Prostate Cancer Vaccine CV9104: {} + mTOR Inhibitor GDC-0349: {} + mTOR Kinase Inhibitor AZD8055: {} + mTOR Kinase Inhibitor CC-223: {} + mTOR Kinase Inhibitor OSI-027: {} + mTOR Kinase Inhibitor PP242: {} + mTOR1/2 Kinase Inhibitor ME-344: {} + mTORC 1/2 Inhibitor LXI-15029: {} + mTORC1/2 Kinase Inhibitor BI 860585: {} + mTORC1/mTORC2/DHFR Inhibitor ABTL0812: {} + ncmtRNA Oligonucleotide Andes-1537: {} + p300/CBP Bromodomain Inhibitor CCS1477: {} + p38 MAPK Inhibitor LY3007113: {} + p53 Peptide Vaccine MPS-128: {} + p53-HDM2 Interaction Inhibitor MI-773: {} + p53-HDM2 Protein-protein Interaction Inhibitor APG-115: {} + p53/HDM2 Interaction Inhibitor CGM097: {} + p70S6K Inhibitor LY2584702: {} + p70S6K/Akt Inhibitor MSC2363318A: {} + p97 Inhibitor CB-5083: {} + p97 Inhibitor CB-5339: {} + p97 Inhibitor CB-5339 Tosylate: {} + pDNA-encoding Emm55 Autologous Cancer Cell Vaccine IFx-Hu2.0: {} + pNGVL4a-CRT-E6E7L2 DNA Vaccine: {} + pNGVL4a-Sig/E7(detox)/HSP70 DNA and HPV16 L2/E6/E7 Fusion Protein TA-CIN Vaccine PVX-2: {} + pan FGFR Inhibitor PRN1371: {} + pan-HER Kinase Inhibitor AC480: {} + pan-PI3K Inhibitor CLR457: {} + pan-PI3K/mTOR Inhibitor SF1126: {} + pan-PIM Kinase Inhibitor AZD1208: {} + pan-PIM Kinase Inhibitor NVP-LGB-321: {} + pan-RAF Inhibitor LXH254: {} + pan-RAF Kinase Inhibitor CCT3833: {} + pan-RAF Kinase Inhibitor TAK-580: {} + pbi-shRNA STMN1 Lipoplex: {} + siG12D LODER: {} + siRNA-transfected Peripheral Blood Mononuclear Cells APN401: {} + ssRNA-based Immunomodulator CV8102: {} + tissue_fixative_enum: + permissible_values: + 95% Ethanol: {} + Acetone: {} + Alcohol: {} + Carbodiimide: {} + Carnoy's Solution: {} + CryoStor: {} + Diimidoester: {} + Dimethylacetamide: {} + Formalin: {} + Glutaraldehyde: {} + Methacarn: {} + NP40 Lysis Buffer: {} + Not applicable: {} + Not recorded: {} + OCT media: {} + Other: {} + PAXgene Tissue: {} + Para-benzoquinone: {} + Poloxamer: {} + RNAlater: {} + Saline: {} + TCL Lysis Buffer: {} + Unknown: {} + tissue_or_organ_of_origin_enum: + permissible_values: + Abdominal Aorta: {} + Abdominal Esophagus: {} + Abdominal Muscle: {} + Abdominal Skin: {} + Abdominal Wall: {} + Abducens Nerve: {} + Accessory Nerve: {} + Acetabulum: {} + Acromioclavicular Joint: {} + Adipose Tissue: {} + Adrenal Cortex: {} + Adrenal Gland: {} + Adrenal Medulla: {} + Ampulla of Vater: {} + Anal Canal: {} + Anal Transitional Zone: {} + Ankle Joint: {} + Ankle Skin: {} + Antecubital Region: {} + Anterior Cranial Fossa: {} + Anterior Mediastinum: {} + Anterior Surface of the Epiglottis: {} + Anterior Wall of the Bladder: {} + Anterior Wall of the Nasopharynx: {} + Antrum Pylori: {} + Anus: {} + Aorta: {} + Aortocaval Lymph Node: {} + Apex of the Tongue: {} + Aponeurosis: {} + Appendage of the Uterus: {} + Appendix: {} + Areola: {} + Arm Skin: {} + Artery: {} + Articular Cartilage: {} + Aryepiglottic Fold: {} + Arytenoid Cartilage: {} + Ascending Colon: {} + Autonomic Nervous System: {} + Axilla: {} + Axillary Artery: {} + Axillary Lymph Node: {} + Axillary Tail of the Breast: {} + Back: {} + Bartholin Gland: {} + Basal Ganglia: {} + Base of the Tongue: {} + Biceps: {} + Biceps Femoris: {} + Bile Canaliculus: {} + Bile Duct: {} + Biliary Tract: {} + Bladder: {} + Bladder Neck: {} + Bladder Trigone: {} + Blood: {} + Blood Vessel: {} + Body of Stomach: {} + Body of the Pancreas: {} + Body of the Penis: {} + Bone: {} + Bone Marrow: {} + Bone of the Extremity: {} + Brachial Lymph Node: {} + Brachial Plexus: {} + Brachialis: {} + Brain: {} + Brain Dura Mater: {} + Brain Stem: {} + Brain Ventricle: {} + Branchial Cleft Remnant: {} + Breast: {} + Broad Ligament: {} + Bronchial Lymph Node: {} + Bronchiole: {} + Bronchus: {} + Buccal Mucosa: {} + Buttock: {} + C1 Vertebra: {} + C2 Vertebra: {} + Calcaneum: {} + Calf: {} + Cardiac Atrium: {} + Cardiac Ventricle: {} + Carina: {} + Carotid Artery: {} + Carotid Body: {} + Carpal Bone: {} + Carpal Region: {} + Cartilage: {} + Cauda Equina: {} + Cecum: {} + Celiac Artery: {} + Celiac Lymph Node: {} + Central Nervous System: {} + Central Portion of the Breast: {} + Cerebellopontine Angle: {} + Cerebellum: {} + Cerebral Cortex: {} + Cerebral Hemisphere: {} + Cerebral Meninges: {} + Cerebral Peduncle: {} + Cerebral White Matter: {} + Ceruminous Gland: {} + Cervical Esophagus: {} + Cervical Gland: {} + Cervical Lymph Node: {} + Cervix Uteri: {} + Cheek: {} + Chest: {} + Chest Wall: {} + Choroid: {} + Choroid Plexus: {} + Choroid Plexus of the Fourth Ventricle: {} + Choroid Plexus of the Lateral Ventricle: {} + Choroid Plexus of the Third Ventricle: {} + Ciliary Body: {} + Clitoris: {} + Coccyx: {} + Cochlear Nerve: {} + Colon: {} + Commissure of the Lip: {} + Common Bile Duct: {} + Concha: {} + Conjunctiva: {} + Connective Tissue: {} + Conus Medullaris: {} + Coracobrachialis: {} + Cornea: {} + Corneoscleral Limbus: {} + Corpus Callosum: {} + Corpus Striatum: {} + Corpus Uteri: {} + Costal Cartilage: {} + Costovertebral Joint: {} + Cowper Gland: {} + Cranial Nerve: {} + Craniopharyngeal Duct: {} + Cricoid Cartilage: {} + Cul-de-sac: {} + Cuneiform Cartilage: {} + Cystic Duct: {} + Descending Colon: {} + Diaphragm: {} + Diaphragmatic Lymph Node: {} + Dome of the Bladder: {} + Duct of Gartner: {} + Ductus Santorini: {} + Duodenum: {} + Dura Mater: {} + Ear: {} + Ear Skin: {} + Ectocervix: {} + Elbow Joint: {} + Elbow Skin: {} + Endocardium: {} + Endocervix: {} + Endocrine Gland: {} + Endometrial Stroma: {} + Endometrium: {} + Ependyma: {} + Epicardium: {} + Epididymis: {} + Epidural Spinal Canal Space: {} + Epiglottis: {} + Epitrochlear Lymph Node: {} + Esophagus: {} + Ethmoid Bone: {} + Ethmoid Sinus: {} + Eustachian Tube: {} + External Acoustic Meatus: {} + External Ear: {} + External Lip: {} + External Lower Lip: {} + External Nose: {} + External Upper Lip: {} + Extrahepatic Bile Duct: {} + Eye: {} + Eyebrow: {} + Eyelid: {} + Facial Bone: {} + Facial Nerve: {} + Fallopian Tube: {} + False Vocal Cord: {} + Falx Cerebelli: {} + Falx Cerebri: {} + Fascia: {} + Female Genitalia: {} + Femoral Artery: {} + Femoral Lymph Node: {} + Femoral Nerve: {} + Femur: {} + Fibrous Tissue: {} + Fibula: {} + Finger: {} + Fingernail: {} + Flank: {} + Floor of Mouth: {} + Foot: {} + Foot Bone: {} + Foot Phalanx: {} + Foot Skin: {} + Forearm: {} + Forehead: {} + Fourth Ventricle: {} + Frontal Bone: {} + Frontal Lobe: {} + Frontal Pole: {} + Frontal Sinus: {} + Fundus Uteri: {} + Fundus of the Stomach: {} + Gallbladder: {} + Gastric Cardia: {} + Gastric Lymph Node: {} + Gastrocnemius Muscle: {} + Gastroesophageal Junction: {} + Gastrointestinal Tract: {} + Gingiva: {} + Gland of Littre: {} + Glans Penis: {} + Globus Pallidus: {} + Glossopharyngeal Nerve: {} + Glottis: {} + Gluteus Maximus: {} + Greater Curvature of the Stomach: {} + Hand: {} + Hand Digit 1: {} + Hand Phalanx: {} + Hand Skin: {} + Hard Palate: {} + Head Skin: {} + Head and Neck Lymph Node: {} + Head of the Pancreas: {} + Heart: {} + Helix: {} + Hematopoietic System: {} + Hepatic: {} + Hepatic Duct: {} + Hepatic Flexure: {} + Hepatic Lymph Node: {} + Hip: {} + Hip Joint: {} + Hippocampus: {} + Humerus: {} + Hymen: {} + Hyoid Bone: {} + Hypoglossal Nerve: {} + Hypopharynx: {} + Hypothalamus: {} + Ileocecal Valve: {} + Ileum: {} + Iliac Artery: {} + Iliac Lymph Node: {} + Iliac Vein: {} + Iliopsoas Muscle: {} + Ilium: {} + Inferior Vena Cava: {} + Infraclavicular Lymph Node: {} + Infraclavicular Region: {} + Infratentorial Brain: {} + Inguinal Lymph Node: {} + Inguinal Region: {} + Inner Canthus: {} + Inner Ear: {} + Intercostal Lymph Node: {} + Intercostal Muscle: {} + Intercostal Nerve: {} + Internal Capsule: {} + Internal Iliac Lymph Node: {} + Internal Mammary Artery: {} + Internal Mammary Lymph Node: {} + Internal Nare: {} + Intervertebral Disc: {} + Intestine: {} + Intra-Abdominal Lymph Node: {} + Intrahepatic Bile Duct: {} + Intraocular Route of Administration: {} + Intrathoracic Lymph Node: {} + Iris: {} + Ischiorectal Fossa: {} + Ischium: {} + Islet of Langerhans: {} + Isthmus Uteri: {} + Jaw Bone: {} + Jaw Joint: {} + Jejunum: {} + Joint: {} + Kidney: {} + Knee Joint: {} + Knee Skin: {} + Labium: {} + Labium Majus: {} + Labium Minus: {} + Lacrimal Gland: {} + Lacrimal Sac: {} + Large Intestine: {} + Laryngeal Cartilage: {} + Larynx: {} + Lateral Ventricle: {} + Lateral Wall of the Bladder: {} + Lateral Wall of the Nasopharynx: {} + Lateral Wall of the Oropharynx: {} + Lateral Wall of the Pharynx: {} + Leg Skin: {} + Lens: {} + Lesser Curvature of the Stomach: {} + Ligament: {} + Lingual Tonsil: {} + Lingula of the Lung: {} + Lip: {} + Liver: {} + Lobule of the Auricle: {} + Lower Extremity: {} + Lower Gingiva: {} + Lower Lobe of the Lung: {} + Lower Third of the Esophagus: {} + Lower-Inner Quadrant of the Breast: {} + Lower-Outer Quadrant of the Breast: {} + Lumbar Nerve: {} + Lumbosacral Plexus: {} + Lung: {} + Lymph Node: {} + Lymph Node of Inguinal Region or Leg: {} + Lymphatic: {} + Main Bronchus: {} + Male Genitalia: {} + Male Prepuce: {} + Mammary Gland: {} + Mandible: {} + Masseter Muscle: {} + Maxilla: {} + Maxillary Sinus: {} + Meckel Diverticulum: {} + Median Nerve: {} + Mediastinal Lymph Node: {} + Mediastinum: {} + Medulla Oblongata: {} + Meibomian Gland: {} + Meninges: {} + Meniscus Lateralis: {} + Meniscus Medialis: {} + Mentum: {} + Mesencephalon: {} + Mesenteric Artery: {} + Mesenteric Lymph Node: {} + Mesentery: {} + Mesonephric Duct: {} + Mesonephros: {} + Mesovarium: {} + Metacarpal Bone: {} + Metatarsal Bone: {} + Middle Cranial Fossa: {} + Middle Ear: {} + Middle Lobe of the Right Lung: {} + Middle Third of the Esophagus: {} + Minor Salivary Gland: {} + Mons Pubis: {} + Mucosa of the Lip: {} + Mucosa of the Lower Lip: {} + Mucosa of the Upper Lip: {} + Muscle: {} + Musculus Latissimus Dorsi: {} + Myocardium: {} + Myometrium: {} + Nasal Bone: {} + Nasal Cartilage: {} + Nasal Cavity: {} + Nasal Septum: {} + Nasal Turbinate: {} + Nasolacrimal Duct: {} + Nasopharynx: {} + Neck Skin: {} + Nerve: {} + Nervous System: {} + Nipple: {} + Nose: {} + Nostril: {} + Obturator Lymph Node: {} + Obturator Nerve: {} + Occipital Bone: {} + Occipital Lobe: {} + Occipital Lymph Node: {} + Oculomotor Muscle: {} + Oculomotor Nerve: {} + Olfactory Nerve: {} + Omentum: {} + Optic Chiasm: {} + Optic Nerve: {} + Optic Tract: {} + Oral Cavity: {} + Orbit: {} + Oropharynx: {} + Other Specified Parts of Pancreas: {} + Outer Canthus: {} + Ovary: {} + Palate: {} + Palatine Tonsil: {} + Palmar Fascia: {} + Pancreas: {} + Pancreatic Duct: {} + Pancreatic Lymph Node: {} + Paraaortic Lymph Node: {} + Paraganglion: {} + Parametrium: {} + Paranasal Sinus: {} + Parasympathetic Nervous System: {} + Parathyroid Gland: {} + Paratracheal Lymph Node: {} + Parietal Bone: {} + Parietal Lobe: {} + Parietal Pleura: {} + Parotid Duct: {} + Parotid Gland: {} + Parotid Gland Lymph Node: {} + Patella: {} + Pectoral Lymph Node: {} + Pectoralis Major: {} + Pelvic Lymph Node: {} + Pelvis: {} + Penis: {} + Pericardium: {} + Perineum: {} + Peripheral Nerve: {} + Peritoneal Cavity: {} + Peritoneum: {} + Pharyngeal Tonsil: {} + Pharynx: {} + Pia Mater: {} + Pineal Gland: {} + Pituitary Gland: {} + Placenta: {} + Plantar Fascia: {} + Plantar Region: {} + Pleura: {} + Pons Varolii: {} + Popliteal Lymph Node: {} + Portal Lymph Node: {} + Postcricoid Region: {} + Posterior Cranial Fossa: {} + Posterior Mediastinum: {} + Posterior Wall of the Bladder: {} + Posterior Wall of the Hypopharynx: {} + Posterior Wall of the Nasopharynx: {} + Posterior Wall of the Oropharynx: {} + Posterior Wall of the Pharynx: {} + Preauricular Lymph Node: {} + Prostate Gland: {} + Prostatic Utricle: {} + Psoas Muscle: {} + Pubic Bone: {} + Pubic Symphysis: {} + Pulmonary: {} + Pulmonary Hilar Lymph Node: {} + Putamen: {} + Pylorus: {} + Pyriform Sinus: {} + Quadriceps Muscle of the Thigh: {} + Radial Artery: {} + Radial Nerve: {} + Radius Bone: {} + Rathke Pouch: {} + Rectosigmoid Colon: {} + Rectosigmoid Region: {} + Rectum: {} + Rectus Abdominis: {} + Renal: {} + Renal Artery: {} + Renal Calyx: {} + Renal Pelvis: {} + Reticuloendothelial System: {} + Retina: {} + Retromolar Trigone: {} + Retroperitoneal Lymph Node: {} + Retroperitoneum: {} + Retropharyngeal Lymph Node: {} + Round Ligament of the Uterus: {} + Sacral Bone: {} + Sacral Lymph Node: {} + Sacral Nerve: {} + Sacral Plexus: {} + Salivary Gland: {} + Scalene Lymph Node: {} + Scalp: {} + Scapula: {} + Sciatic Nerve: {} + Sclera: {} + Scrotum: {} + Sella Turcica: {} + Seminal Vesicle: {} + Shoulder: {} + Shoulder Girdle: {} + Shoulder Joint: {} + Sigmoid Colon: {} + Skeletal Muscle Tissue: {} + Skin: {} + Skin Of The Axilla: {} + Skin of the Face: {} + Skin of the Lip: {} + Skin of the Lower Limb and Hip: {} + Skin of the Scalp and Neck: {} + Skin of the Trunk: {} + Skin of the Upper Limb and Shoulder: {} + Skull: {} + Skullcap: {} + Small Intestine: {} + Spermatic Cord: {} + Sphenoid Bone: {} + Sphenoid Sinus: {} + Sphincter of Oddi: {} + Spinal Cord: {} + Spinal Cord Dura Mater: {} + Spinal Meninges: {} + Spinal Nerve: {} + Spleen: {} + Splenic Flexure: {} + Splenic Hilar Lymph Node: {} + Sternocleidomastoid Muscle: {} + Sternocostal Joint: {} + Stomach: {} + Subclavian Artery: {} + Subcutis: {} + Subglottis: {} + Sublingual Lymph Node: {} + Sublingual Salivary Gland: {} + Submandibular Duct: {} + Submandibular Gland: {} + Submandibular Lymph Node: {} + Superior Vena Cava: {} + Superior Wall of the Nasopharynx: {} + Supraclavicular: {} + Supraclavicular Lymph Node: {} + Supraglottis: {} + Suprasellar Region: {} + Supratentorial Brain: {} + Sympathetic Nervous System: {} + Synovial Bursa: {} + Synovial Fluid: {} + Tail of the Pancreas: {} + Tarsal Bone: {} + Temporal Bone: {} + Temporal Lobe: {} + Tendon: {} + Tendon Sheath: {} + Tentorium Cerebelli: {} + Testis: {} + Thalamus: {} + Thigh: {} + Third Ventricle: {} + Thoracic Duct: {} + Thoracic Esophagus: {} + Thoracic Lymph Node: {} + Thorax: {} + Thymus Gland: {} + Thyroglossal Duct: {} + Thyroid Cartilage: {} + Thyroid Gland: {} + Tibia: {} + Toe: {} + Toenail: {} + Tongue: {} + Tonsillar Fossa: {} + Tonsillar Pillar: {} + Tooth Socket: {} + Trachea: {} + Tracheobronchial Lymph Node: {} + Tragus: {} + Transverse Colon: {} + Trapezius Muscle: {} + Triceps Brachii: {} + Trigeminal Nerve: {} + Trochlear Nerve: {} + True Vocal Cord: {} + Trunk: {} + Tunica Vaginalis: {} + Ulna: {} + Ulnar Artery: {} + Ulnar Nerve: {} + Umbilicus: {} + Uncus: {} + Undescended Testes: {} + Upper Extremity: {} + Upper Gingiva: {} + Upper Lobe of the Lung: {} + Upper Third of the Esophagus: {} + Upper-Inner Quadrant of the Breast: {} + Upper-Outer Quadrant of the Breast: {} + Urachus: {} + Ureter: {} + Ureteric Orifice: {} + Ureteropelvic Junction: {} + Urethra: {} + Uterine Gland: {} + Uterine Ligament: {} + Uterus: {} + Uvea: {} + Uvula: {} + Vagina: {} + Vaginal Fornix: {} + Vagus Nerve: {} + Vallecula: {} + Vas Deferens: {} + Vein: {} + Vena Cava: {} + Vermis: {} + Vertebra: {} + Vertebral Column: {} + Visceral Pleura: {} + Vocal Cord: {} + Vulva: {} + Waldeyer's Tonsillar Ring: {} + Wall of the Pharynx: {} + Wrist Joint: {} + Wrist Skin: {} + treatment_outcome_enum: + permissible_values: + Complete Remission: {} + Minor Response: {} + Mixed Response: {} + No Evidence of Disease: {} + Non-Response: {} + Not Applicable: {} + Not Done: {} + Not Evaluable: {} + Not Reported: {} + Partial Response: {} + Progressive Disease: {} + Stable Disease: {} + Unknown: {} + Very Good Partial Response: {} + treatment_type_enum: + permissible_values: + 3-Dimensional Conformal Radiation Therapy: {} + Allogeneic Hematopoietic Stem Cell Transplantation: {} + Autologous Stem Cell Transplantation: {} + Brachytherapy: {} + Cellular Therapy: {} + Chemotherapy: {} + Concurrent Chemoradiation: {} + Conventional Radiotherapy: {} + Electron Beam Radiation Therapy: {} + External Beam Radiation Therapy: {} + High-Dose Rate Brachytherapy: {} + Hormone Therapy: {} + Immunotherapy: {} + Intensity-Modulated Radiation Therapy: {} + Low-Dose Rate Brachytherapy: {} + Not Reported: {} + Pharmacotherapy: {} + Photon Beam Radiation Therapy: {} + Proton Beam Radiation Therapy: {} + Radiation Therapy: {} + Radiofrequency Ablation: {} + Radiopharmaceutical: {} + Stem Cell Transplant: {} + Stereotactic Body Radiation Therapy: {} + Stereotactic Radiosurgery: {} + Surgical Procedure: {} + Targeted Molecular Therapy: {} + Unknown: {} + tumor_grade_enum: + permissible_values: + G1: {} + G2: {} + G3: {} + G4: {} + GB: {} + GX: {} + High Grade: {} + Intermediate Grade: {} + Low Grade: {} + Not Reported: {} + Unknown: {} + tumor_stage_clinical_m_enum: + permissible_values: + M0: {} + M1: {} + M1a: {} + M1b: {} + M1c: {} + MX: {} + Not Reported: {} + Unknown: {} + cM0 (i+): {} + tumor_stage_clinical_n_enum: + permissible_values: + N0: {} + N0 (i+): {} + N0 (i-): {} + N0 (mol+): {} + N0 (mol-): {} + N1: {} + N1a: {} + N1b: {} + N1bI: {} + N1bII: {} + N1bIII: {} + N1bIV: {} + N1c: {} + N1mi: {} + N2: {} + N2a: {} + N2b: {} + N2c: {} + N3: {} + N3a: {} + N3b: {} + N3c: {} + N4: {} + NX: {} + Not Reported: {} + Unknown: {} + tumor_stage_clinical_t_enum: + permissible_values: + Not Reported: {} + T0: {} + T1: {} + T1a: {} + T1a1: {} + T1a2: {} + T1b: {} + T1b1: {} + T1b2: {} + T1c: {} + T1mi: {} + T2: {} + T2a: {} + T2a1: {} + T2a2: {} + T2b: {} + T2c: {} + T2d: {} + T3: {} + T3a: {} + T3b: {} + T3c: {} + T3d: {} + T4: {} + T4a: {} + T4b: {} + T4c: {} + T4d: {} + T4e: {} + TX: {} + Ta: {} + Tis: {} + Tis (DCIS): {} + Tis (LCIS): {} + Tis (Paget's): {} + Unknown: {} + vital_status_enum: + permissible_values: + Alive: {} + Dead: {} + Not Reported: {} + Unknown: {} + +slots: + CTAquisitionProtocolElement_ctdiPhantomTypeCode: + description: The type of phantom to use for CTDI measurement according to IEC + 60601-2-44 + range: string + required: false + CTAquisitionProtocolElement_ctdiVol: + description: The average dose over the total volume scanned for the selected CT + conditions of operation (calculated according to IEC 60601-2-44, Ed.2.1 (Clause + 29.1.103.4)). The units are energy dose, e.g. mGy. + range: string + required: false + CTAquisitionProtocolElement_exposureModulationType_Code: + description: The manner in which tube current is varied in order to limit the + dose. + range: CTAquisitionProtocolElement_exposureModulationType_Code_enum + required: false + CTAquisitionProtocolElement_gantryDetectorTilt: + description: Nominal angle of tilt in degrees of the scanning gantry. The units + are of plane angle , e.g. degrees. Zero degrees means the gantry is not tilted, + negative degrees are when the top of the gantry is tilted away from where the + table enters the gantry. + range: string + required: false + CTAquisitionProtocolElement_kVp: + description: Peak kilovoltage output of the x-ray generator. The units are of + electrical potential. + range: string + required: false + CTAquisitionProtocolElement_singleCollimationWidth: + description: The width of a single row of acquired data. The units are of linear + distince, e.g. mm. + range: string + required: false + CTAquisitionProtocolElement_spiralPitchFactor: + description: Ratio of the distance that the table moves during a complete revolution + of the source around the gantry orbit, to the width of the total collimation + over the area of active x-ray detection. The units are of unity. + range: string + required: false + CTAquisitionProtocolElement_totalCollimationWidth: + description: The width of the total collimation over the area of active x-ray + detection. The units are of linear distince, e.g. mm. + range: string + required: false + CTImageReconstructionProtocolElement_convolutionKernel: + description: A label describing the mathematical operations used to reconstruct + images from the acquired data. The values for this attribute are vendor specific + and not coded. + range: string + required: false + CTImageReconstructionProtocolElement_convolutionKernelGroupCode: + description: A coded value specifying the family of mathematical operations to + use to reconstruct images from the acquired data + range: string + required: false + MRImageAcquisitionProtocolElement_acquisitionContrastCode: + description: A coded value specifying the inherent (as opposed to exogenous) contrast + in the acquisition. + range: MRImageAcquisitionProtocolElement_acquisitionContrastCode_enum + required: false + MRImageAcquisitionProtocolElement_arterialSpinLabelingContrastCode: + description: A coded value specifying how arterial water is used as a diffusable + tracer. + range: string + required: false + MRImageAcquisitionProtocolElement_diffusionBValue: + description: The factor by which the acquisition is sensitized to the Brownian + motion of water molecules. The units are of time/area, e.g. s/mm2 + range: string + required: false + MRImageAcquisitionProtocolElement_diffusionDirectionalityCode: + description: A coded value specifying whether diffusion conditions for the frame + are directional, or isotropic with respect to direction + range: MRImageAcquisitionProtocolElement_diffusionDirectionalityCode_enum + required: false + MRImageAcquisitionProtocolElement_echoPlanarPulseSequenceIndicator: + description: Specifies whether multiple echos of different phase steps are acquired + using rephasing gradients instead of repeated 180-degree pulses. + range: string + required: false + MRImageAcquisitionProtocolElement_echoPulseSequenceCategoryCode: + description: A coded value specifying an echo category of pulse sequences. + range: MRImageAcquisitionProtocolElement_echoPulseSequenceCategoryCode_enum + required: false + MRImageAcquisitionProtocolElement_inversionRecoveryIndicator: + description: Specifies whether an inversion recovery preparatory sequence is used + in the acquisition. + range: string + required: false + MRImageAcquisitionProtocolElement_magneticFieldStrength: + description: "A vector quantity indicating the ability of a magnetic field to\ + \ exert a force on moving electric charges. [The American Heritage\xAE Science\ + \ Dictionary]. The units are of magnetic flux density, e.g. tesla." + range: string + required: false + MRImageAcquisitionProtocolElement_multipleSpinEchoIndicator: + description: Specifies whether different lines in k-space are collected for a + single frame. + range: string + required: false + MRImageAcquisitionProtocolElement_phaseContrastIndicator: + description: Specifies whether this is a pulse sequence in which the flowing spins + are velocity encoded in phase. + range: string + required: false + MRImageAcquisitionProtocolElement_pulseSequenceName: + description: Name of the pulse sequence that is used for the acquisition. This + is usually a vendor-specific name. + range: string + required: false + MRImageAcquisitionProtocolElement_resonantNucleusCode: + description: A coded value specifying the atomic nucleus that is the target of + the acquisition + range: MRImageAcquisitionProtocolElement_resonantNucleusCode_enum + required: false + MRImageAcquisitionProtocolElement_saturationRecoveryIndicator: + description: Specifies whether a saturation recovery pulse sequence is used + range: string + required: false + MRImageAcquisitionProtocolElement_spectrallySelectedSuppressionCode: + description: A coded value specifying the type of substance-specific signal suppression + is used. + range: MRImageAcquisitionProtocolElement_spectrallySelectedSuppressionCode_enum + required: false + MRImageAcquisitionProtocolElement_steadyStatePulseSequenceCode: + description: A coded value specifying how residual transverse magnetization is + maintained during the acquisition. + range: MRImageAcquisitionProtocolElement_steadyStatePulseSequenceCode_enum + required: false + MRImageAcquisitionProtocolElement_timeOfFlightContrastIndicator: + description: Specifies whether contrast is created by the inflow of blood in the + saturated plane. + range: string + required: false + MRImageReconstructionProtocolElement_complexImageComponentCode: + description: A coded value specifying the channel of the quadrature detected data, + or the combination derived from those channels, used to reconstruct the image + range: MRImageReconstructionProtocolElement_complexImageComponentCode_enum + required: false + PETImagingAcquisitionProtocolElement_gantryDetectorTilt: + description: Nominal angle of tilt in degrees of the scanning gantry. The units + are of plane angle , e.g. degrees. Zero degrees means the gantry is not tilted, + negative degrees are when the top of the gantry is tilted away from where the + table enters the gantry. + range: string + required: false + Radiopharmaceutical_radionuclideCode: + description: A coded value that specifies the radioactive isotope in the radiophamaceutical. + range: string + required: false + acl: + description: open or restricted access to data + range: string + required: false + acquisition_method_type: + description: Records the method of acquisition or source for the specimen under + consideration + range: string + required: false + adult_or_childhood_study: + description: Study participants are adult, pediatric, or other + range: adult_or_childhood_study_enum + required: false + age_at_diagnosis: + description: Participant age at relevant diagnosis + range: integer + required: false + antibody_name: + description: short descriptive name for this antibody + range: string + required: false + authz: + description: multifactor authorization + range: string + required: false + avg_read_length: + description: Average sequence read length + range: number + required: false + bases: + description: Total number of unique bases read + range: integer + required: false + bioproject_accession: + description: NCBI BioProject accession ID + pattern: ^PRJNA[0-9]+$ + range: string + required: false + biosample_accession: + description: NCBI BioSample accession ID (SAMN) for this sample + pattern: ^SAMN[0-9]+$ + range: string + required: false + catalog_number: + description: catalog number from vendor + range: string + required: false + cds_primary_bucket: + description: The primary bucket for depositing data + range: string + required: false + cds_requestor: + description: Identifies the user requesting storage in CDS + range: string + required: false + cds_secondary_bucket: + description: Secondary bucket for depositing data (non-sequence files) + range: string + required: false + cds_tertiary_bucket: + description: Secondary bucket for depositing data (non-sequence files) + range: string + required: false + channel_id: + description: The unique channel identifier for each channel in this image must + match the corresponding field in the OME-TIFF header + range: string + required: false + channel_metadata_file_url_in_cds: + description: '' + range: string + required: false + channel_metadata_filename: + description: File name of uploaded companion CSV file containing channel-level + metadata details + range: string + required: false + channel_name: + description: Channel label for each channel in this image must match the corresponding + field in the OME-TIFF header + range: string + required: false + checksum_algorithm: + description: The method by which the file checksum was calculated. + range: string + required: false + checksum_value: + description: checksum (hash) for file (using checksum_algorithm) - if you want + to use a checksum other than md5 + range: string + required: false + citation_or_DOI: + description: Publication and/or digital object identifier of the publication for + open access studies + range: string + required: false + clinical_trial_arm: + description: Arm of clinical trial, if appropriate + range: string + required: false + clinical_trial_identifier: + description: Study identifier in the given clinical trial system + range: string + required: false + clinical_trial_repository: + description: The name of the organization that provides the clinical trial identifier. + range: string + required: false + clinical_trial_system: + description: Organization that provides clinical trial identifier (if study is + a clinical trial) + range: string + required: false + clone: + description: Unique clone identifier + range: string + required: false + co_investigator_email: + description: Email of co-principal investigator + range: string + required: false + co_investigator_name: + description: Name of co-principal investigator + range: string + required: false + concentration: + description: Final concentration used in experiment + range: string + required: false + coverage: + description: Average depth of coverage on reference used + range: number + required: false + crdc_id: + description: The crdc_id is a unique identifier that is generated by Data Hub + range: string + required: false + custom_assembly_fasta_file_for_alignment: + description: File name of any custom assembly fasta file used during alignment + range: string + required: false + cycle_number: + description: 'the cycle # in which the co-listed reagent(s) was(were) used' + range: string + required: false + data_access_level: + description: Is data open, controlled, or mixed? + range: data_access_level_enum + required: false + data_types: + description: Data types for storage + range: string + required: false + days_to_last_followup: + description: Days to last participant followup, relative to study index date + range: integer + required: false + days_to_last_known_disease_status: + description: The number of days from the date of the initial cancer diagnosis + to the date of last known disease status. + range: number + required: false + days_to_last_known_status: + description: Days to last known status of participant, relative to study index + date + range: integer + required: false + days_to_recurrence: + description: Days to disease recurrence, relative to study index date + range: integer + required: false + days_to_treatment: + description: Days to start of treatment, relative to index date + range: integer + required: false + dbGaP_subject_id: + description: Identifier for the participant as assigned by dbGaP + range: string + required: false + de_identification_method_description: + description: Description of the process of removing potentially identifying data + or data elements to render data into a form that does not identify individuals + and where identification is not likely to take place. + range: string + required: false + de_identification_method_type: + description: General description of the de-identification method + range: de_identification_method_type_enum + required: false + de_identification_software: + description: Software that was used to de-identify the images (if used) + range: string + required: false + derived_from_specimen: + description: Identier of the parent specimen of this sample + range: string + required: false + design_description: + description: Human-readable description of methods used to create sequencing library + range: string + required: false + diagnosis_id: + description: Internal identifier + range: string + required: false + dilution: + description: Final dilution ratio used in experiment + range: string + required: false + disease_type: + description: Type of disease [?] + range: disease_type_enum + required: false + email: + description: The string of characters that represents the electronic mail address + of a person. + range: string + required: false + embedding_medium: + description: A material that infiltrates and supports a specimen and preserves + its shape and structure for sectioning and microscopy. + range: embedding_medium_enum + required: false + emission_bandwidth: + description: nominal width of emission spectrum (nm) + range: string + required: false + emission_wavelength: + description: center/peak of the emission spectrum (nm) + range: string + required: false + ethnicity: + description: OMB Ethinicity designator + range: ethnicity_enum + required: false + excitation_bandwidth: + description: nominal width of excitation spectrum (nm) + range: string + required: false + excitation_wavelength: + description: center/peak of the excitation spectrum (nm) + range: string + required: false + experimental_strategy_and_data_subtypes: + description: What is the experimental strategy used for the study (or what type + of data subtypes exist in the study)? + range: string + required: false + file_access: + description: File access + range: file_access_enum + required: false + file_description: + description: Human-readable description of file + range: string + required: false + file_id: + description: File identifier + range: string + required: false + file_mapping_level: + description: Describes if the file belongs to a Participant, a Sample, or a Study + range: file_mapping_level_enum + required: false + file_name: + description: Name of file + range: string + required: false + file_size: + description: File size in bytes + range: integer + required: false + file_type: + description: File type from enumerated list + range: file_type_enum + required: false + file_types: + description: File types for storage + range: string + required: false + file_types_and_format: + description: Specific kinds of files in the dataset that will be uploaded to CDS + range: string + required: false + file_url_in_cds: + description: Location of the file on the CDS cloud, using AWS S3 protocol + range: string + required: false + first_name: + description: A word or group of words indicating a person's first (personal or + given) name; the name that precedes the surname. Synonym = Given Name. + range: string + required: false + fluorophore: + description: Fluorescent dye label + range: string + required: false + funding_agency: + description: Funding agency of the requestor study + range: string + required: false + funding_source_program_name: + description: The funding source organization/sponsor + range: string + required: false + gender: + description: Biological gender at birth + range: gender_enum + required: false + genomic_info_id: + description: Genomic info identifier, the ID property for the ndoe genomic_info. + range: string + required: false + grant_id: + description: Grant or contract identifier + range: string + required: false + image_modality: + description: The method in which the images are generated. + range: image_modality_enum + required: false + imaging_assay_type: + description: Type of imaging assay + range: string + required: false + imaging_equipment_manufacturer: + description: Producer of the imaging equipment that was used to generate the digital + image + range: string + required: false + imaging_equipment_model: + description: The words used to describe the specific model of the instrument used + to carry out an imaging experiment. + range: string + required: false + imaging_protocol: + description: A rule which guides how an activity should be performed. Protocols.io + ID or DOI link to a free/open protocol resource describing in detail the assay + protocol (e.g. surface markers used in Smart-seq, dissociation duration, lot/batch + numbers for key reagents such as primers, sequencing reagent kits, etc.) or + the protocol by which the image was obtained or generated. + range: string + required: false + imaging_sofware: + description: The name of the software package that was used to capture, generate, + and process the image. + range: string + required: false + immersion: + description: Immersion medium + range: string + required: false + incidence_type: + description: For this diagnosis, disease incidence relative to prior status of + subject + range: incidence_type_enum + required: false + index_date: + description: Index date (Day 0) to which all dates are relative, for this study + range: index_date_enum + required: false + institution: + description: TBD + range: String + required: false + instrument_model: + description: Instrument model + range: instrument_model_enum + required: false + last_known_disease_status: + description: Last known disease incidence for this subject and diagnosis + range: last_known_disease_status_enum + required: false + last_name: + description: A means of identifying an individual by using a word or group of + words indicating a person's last (family) name. Synonym = Last Name, Surname. + range: string + required: false + lens_numerical_aperture: + description: The numerical aperture of the lens. Floating point value > 0. + range: string + required: false + library_id: + description: Library identifier as submitted by requestor + range: string + required: false + library_layout: + description: Library layout as submitted by requestor + range: library_layout_enum + required: false + library_selection: + description: Library selection method + range: library_selection_enum + required: false + library_source: + description: Source material used to create library + range: library_source_enum + required: false + library_source_material: + description: Source Material + range: library_source_material_enum + required: false + library_source_molecule: + description: Source Molecule + range: library_source_molecule_enum + required: false + library_strategy: + description: Nucleic acid capture or processing strategy for this library + range: library_strategy_enum + required: false + license: + description: Official or legal permission to do or own a specified thing. + range: license_enum + required: false + longitudinal_temporal_event_offset: + description: An offset in days from a particular event of significance. May be + fractional. In the context of a clinical trial, this is often the days since + enrollment, or the baseline imaging Study. + range: number + required: false + longitudinal_temporal_event_type: + description: The type of event to which Longitudinal Temporal Offset from Event + is relative. + range: number + required: false + lot: + description: lot number from vendor + range: string + required: false + md5sum: + description: MD5 hex digest for this file + pattern: ^[0-9a-fA-F]{32}$ + range: string + required: false + metal_isotope_element_abbreviation: + description: Element abbreviation + range: string + required: false + metal_isotope_element_mass: + description: Element mass number + range: string + required: false + methylation_platform: + description: The equipment used to detect the presence and/or location of methyl + groups during DNA or protein analysis. + range: string + required: false + middle_name: + description: A means of identifying an individual by using a word or group of + words indicating a person's middle name. + range: string + required: false + morphology: + description: ICD-O-3 Morphology term associated with this diagnosis + range: morphology_enum + required: false + nominal_magnification: + description: The magnification of the lens as specified by the manufacturer - + i.e. '60' is a 60X lens. floating point value > 1(no units) + range: string + required: false + number_of_participants: + description: How many participants in the study + range: number + required: false + number_of_reads: + description: Total number of reads performed + range: integer + required: false + number_of_samples: + description: How many total samples in the study + range: number + required: false + objective: + description: An objective is an optical element that gathers light from an object + being observed and focuses the light rays from it to produce a real image of + the object. + range: string + required: false + oligo_barcode_lower_strand: + description: DNA barcode used for labeling + range: string + required: false + oligo_barcode_upper_strand: + description: DNA barcode used for labeling + range: string + required: false + organ_or_tissue: + description: Site where images are associated + range: string + required: false + organism_species: + description: Species binomial of study participants + range: string + required: false + participant_id: + description: A number or a string that may contain metadata information, for a + participant who has taken part in the investigation or study. + range: string + required: false + performed_imaging_study_acquisitionTypeCode: + description: A coded value specifying spatial aspects of the mechanism of data + collection. + range: string + required: false + performed_imaging_study_admittingDiagnosisCode: + description: The identified disease(s) or illness(es) at the time of the admission + during which imaging was performed. + range: string + required: false + performed_imaging_study_algorithmCode: + description: A coded value specifying the algorithm to use when reconstructing + the image from the data acquired during the acquisition process + range: string + required: false + performed_imaging_study_bodyPositionCode: + description: A coded value specifying the 3-dimensional spatial orientation of + a subject during this imaging acquisition protocol element. + range: performed_imaging_study_bodyPositionCode_enum + required: false + performed_imaging_study_cardiacSynchronizationTechniqueCode: + description: The means used to coordinate the collection or reconstruction of + data with the cardiac cycle. + range: performed_imaging_study_cardiacSynchronizationTechniqueCode_enum + required: false + performed_imaging_study_dataCollectionDiameter: + description: The diameter of the region over which information is acquired. + range: string + required: false + performed_imaging_study_description: + description: The textual representation of the certain or salient aspects, characteristics, + or features of the imaging study. [Adapted from www.businessdictionary.com] + range: string + required: false + performed_imaging_study_lossyImageCompressionIndicator: + description: Specifies whether any images in the study are irreversibly altered + during encoding at any time during its life. + range: performed_imaging_study_lossyImageCompressionIndicator_enum + required: false + performed_imaging_study_nonAcquisitionModalitiesInStudyCode: + description: A coded value specifying the type of equipment that created the images + in this imaging study other than that used to acquire the original data. + range: string + required: false + performed_imaging_study_primaryAnatomicSiteCode: + description: A coded value specifying the anatomic location that is the focus + of this imaging process protocol element. + range: string + required: false + performed_imaging_study_reconstructionDiameter: + description: The diameter of the region from which data is used in creating the + reconstruction of the image. + range: string + required: false + performed_imaging_study_reconstructionFieldOfViewHeight: + description: The vertical dimension of the rectangular region from which data + is used in creating the reconstruction of the image. + range: string + required: false + performed_imaging_study_reconstructionFieldOfViewWidth: + description: The horizontal dimension of the rectangular region from which data + is used in creating the reconstruction of the image. + range: string + required: false + performed_imaging_study_reconstructionInterval: + description: The cross plane distance between the centers of adjacent, parallel + reconstructed images. + range: string + required: false + performed_imaging_study_respiratoryMotionTechniqueCode: + description: The means to be used to coordinate the collection or reconstruction + of data with breathing. + range: performed_imaging_study_respiratoryMotionTechniqueCode_enum + required: false + performed_imaging_study_sliceThickness: + description: The cross plane dimension of the reconstructed image. + range: string + required: false + performed_imaging_study_summary: + description: A brief statement about the characteristics of this element, which + is intended for use by the radiologist, technologist and/or physicist during + management of the imaging protocol to understand the characteristics of the + element in the protocol. + range: string + required: false + performed_imaging_study_typeCode: + description: A coded value specifying the kind of algorithm used when reconstructing + the image from the data acquired during the acquisition process. + range: string + required: false + phs_accession: + description: PHS accession number (a.k.a dbGaP accession) + pattern: ^phs[0-9]+([.]v[0-9]+)*$ + range: string + required: false + physical_size_x: + description: Physical size (X-dimension) of a pixel. Floating point value > 0. + Size needs to be specified in microns (um) + range: string + required: false + physical_size_y: + description: Physical size (Y-dimension) of a pixel. Floating point value > 0. + Size needs to be specified in microns (um) + range: string + required: false + physical_size_z: + description: Physical size (Z-dimension) of a pixel. Floating point value > 0. + Size needs to be specified in microns (um) + range: string + required: false + platform: + description: Instrument platform or manufacturer + range: platform_enum + required: false + primary_diagnosis: + description: Primary disease diagnosed for this diagnosis and subject + range: primary_diagnosis_enum + required: false + primary_investigator_email: + description: Email of principal investigator + range: string + required: false + primary_investigator_name: + description: Name of principal investigator + range: string + required: false + primary_site: + description: Anatomical site of disease in primary diagnosis for this diagnosis + range: primary_site_enum + required: false + program_acronym: + description: The name of the program under which related studies will be grouped, + expressed in the form of the acronym by which it will identified within the + UI.
This property is used as the key via which study records can be associated + with the appropriate program during data loading, and to identify the correct + records during data updates. + range: string + required: false + program_external_url: + description: The external url to which users should be directed in order to learn + more about the program. + range: string + required: false + program_full_description: + description: A more detailed, multiple sentence description of the program. + range: string + required: false + program_name: + description: The name of the program under which related studies will be grouped, + in full text and unabbreviated form, exactly as it will be displayed within + the UI. + range: string + required: false + program_short_description: + description: An abbreviated, single sentence description of the program. + range: string + required: false + program_short_name: + description: An acronym or abbreviated form of the title of a broad framework + of goals under which related projects or other research activities are grouped. + Example - CPTAC + range: String + required: false + program_sort_order: + description: An arbitrarily-assigned value used to dictate the order in which + programs are displayed within the application's UI. + range: integer + required: false + progression_or_recurrence: + description: Yes/No/Unknown indicator to identify whether a patient has had a + new tumor event after initial treatment. + range: progression_or_recurrence_enum + required: false + pyramid: + description: The data file contains an image pyramid + range: string + required: false + race: + description: OMB Race designator + range: race_enum + required: false + reference_genome_assembly: + description: Accession or name of genome reference or assembly used for alignment + range: reference_genome_assembly_enum + required: false + reporter_label: + description: The text term used to describe the labeled methyl group used as a + molecular tag. + range: string + required: false + response: + description: Text term that describes the patient's final outcome after the treatment + was administered. + range: string + required: false + role_or_affiliation: + description: The text that describes the distinguishable characteristics of the + action or activity assigned to or required or expected of a person in a formal + association with a group or organization. + range: string + required: false + rrid_identifier: + description: Research Resource Identifier + range: string + required: false + sample_age_at_collection: + description: Number of days to collection, relative to index date + range: integer + required: false + sample_anatomic_site: + description: Anatomic site from which sample was collected + range: sample_anatomic_site_enum + required: false + sample_description: + description: Text description of a sample or specimen. + range: string + required: false + sample_id: + description: Sample identifier as submitted by requestor + range: string + required: false + sample_tumor_status: + description: Tumor or normal status + range: sample_tumor_status_enum + required: false + sample_type: + description: Tissue type of this sample + range: sample_type_enum + required: false + sample_type_category: + description: The kind of material that forms the sample. + range: string + required: false + sequence_alignment_software: + description: Name of software program used to align nucleotide sequence data + range: string + required: false + sex: + description: A textual description of a person's sex at birth. + range: sex_enum + required: false + short_description: + description: 'Short description that will identify the dataset on public pages + A clear and concise formula for the title would be like: {methodology} of {organism}: + {sample info}' + range: string + required: false + site_of_resection_or_biopsy: + description: The organ or part of the body resected or biopsied, as described + by the topography codes of the International Classification of Diseases for + Oncology, 3rd Edition (ICD-O-3). + range: site_of_resection_or_biopsy_enum + required: false + size_c: + description: Number of channels. Integer >= 1 + range: string + required: false + size_of_data_being_uploaded: + description: Size of the data being uploaded to CDS + range: string + required: false + size_t: + description: Number of time points. Integer >= 1 + range: string + required: false + size_x: + description: 'Size of image: X dimension (in pixels). Integer >= 1' + range: string + required: false + size_y: + description: 'Size of image: Y dimension (in pixels). Integer >= 1' + range: string + required: false + size_z: + description: 'Size of image: Z dimension (in pixels). Integer >= 1' + range: string + required: false + species: + description: Use the NCBI Taxonomy ID to identify species. A label provided by + NCBI Taxonomy Database (https://www.ncbi.nlm.nih.gov/taxonomy/), which uniquely + identifies group or category, at any level, in a system for classifying plants + or animals (including humans) providing ranked categories for the classification + of organisms according to their suspected evolutionary relationships. + range: string + required: false + specimen_id: + description: Identifier for specimen (parent of sample) as provided by requestor + range: string + required: false + staining_method: + description: Any of the various methods that use a dye, reagent, or other material + for producing coloration in tissues or microorganisms for microscopic examination. + range: staining_method_enum + required: false + study_access: + description: Study access + range: study_access_enum + required: false + study_acronym: + description: Short acronym or other study desginator + range: string + required: false + study_data_types: + description: Types of scientific data in the study + range: study_data_types_enum + required: false + study_description: + description: Human-readable study description + range: string + required: false + study_diagnosis_id: + description: The property study_diagnosis_id is a compound property, combining + the property diagnosis_id and the parent property participant.study_participant_id. + It is the ID property for the node diagnosis. + range: string + required: false + study_external_url: + description: Website or other url relevant to study + range: url + required: false + study_link_id: + description: The study_link_id is ID property for the node image. It should consist + of a string and a number. + range: string + required: false + study_name: + description: Official name of study + range: string + required: false + study_participant_id: + description: The property study_participant_id is a compound property, combining + the property participant_id and the parent property study.phs_accession. It + is the ID property for the node participant. The reason why we are doing that + is because is some cases, there are same participant id in different studies + repersent different participants. + range: string + required: false + study_version: + description: The version of the phs accession + range: string + required: false + sub_cycle_number: + description: 'sub-cycle #' + range: string + required: false + submission_version: + description: The version of the metadata file submitted to CDS + range: string + required: false + suffix: + description: Text term to represent an individual's position in a family lineage + or pedigree. + range: string + required: false + target_name: + description: short descriptive name (abbreviation) for this target (antigen) + range: string + required: false + therapeutic_agents: + description: Text identification of the individual agent(s) used as part of a + treatment regimen. + range: therapeutic_agents_enum + required: false + tissue_fixative: + description: A compound that preserves tissues and cells for microscopic study. + range: tissue_fixative_enum + required: false + tissue_or_organ_of_origin: + description: The text term used to describe the anatomic site of origin, of the + patient's malignant disease, as described by the World Health Organization's + (WHO) International Classification of Diseases for Oncology (ICD-O). + range: tissue_or_organ_of_origin_enum + required: false + title: + description: The abbreviation that represents an affix occurring at or before + the beginning of an individual's name. + range: String + required: false + treatment_id: + description: Internal identifier + range: string + required: false + treatment_outcome: + description: Text term that describes the patient's final outcome after the treatment + was administered + range: treatment_outcome_enum + required: false + treatment_type: + description: Text term that describes the kind of treatment administered + range: treatment_type_enum + required: false + tumor_grade: + description: Numeric value to express the degree of abnormality of cancer cells, + a measure of differentiation and aggressiveness. + range: tumor_grade_enum + required: false + tumor_stage_clinical_m: + description: Extent of the distant metastasis for the cancer based on evidence + obtained from clinical assessment parameters determined prior to treatment. + range: tumor_stage_clinical_m_enum + required: false + tumor_stage_clinical_n: + description: Extent of the regional lymph node involvement for the cancer based + on evidence obtained from clinical assessment parameters determined prior to + treatment. + range: tumor_stage_clinical_n_enum + required: false + tumor_stage_clinical_t: + description: Extent of the primary cancer based on evidence obtained from clinical + assessment parameters determined prior to treatment. + range: tumor_stage_clinical_t_enum + required: false + tumor_tissue_type: + description: Text that describes the kind of disease present in the tumor specimen + as related to a specific timepoint (add rows to select multiple values along + with timepoints) + range: string + required: false + vital_status: + description: Vital status as of last known follow up + range: vital_status_enum + required: false + working_distance: + description: The working distance of the lens, expressed as a floating point number. + Floating point > 0. Size needs to be specified in microns (um) + range: string + required: false